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ABSTRACT 
Campylobacter jejuni is a gram-negative thermotolerant microaerobic 
pathogen that causes human gastroenteritis worldwide. The production of 
extracellular polymeric substances to create a biofilm is a mechanism by which 
C. jejuni can protect itself from unfavourable environments, and is a 
contributory factor to the survival and transmission of the organism to farms 
animals and into the human food chain. Bacteriophages are natural predators of 
bacteria that have the potential for use as targeted biocontrol agents with the 
advantage that they can penetrate and affect bacteria embedded in biofilms. 
The effects of virulent Campylobacter-specific bacteriophages CP8 and CP30 
on C. jejuni biofilms formed on glass by strains NCTC 11168, PT14 and HPC5 
at 37 °C under microaerobic conditions were investigated. Independent 
bacteriophage treatment led to 1 to 3 Log10 CFU/cm2 reductions in the viable 
count 24 h postinfection compared with control levels. In contrast, 
bacteriophage applied under these conditions effected a reduction of less than 1 
Log10 CFU/ml in planktonic cells. Resistance to bacteriophage in bacteria 
surviving bacteriphage treatment of C. jejuni NCTC 11168 biofilms was 
>80%, whereas bacteriophage resistance was not found in similarly recovered 
C. jejuni PT14 cells. Concomitant dispersal of the biofilm matrix by 
bacteriophage was demonstrated by crystal violet staining and transmission 
electron microscopy (TEM). 
The resistant survivors of bacteriophage treatment of biofilms formed by HPC5 
and PT14 remained closely associated with the phage but not NCTC 11168. 
Analysis of the DNA contents of these isolates by PFGE and Southern transfer 
confirmed the presence of phage genomic DNA (approximately 140 kb) 
leading to the conclusion that these strains represent examples of the carrier 
state life cycle (CSLC) reported for other bacterial species. TEMs of CSLC 
cultures demonstrated the association of bacteriophage particles with 
Campylobacter cells that were devoid of flagella. Physiological studies of the 
CSLC strains showed the bacteria were non-motile but able to grow at a similar 
rate to parental cultures until reaching the phage proliferation threshold (7 
Log10 CFU/ml) when growth rate declined and the phage titre increased. Of 
further note the CSLC strains had a greater capacity to survive atmospheric 
oxygen under nutrient limited conditions. CSLC phages exhibited differences 
in host binding, efficiency of plating and host range.  Transcriptome analyses 
of CSLC strains harvested from microaerobic cultures at early exponential 
phase prior to phage proliferation were performed using DNA microarrays to 
demonstrate changes in host gene expression as compared with parental 
cultures.  Notably genes involved in metabolism and the modification of 
macromolecules were up-regulated and specific flagella biosynthesis functions 
down-regulated in the CSLC strains.  
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CHAPTER 1 
GENERAL INTRODUCTION 
1.1 Campylobacter 
1.1.1 Characteristics of Campylobacter  
Campylobacter spp. are Gram-negative, microaerophilic bacteria that are 
members of the family Campylobacteraceae. The genus of Campylobacter is 
composed of 17 species (Korczak et al., 2006). There are several 
morphological forms of Campylobacter spp. including rod-shaped forms, spiral 
S-shaped,and curved cells in fresh cultures but in old cultures a coccoid form 
becomes the predominant, which is associated with a loss in viability (Moran 
and Upton, 1987; Penner, 1988). The cell dimensions of Campylobacter spp. 
are in the range of 0.2 to 0.8 Pm wide and 0.5 to 5 Pm long (Vandamme, 
2000).  Motility is a distinctive phenotypic characteristic, which is observed to 
be a corkscrew-like motion of the spiral rods using a polar unsheathed 
flagellum at one or both ends of the cells (Vandamme, 2000). Their guanine-
cytosine (G+C) content is low at approximately 28-30 mol% (Penner, 1988). 
The organisms grow under microaerobic conditions, in which the atmosphere 
contains 3-5% oxygen and 2-10% carbon dioxide for optimal growth 
(Vandamme, 2000) and within a narrow temperature range of 30 to 47 °C 
(Skirrow and Benjamin, 1979).  However, some species and strains have been 
documented to grow under aerobic or anaerobic conditions (Vandamme, 2000).  
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Campylobacter exhibit typical biochemical characteristics as regards the 
reduction of fumarate to succinate; negative methyl red reaction and acetoin 
and indole production. The additional biochemical characteristics of most 
species are: reduction of nitrate, absence of hippurate hydrolysis, and the 
presence of oxidase activity (Vandamme, 2000). The major respiratory 
substrates are menaquinones with a chemoorganotrophic type of metabolism 
(Vandamme, 2000). The main source of energy is derived from amino acids 
and keto acids such as glutamine, asparagine, glutathione or tricarboxylic acid 
cycle intermediates, not from carbohydrates due to the lack of 
phosphofrutokinase essential for glycolysis (Dasti et al., 2010). The pathways 
characteristic of anaerobic metabolism have been suggested as an alternative 
respiratory method by which C. jejuni can use fumarate, nitrate, nitrite, 
trimethylamine-N-oxide (TMAO), and dimethyl sulfoxide (DMSO) instead of 
oxygen as a terminal acceptor (Sellars et al., 2002; Weingarten et al., 2008).  
Campylobacter have an extended glycome in the form of cell surface 
lipooligosaccharide (LOS), capsular polysaccharide (CPS), glycolipids and 
glycoproteins (Karlyshev et al., 2005). The presence of glycoprotein in a 
bacterial species is unusual, where campylobacters notably exhibit both O- and 
N-linked protein glycosylation with the former being restricted to the flagellins 
that polymerise to form a major component of the flagellum (Linton et al., 
2001).   
 
The Campylobacter species are fragile in that they are unable to grow in the 
presence of oxygen outside the animal host, and are generally sensitive to 
environmental stresses such as drying, exposure to disinfectants and acidic 
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conditions (challenged at pH 4.5) (Murphy et al., 2006). However, 
Campylobacter spp. have developed survival mechanisms to overcome these 
stresses. The mechanisms of adaptation to environmental stresses are believed 
to include: a viable but non-culturable (VBNC) state, genome plasticity, 
quorum sensing, the formation of biofilms and stationary phase survival 
mechanisms (Murphy et al., 2006). The VBNC state of Campylobacter spp. is 
controversial being associated with starved or aged cultures likely under 
oxidative stress. These result in a decline in viability with the associated 
morphological change from spiral to coccoid forms but that these cells can be 
recovered through the colonisation of chickens, which represent favourable 
conditions. The recovery in chickens notwithstanding, there are significant 
differences in the aerotolerance between strains and the culture conditions 
under which they can recovered, placing the concept of a VBNC state as a 
XQLIRUP PHFKDQLVP RI VXUYLYDO LQ GLVSXWH .ODQþQLN et al., 2009; Jackson et 
al., 2009; Federighi et al., 1998). C. jejuni unlike other foodborne pathogens, 
lacks the key regulators SoxRS and OxyR responsible for the coordinated 
defence against oxidative stress in E. coli and S. Typhimurium. However, it has 
been proposed that alternative regulators, termed Fur and PerR mediate at least 
part of the response to oxidative stress in Campylobacter by repressing the key 
enzymes alkyl hydroperoxide reductase (AhpC) and catalase (KatA) (Baillon et 
al., 1999; van Vliet et al., 2001). Campylobacters also encode other antioxidant 
enzymes, such as thiolperoxidase (Tpx) and bacterioferritin co-migratory 
protein (Bcp) that act together to protect against oxidative stress (Atack et al., 
2008). According to Duong and Konkel (2009), campylobacters have seven 
hyper-variable plasticity regions (PR) identified as PR1-PR7 based on 
                                                                            Chapter 1 General introduction 
4 
 
comparative genome hybridization (CGH) analysis. The PR1 region includes 
genes that encode the utilisation of alternative electron acceptors during 
respiration that contribute to overcome in restricted oxygen environments. 
Regions of PR2, PR3, and PR7 contain genes that encode outer membrane and 
periplasmic proteins, which may contribute to phenotypic variation and 
adaptation to different ecological niches. The genes encoded in the PR4, PR5 
and PR6 regions have functions that are involved in the biosynthesis and 
modification of flagella, LOS and capsular polysaccharide. The hyper-variable 
genome plasticity regions of Campylobacter spp. play a critical role in the 
survival of the organism in harsh environments including those that create 
oxidative stress.  Quorum sensing is a system of stimulus and response 
correlated to population densities of bacteria. In Campylobacter quorum 
sensing has been implicated in the synthesis, secretion and detection of 
extracellular signalling molecules known as autoinducers through the function 
of LuxS (Jeon et al., 2005; Plummer et al., 2011).  Autoinducer (AI2) of C. 
jejuni has been reported in several food environments such as milk, fruit juice 
and chicken (Cloak et al., 2002). However, that AI2 functions as a quorum 
sensing molecule in C. jejuni at all, has been disputed (Holmes et al., 2009). 
The formation of biofilms, which may protect campylobacters in extreme 
conditions by enclosing them in an extracellular polymeric substance is another 
significant defence mechanism that will be discussed later in this chapter. 
Thus, these various mechanisms may allow cells to survive in the host 
intestinal tract, on food, and in the environment.  
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Factors that may contribute to infection in humans and animals include: genetic 
variation of the C. jejuni genome involving intragenomic mechanisms leading 
to the presence of hypervariable sequences in particular in genes involved in 
the biosynthesis or modification of surface structures such as capsular 
polysaccharide (CPS), lipooligosaccharide (LOS) and flagellum (reviewed by 
Young et al., 2007). Natural transformation has an important role in genome 
plasticity and in the spread of new factors such as antibiotic resistance, due to 
the fact that C. jejuni is naturally competent (Wilson et al., 2003). The 
pathogenesis of C. jejuni is comprised of four main stages: adhesion to 
intestinal cells, colonization of the digestive tract, invasion of targeted cells, 
and toxin production (Konkel et al., 2001). C. jejuni is a unique pathogen that 
can execute glycosylation of several proteins related to colonization, adherence 
and invasion such as flagellum, CPS, LOS and Campylobacter-invasive agents 
(Cia) (Dasti et al., 2010). The presence of LOS can contribute to post-infection 
disorders because it may mimic human neuronal gangliosides leading to 
autoimmune disorders (Gilbert et al., 2002; Naito et al., 2010). The CPS and 
flagella motility of C. jejuni plays a crucial role in serum resistance, the 
adherence and invasion of epithelial cells, and colonization (Jones et al., 2004; 
Karlyshev et al., 2002). Cytolethal distending toxin (CDT) produced by C. 
jejuni that encode by cdtABC and has been ascribed a role in pathogenesis by 
contribution to secretion of interleukin (IL)-8 in INT407 intestinal cell line 
(AbuOun et al., 2005). In conclusion many factors lead to the ultimate 
pathogenicity of C. jejuni and its transmission from food to human infection.   
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1.1.2 Impact on food safety and health 
Campylobacters are prevalent bacterial food borne pathogens in human and 
animals that are ubiquitous in the environment. Campylobacter spp. are a cause 
of bacterial gastroenteritis and food borne disease worldwide, especially in 
developed countries. The illness is generally self-limiting and ranges from mild 
to severe disease leading to one or more symptoms which include 
inflammation, abdominal pain, fever and bloody diarrhoea (Konkel et al., 
2001; Butzler, 2004).  In severe cases, patients are treated with erythromycin 
(Konkel et al., 2001). Other diseases that have been associated with 
Campylobacter infection are the autoimmuneneuropathies Guillain-Barré 
syndrome (GBS) leading to acute neuromuscular paralysis and the ocular 
version Miller-Fisher syndrome (Stern, 2001). Campylobacter associated cases 
of these diseases are thought to involve molecular mimicry of human 
gangliosides by C. jejuni lipooligosaccharide, where sero-conversion results in 
the production of antibodies in patients recovering from Campylobacter 
infection that cross-react with nerve cell gangliosides GM1, GM1b and GD1a  
(Corcoran and Moran, 2007). Campylobacteriosis accounted for 198,252 
human cases reported in 2009 in the EU 
(http://www.efsa.europa.eu/en/press/news/zoonoses110322.htm). The cases of 
Campylobacter infection reported include a 10% increase in England and 
Wales in 2010 compared to those recorded in 2009 
(http://www.hpa.org.uk/hpr/archives/2010/news4810.htm#campy). In the 
United States, C. jejuni is reported as a major cause of bacterial diarrhoeal 
illness with more cases than a combination of Shigella spp. and Salmonella 
spp. together (Anonymous, FDA, 2008). The WHO also reported that 
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Campylobacter species are a major cause of gastroenteritis throughout the 
world, where the reported number of cases surpassed the incidence of 
Salmonella (Anonymous, WHO, 2008). More than 90% of human 
campylobacter infection is reported to be caused by C. jejuni and C. coli 
(Moore et al., 2001; Dasti et al., 2010). 
 
In England and Wales, cases of Campylobacter enteritis have been reported to 
be caused by transmission from food such as poultry, private water supplies or 
due to the consumption of raw or inadequately pasteurized milk (Pebody et al., 
1997; Esteban et al., 2008). The sources of Campylobacter spp. that 
contaminate food are usually from animals such as chicken and other poultry, 
swine, cattle and other domestic animals (Newell and Fearnley, 2003; Guan 
and Holley, 2003). Similarly, campylobacter contamination of meat, poultry 
and milk has been observed in Pakistan, Belgium, Poland and other countries 
around the world (Hussain et al., 2007; Ghafir et al.  0DüNLZ et al., 
2008). Moreover, Campylobacter species have been isolated from untreated 
water sources such as lake water, drinking water supplies and water from dairy 
farms, resulting in waterborne campylobacteriosis (Korhonen and Martikainen, 
1991; Jones and Roworth, 1996; Moore et al., 2001; and Kemp et al., 2005). 
The survival of C. jejuni in natural mineral water has also been observed 
(Tatchou-Nyamsi-König et al., 2007).  Consequently, campylobacter is of real 
public concern in terms of human health and food safety.  
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1.2 Bacterial Biofilm Formation 
1.2.1 Development of biofilm formation 
Biofilms are naturally composed of multicultural species or monocultures 
attached to a surface and embedded in an extracellular polymeric matrix that 
include polysaccharides, protein, nucleic acid and lipids (Flemming and 
Wingender, 2010). This is produced to protect the microorganisms from 
environmental stresses such as desiccation, oxygen toxicity, starvation, and 
DQWLPLFURELDODJHQWV 2¶7RROHet al., 2000; Kalmokoff et al., 2006; Joshua et 
al., 2006). Biofilms create microenvironments for a consortium of bacteria 
including variations in pH, nutrient concentrations and oxygen levels (Else et 
al., 2003). There are four stages of biofilm development that have been 
envisaged as follows: (i) Initial attachment to surface; (ii) Microbial 
development or growth to form microcolonies; (iii) Maturation of biofilms; and 
LY'HWDFKPHQWDVVKRZQRQILJXUH2¶7RROHet al., 2000). 
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Figure 1.1-Model of biofilm development. Individual planktonic cells can form 
cell-to-surface and cell-to-cell contacts resulting in the formation of 
microcolonies. Cells in the biofilm can return to a planktonic lifestyle to 
complete the cycle of biofilm development. 
SourFH2¶7RROHet al. (2000) 
 
In the initial stages of biofilm formation, the planktonic cells or free cells 
floating in liquid medium begin to attach to the surface. The Derjaguin and 
Landau, Verwey and Overbeek (DLVO) theory explains that the forces 
between charged surfaces interacting through a liquid medium are the
combined effects of Van der Waals attraction and electrostatic repulsion forces, 
and has been used extensively to calculate the conditions for biofilm formation 
and microbe retention within biofilms (Russel et al., 1989; Hermansson, 1999). 
A charged surface will attract counter-ions from solution and repel co-ions to 
form an electrical double layer, and the interaction of these layers represented 
on the substrate and the approaching bacteria give rise to two energy minima. 
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Association of bacteria at the first minima are thought to be loosely attached or 
reversibly bound, whereas those that progress to overcome the repulsive forces 
to achieve the second minima are bound irreversibly. The magnitudes of these 
forces are dependent on the ionic strength of the solution.  However, the 
attachment process of microorganisms to surfaces depends both on bacterial 
motility and the physiochemical properties of the bacterial cell (Kumar and 
Anand, 1998). Adhesion develops firstly between the bacterial cells and the 
substratum, which can take place in two stages: a reversible adhesion to the 
surface and subsequently an irreversible adhesion process (Kumar and Anand, 
1998). The interaction forces involved in the reversible process between the 
bacterial cells and a surface include van der Waals interactions, electrostatic 
forces and hydrophobic interactions (Palmer et al., 2007). Meanwhile, the 
irreversible attachment of cells is a crucial stage in biofilm development. The 
synthesis of components for biofilm formation can proceed after the cells have 
attached to a surface.  Bacterial cells may produce surface appendages such as 
flagella, fimbriae, pili and extracellular polysaccharide fibrils to support their 
contact with the surface (Jones and Isaaoson, 1983). The forces that are related 
with this mechanism are dipole-dipole interactions, hydrogen bonding, ionic, 
covalent bonding and hydrophobic interactions (Kumar and Anand, 1998).  
 
The control of bacterial motility is a key to the formation of biofilms. The 
control of motility and therefore the commitment to biofilm formation has been 
linked to intracellular cyclic-di GMP levels in bacteria (Kuchma et al., 2007). 
Intracellular cyclic-di GMP levels are increased through expression of 
diguanylate cyclases (DGCs) or conversely degraded by c-di-GMP 
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phosphodiesterases (PDEs). DGC activity is provided by GGDEF domains and 
PDE activity is provided by either EAL or HD-GYP domains, where the 
domain names relate to the amino acid motifs they contain and contribute to 
their respective enzymatic activities. Environmental and cellular signals control 
the expression and, through amino-terminal sensory domains, activities of 
DGCs and PDEs (Hengge, 2009). For example, Pseudomonas aeruginosa, 
BifA protein has PDE activity which plays a role in polysaccharide production 
required for biofilm formation (Kuchma et al., 2007). Alternatively Bassis and 
Visick (2010) reported that in Vibrio fischeri had a gene, binA that encodes c-
diGMP phosphodiesterase. The deletion of binA results in an increase in 
biofilm formation.   
 
Cell to cell communication and/or signalling may play an important role in 
biofilm formation and development, in particular regulation of the attachment 
and detachment steps. Quorum sensing is a mechanism of cell-cell signalling 
that has been reported to be involved in biofilm development.  Quorum sensing 
is based on the process of autoinduction for self-organisation and regulation of 
microbial cells (Parsek and Greenberg, 2005). This mechanism is mediated by 
small molecules, hormone-like diffusible molecules called autoinducers (AIs) 
from Gram negative bacteria, which have been characterised as homoserine-
lactones (AHL) in some species (Lazar, 2011). However in Gram positive 
bacteria peptidic molecules (AIP) have been identified as the signalling 
compounds responsible for intra-specific communication (Lazar, 2011). 
Boronated diester molecules (AI-2) are involved in inter-specific 
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communication among both Gram-positive and Gram-negative bacteria 
(Simoes et al., 2010).  
 
1.2.2 The impact of biofilms on the food chain  
The ability of microorganisms to attach and grow on food and food-contacted 
surfaces under favourable conditions is a significant factor in food safety 
(Kumar and Anand, 1998). Moreover, the attachment and growth of microbial 
cells to natural surfaces not only plays an important role in the survival of 
pathogenic bacteria within biofilms but it also increases the resistance of the 
cells within the biofilm to antimicrobial agents and sanitizers (Costerton et al., 
1999). Possible mechanisms of biofilm resistance to antimicrobial agents 
include (i) the failure of the antimicrobial agents to penetrate the biofilms in 
which the extracellular matrix acts as a barrier, (ii) slow growth rate and stress 
response: bacterial cells grow slowly under starvation conditions encountered 
within mature biofilms leading to physiological changes that can lead to the 
emergence of spatially separated sub-populations that can survive in the 
stationary state under nutrition limitation, and can  survive the application of 
antimicrobial agents due to reduced susceptibility of minimal or non-growing 
cells in, (iii) environmental heterogeneity within biofilm: bacterial cells within 
biofilms may grow at different rates as a result of different rates of protein 
synthesis and/or respiratory activity, which in turn will lead to varied responses  
to antimicrobial agents that effect these metabolic processes, (iv) the induction 
of an insensitive biofilm phenotype:  sub-populations of bacteria can  be 
selected that are altered in their expression of multidrug efflux pumps, 
membrane protein composition  or antimicrobial resistance genes that can 
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independently or collectively act to block the antimicrobial agent passage into 
WKHEDFWHULDOFHOOV0DKDQG2¶7RROH 
 
Arnold and Silvers (2000) reported the attachment and biofilm formation by 
mixed populations of bacteria from rinsed broiler carcasses on several types of 
surface during poultry processing. Reeser et al. (2007) reported the formation 
of biofilms by Campylobacter jejuni on a variety of abiotic surfaces commonly 
used in the provision of water for poultry flocks, including acrylonitrile 
butadiene styrene and polyvinyl chloride plastics. These biofilms may well 
harbour Campylobacter in the poultry processing environment and constitute a 
reservoir of contamination. However, Dykes et al. (2003) compared the 
survival and cellular protein expression patterns of planktonic and biofilm 
Campylobacter jejuni cultures formed on glass beads using a growth medium 
of heart infusion broth with 1% yeast extract. The biofilm associated bacteria 
were reported to decline in viable count upon storage in phosphate buffered 
saline faster that the planktonic cells over a 14 day period. Resolution of the 
cellular protein by 2D gel electrophoresis showed differences between 
planktonic and biofilm cells with seven unique and 12 up-regulated protein 
spots based on normalised pixel densities. The reduced survival ability of the 
biofilm bacteria coupled with the tentative identification of stress related 
proteins amongst those upregulated upon the 2D-gels, led Dykes et al. to 
conclude that biofilm associated campylobacters may be more sensitive 
inimical stresses encountered in food production.     
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1.3 Campylobacter biofilms 
1.3.1 Biofilm formation by Campylobacter 
Campylobacter strains that were able to form biofilms, or associate with 
biofilms formed by other organisms, have been reported by several authors. 
Buswell et al. (1998) reported that the survival and persistence of 
Campylobacter spp. was extended when attached on water conduits and in 
aquatic biofilms. Tang (2000) demonstrated that C. jejuni containing biofilms 
were formed when grown on surfaces pre-colonized with Pseudomonas putida. 
According to Trachoo et al. (2002) C. jejuni was attached on biofilms formed 
by Gram-positive chicken house isolates including named P1, Y1, W1 and a 
Pseudomonas sp. on polyvinyl chloride (PVC) coupons.   Campylobacter cells 
were detected by immunofluorescence in biofilms present in the water lines of 
a commercial broiler house (Zimmer et al., 2003). Sanders et al. (2007) also 
reported that C. jejuni attached to other Gram-positive bacterial biofilms that 
were collected from the whole carcass rinses (WCR) that also included bacteria 
of the genera Enterobacter, Escherichia, Klebsiella, Pseudomonas, Bacillus, 
Enterococcus, and Micrococcus on stainless steel. Furthermore, Sanders et al. 
(2008) reported that C. jejuni 1221 green fluorescent protein (gfp) was able to 
attach on the gram-positive bacterial biofilms collected from WCR and 
subsequently establishment biofilms on stainless steel under nutrition limitation 
and at various temperatures (13, 20, 37 and 42 ºC). Hanning et al. (2008) 
reported that C. jejuni was able to attach on the mixed bacterial poultry 
biofilms of Pseudomonas sp., Staphylococcus sp., E. coli, Bacillus sp. and 
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Flavobacterium sp. as a secondary colonizer. Later Teh et al. (2010) reported 
that C. jejuni strains found in New Zealand could form biofilms but were 
associated with mixed-population biofilms of Enterococcus faecalis and 
Staphylococcus simulans.   
 
The ability of Campylobacter spp. to form monospecies biofilms has been 
demonstrated. Dykes et al. (1993) reported that a C. jejuni strain was able to 
attach to glass beads during incubation at 37 °C for 48 h under microaerobic 
conditions to form biofilms. Joshua et al. (2006) showed that axenic C. jejuni 
could attach and form biofilms on glass surfaces and recognised three types of 
forming structures that included: the attached structures on the glass surface, 
unattached aggregates (flocs) and a pellicle structure at the liquid-gas interface. 
Fratamico et al. (2007) reported that 14 Campylobacter strains were able to 
form biofilms on glass, stainless steel and polystyrene plastic, for example, C. 
jejuni strain 81-176 produced a visible biofilm on multiple surfaces. This strain 
was also reported to produce a heterogeneous biofilm containing similar 
quantities of spiral and coccoid forms (Gunther IV and Chen, 2009). Duffy and 
Dykes (2009) reported that the viability of C. jejuni cultures on a stainless steel 
surface were reduced to zero during storage in distilled water at 4 ºC over 20 
days.  However, the authors noted that 3.5 Log10 cells/cm2 remained attached 
throughout the period based on observations using confocal scanning laser 
microscopy. The application of discriminative live/dead strains suggested the 
biofilm were viable but that these cells were not culturable (VBNC). Similarly 
Ica et al. (2012) investigated the survival of C. jejuni in mono- and mixed-
culture active biofilms using confocal scanning laser microscopy in 
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conjunction with live/dead stains. These authors found that cells from 
monoculture biofilms were alive according to live/dead staining but that these 
cells were not culturable. In contrast, in mixed-culture biofilms, C. jejuni 
remained culturable. The variation in the abilities of laboratories to culture 
stressed campylobacters notwithstanding these findings highlight that biofilms 
are a mechanism for persistence of C. jejuni within harsh environments.  
 
1.3.2 The molecular mechanisms of Campylobacter biofilm formation  
Genetic and molecular approaches have been used to study Campylobacter 
biofilms since the complete genome sequence of C. jejuni NCTC 11168 was 
documented by Parkhill et al. (2000). There are many reports investigating the 
genes involved in biofilm formation. The genes that control motility may be 
responsible for changing the planktonic mode of growth to the sessile mode of 
growth. Naoaki (2002) reported that an aflagellate (fla-) mutant constructed 
from C. jejuni strain 81-176 could not form biofilms. Komokoff et al. (2006) 
reported that the flagellar motility complex including flagellins (FlaA, FlaB), 
the filament cap (FliD), the basal body (FlgG, FlgG2) and chemotactic protein 
(CheA) play a crucial role in attachment of C. jejuni 11168 to solid surfaces 
during biofilm formation.  Moreover, the aflagellate mutant maf5 in C. jejuni 
did not form a pellicle or attach to a glass surface (Joshua et al., 2006).  
According to Reeser et al. (2007) C. jejuni flaAB mutants were significantly 
decreased in their capability to form biofilms compared with the wild type 
strain. Thus, the motility may have a critical role in an initial attachment of C. 
jejuni to a surface.  
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The outer membrane of Campylobacter contains lipo-oligosaccharide (LOS), 
capsular polysaccharide (CPS) and N-linked polysaccharides participating in 
stress survival, transmission and virulence in C. jejuni (McLennan et al., 2008).  
It is notable that cell surface structures may play a role in biofilm formation.  
Extracellular polysaccharides are component of biofilms that formed to protect 
microbial cells from environmental stress (Sutherland, 2001). In C. jejuni, 
capsular polysaccharides were encoded by the kps operon (Karlyshev et al., 
2005). However, kpsM mutants deficient in capsular polysaccharide 
production, were able to attach to the surfaces (Naoaki, 2002). Similarly, 
Joshua et al. (2006) also reported that mutation of kpsM in C. jejuni did not 
affect biofilm formation. However, Naoaki (2002) also reported that the kpsM 
mutant had a shorter survival period than wild type. Thus, capsular 
polysaccharide may play a necessary role in protecting from environmental 
stresses.  Strains carrying mutations of pglH and neuB1 that encode a 
glycosyltransferase for N-linked protein glycosylation biosynthesis and a sialic 
acid synthase for lipo-oligosaccharide biosynthesis respectively were able to 
form unattached aggregates or flocs (Joshua et al., 2006). In C. jejuni, O-linked 
flagellin glycosylation was encoded by five genes including Cj1321 to Cj1326, 
of which Cj1325 and Cj1326 are a single gene (Howard et al., 2009). A C. 
jejuni 11168H strain carrying a deletion in Cj1324, resulting in the absence of 
two legionaminic glycan modifications that alter the surface charge of flagella, 
was less capable of biofilm formation than the wild type (Howard et al., 2009). 
Based on a hyper-reactive phenotype to the UV fluorescent dye calcofluor 
white (CFW) that binds polysaccharides. Naito et al. (2010) identified two 
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mutations in C. jejuni 81-176 that increased biofilm formation. Surprising to 
the authors the mutations were located in waaF and lgtF that encode S-
heptosyltransferase and a two-domain glycosyltransferase respectively, which 
would result in the complete loss of the LOS outer core region. However, the 
same group had previously reported that a kpsM knock-out mutant defective in 
capsular polysaccharide export was also CFW hyper-reactive and hyper-
biofilm forming (McLennan et al., 2008). It is evident that the cell envelope of 
C. jejuni is highly dynamic, in which multiple compensatory changes can 
enhance or cause steric or charge clashes of carbohydrate moieties to hinder 
biofilm formation and other phases of the bacterial life cycle. Asakura et al. 
(2007) reported that deletion of the peb4 gene encoding major antigenic 
peptide in C. jejuni NCTC 11168 lead to an alteration in the membrane protein 
content that caused a reduction in biofilm formation compared to wild type. 
Previously, C. jejuni within biofilms had been shown to express greater 
quantities of the peb4 product compared to planktonic cells, which was also 
implicated in the binding of mammalian cells (Kalmokoff et al., 2006). Nguyen 
et al. (2011) additionally reported that the abilities of C. jejuni and C. coli to 
form biofilms on abiotic surfaces were depended on the surface hydrophobicity 
and surface charge of campylobacters.  
 
Quorum sensing or cell-to-cell signalling is a cell-population density-
dependent signalling system by which bacteria can regulate gene expression 
(Miller and Bassler, 2001). The quorum sensing molecule responsible for cell-
to-cell signalling was first identified in Vibrio harveyi and V. fischeri (Nealson 
et al., 1970). There are two types of density-dependent signal systems that are 
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comprised of a sensor and a quorum sensing molecule (Cloak et al., 2002). 
Signalling system 1 is composed of sensor 1 and autoinducer-1 (AI-1) and is 
strongly species-specific, involving homoserine lactones (Cao and Meighen, 
1989). Signal system 2 is composed of sensor 2 and autoinducer-2 (AI-2) that 
is poorly species specific. Cloak et al. (2002) revealed that C. jejuni and C. coli 
could produce autoinducer-2 (AI-2).  The luxS gene is required for AI-2 
production in signalling system 2 (Cloak et al., 2002).  Moreover, quorum 
sensing has been reported to involve attachment, biofilm development and 
GHWDFKPHQWIURPELRILOPV2¶7RROHet al., 2000; Elvers and Park, 2002; Chang, 
2006). Jeon et al. (2003) also suggested that the motility and surface properties 
of C. jejuni was regulated by quorum sensing. According to Reeser et al. 
(2007), a C. jejuni luxS mutant, deficient in the production of AI-2 resulted in a 
reduction in the formation of biofilm when compared with wild type.   
 
McLennan et al. (2008) reported that a 'spoT mutant defective in the stringent 
response (SR) showed an increase in exopolysaccharide production with 
extended growth at 42 qC under anaerobic conditions. The reagent calcofluor 
white was used to demonstrate E1-3 and/or E1-4 linkages of polysaccharides, 
as components of the surface polysaccharide of C. jejuni. Based on the reaction 
with calcofluor white they suggested that the C. jejuni 'spoT mutant was the 
first SR mutant identified as up-regulating biofilms. In addition, the CsrA 
(Carbon starvation regulator) gene was responsible for regulation of stationary 
phase metabolism and virulence determinants including host cell invasion, 
quorum sensing, biofilm formation, iron acquisition, type III secretion systems 
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and outer membrane protein expression (Fields and Thompson, 2008). A 
Campylobacter jejuni CsrA mutant was able to form thin biofilms when 
compared with the wild type strain (Fields and Thompson, 2008). However, the 
reduction of biofilm formation by the C. jejuni CsrA mutant is consistent with 
the observation that there is a reduction in motility. The mutant of 'cprS 
(Campylobacter planktonic growth regulation) that encodes the CprS kinase 
sensor dramatically increased biofilm formation of C. jejuni (Svensson et al., 
2009). These findings suggested that several different genes are involved in the 
regulation of biofilm formation by C. jejuni, importantly those involved in the 
surface structure of membrane, flagella and possibly those related to quorum 
sensing. 
 
1.3.3 The effect of environmental factors on biofilm formation by 
Campylobacter   
Attachment and biofilm formation is one of the mechanisms by which 
microbial cells enhance survival and cope with environmental stresses. Factors 
affecting the attachment and biofilm formation of microbial cells to a surface 
have been studied. Firstly, microorganisms form biofilms when nutrients 
become limited (Poulsen, 1999). Reeser et al. (2007) demonstrated that biofilm 
formation by C. jejuni was inhibited by growth in nutrient rich media.  Sanders 
et al. (2008) also demonstrated that nutrient limitation affected C. jejuni 
attached to stainless steel and in biofilms. These data suggest that the starvation 
may trigger the formation of Campylobacter biofilms. However, Hunt et al. 
(2004) suggested that the onset of starvation could induce detachment from 
biofilms due to the accumulation of metabolic products and a lack of nutrients 
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for bacterial growth.  In addition, high osmolarity in the overlaying media 
containing high concentrations of sugar and salt has been shown to affect 
biofilm formation by C. jejuni, resulting in reduction of biofilms (Reeser et al., 
2007). Temperature has been shown not only to affect the growth of 
microorganisms, but also to effect the development of attachment and biofilm 
formation on surfaces. Dykes et al. (2003) demonstrated that the numbers of 
culturable cells of C. jejuni grown as biofilms during storage in phosphate 
buffer saline (PBS), at 4 and 10 qC, was constant throughout 3 days; whereas, 
the viability of cells in biofilms incubated at 25 and 37 qC was dramatically 
decreased. Sanders et al. (2008) studied the attachment of C. jejuni 1221 
marked with gfp to biofilms formed on the stainless steel by bacteria recovered 
from whole carcass rinses of processed broiler chickens. These authors found 
no  significant difference in the attachment of C. jejuni  at four temperatures 
examined (13, 20, 37 and 42 ºC); however, viable C. jejuni 1221 gfp were only 
recoverable at 13 and 20 ºC. Moen et al. (2005) reported that the amount of 
polysaccharide and oligosaccharide increased under non-growth survival 
conditions, in particular at 25 qC under anaerobic conditions resulting in the 
expression of a few genes that were stress related components of cell 
membranes. Reeser et al. (2007) suggested that temperature had a significant 
effect on biofilm formation when comparing incubation at 25 and 37 qC. It was 
shown that C. jejuni M129 was able to form a biofilm at 37 qC to a much 
greater extent than at 25 qC. Oxidative stress resistance of Campylobacter 
strains may involve the production of biofilms. Reeser et al. (2007) suggested 
that C. jejuni exposure to atmospheric oxygen led to a reduction in biofilm 
when compared with the presence of carbon dioxide (10%). However, Asakura 
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et al. (2007) reported that C. jejuni NCTC 11168 was better able to form 
biofilms under aerobic conditions than microaerobic conditions over 24 and 48 
h but not at 72 h using quantitative crystal violet staining.  Reuter et al. (2010) 
suggested that biofilm formation of C. jejuni increased rapidly under aerobic 
conditions compared to microaerobic conditions and could assist in the survival 
of C. jejuni when exposed to atmospheric levels of oxygen, although the 
quantity of biofilm formed based on crystal violet staining was not 
significantly different after longer incubation times. Interestingly, Ica et al. 
(2012) reported that the quantity of oxygen in the mono-culture C. jejuni 
biofilms was not measureable, and Sulaeman et al. (2012) also reported the 
over-expression of proteins involved in biofilm initiation under oxygen-
enriched conditions. In conclusion reports in the literature suggest that biofilm 
formation by C. jejuni is dependent on environmental factors including 
temperature, oxidative stress, nutritional limitation and the physiological phase 
of growth.  
 
1.4 Bacteriophages 
1.4.1 Characteristics of bacteriophage  
Bacteriophages were independently discovered by Frederick W. Twort and 
Felix ćHérelle in 1915 and 1917 (Stent, 1963). Bacterial viruses can kill or 
infect specific bacteria and are parasites to bacteria. Bacteriophages are 
ubiquitous and can be found in a variety of environments such as sea water, 
soil, food, sewage and waste water. The number of bacteriophage on earth is 
estimated to be in the range of 1030 to 1032. Additionally, bacteriophages play a 
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substantial role in regulation of the microbial balance in the ecosystems where 
the roles of bacteriophages have been explored (Kutter and Sulakvelidze, 
2005). Bacteriophages are constantly diffusing, decaying, or exploring bacteria 
to adsorb and infect that has profound impact on bacterial communities, and on 
ecosystem nutrient flow (Abedon, 2008). Individual phage particles contain a 
nucleic acid genome (DNA or RNA) enclosed in a protein or lipoprotein coat 
or capsid (Guttman et al., 2005). They have no machinery for producing 
energy and no ribosomes for making proteins. High levels of specificity to a 
particular bacterial host is due to the fact that bacteriophage can attach to 
specific receptors on the surface of the target bacteria including 
lipopolysaccharides, teichoic acids and flagella (Guttman et al., 2005). The 
majority of the identified phages are tailed phage, of which 60% are in the 
family Siphoviridae, 25% in Myoviridae and 15% in Podoviridae (Guttman et 
al., 2005). Tailless phages are often differentiated by shape compared to the 
tailed phages, where morphologies such as rods, spherical, lemon shapes or 
pleiomorphic shapes have been observed (Guttman et al., 2005). Besides 
morphology, bacteriophages have been classified by having either double or 
single stranded DNA or RNA (Figure 1.2).  
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Figure 1.2-Basic morphologies of different families of virions of prokaryotes.  
Source: Ackermann (2006) 
 
1.4.2 Bacteriophage life cycles 
According to Abedon (2006) the general phage life cycle basically involves 
adsorption, infection and phage release, followed by phage decay (Figure 1.3).  
Bacteriophages are divided into two classes based on lifecycle: virulent phage 
that have a lytic cycle, and temperate phage that potentially have a lysogenic 
phase in their life cycle. Virulent bacteriophage infect and insert their genome 
in to a bacteria host cell, where upon it takes over the bacterial energy and 
synthesis mechanisms to produce progeny, leading to host lysis and progeny 
phage release, for instance, the bacteriophage T4 life cycle (Figure 1.4). 
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Whereas, when temperate phage infect bacteria the phage genome can become 
integrated into the bacterial host genome and remain dormant until stimulated 
by environmental factors to enter the lytic cycle and produce progeny 
(Guttman et al., 2005), for example, the lysogenic life cycle of ȜSKDJH (Figure 
1.5).  Additionally, pseudolysogeny or the carrier state has been reported as an 
alternative life cycle of both virulent and temperate phages (Miller and Ripp, 
2002).  
 
 
Figure 1.3- General phage life cycle 
Source: Abedon (2006). 
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Figure 1.4-Bacteriophage T4 life cycle. 
Source: http://bacteriophageucd.files.wordpress.com/2011/04/t4-lifecycle.jpg 
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Figure 1.5-Lysogenic life cycle of Ȝphage. 
Source: http://bacteriophageucd.files.wordpress.com/2011/04/lambda-life-
jpg.gif 
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1.5 Pseudolysogeny 
The definition of pseudolysogeny is an unstable state where the viral DNA is 
maintained or carried in a bacterial culture, in contrast to true lysogeny where 
the bacteriophage genome is integrated in to or replicates with the bacterial 
genome (Grange, 1975; Ripp and Miller, 1997, 1998). Pseudolysogenic 
bacteria can form plaques spontaneously when cultured on suitable media 
(Grange, 1975). Pseudolysogens have been documented for more than 30 years 
but research in to the phenomenon has been limited. The formation of 
pseudolysogens by Mycobacterium had been reported in 1970s, where the 
characteristics of pseudolysogenic Mycobacterium diernhoferi ATCC 19341 
were observed, and that cured variants showed no cultural, biochemical or 
serological variation compared to the original culture (Grange, 1975). 
Pseudolysogenic M. chelonei with phage Ɏ630 was reported by Jones and 
Greenberg (1977), who showed differences in host modification and restriction 
with a mycobacteriophage isolated from this bacteria. The resultant progeny 
phage propagating on an alternative host exhibited a marked reduction in 
efficiency of plating compared to the original host. Furthermore, the 
establishment of a pseudolysogenic state in Azotobacter vinelandii strain O, 
was identified as resulting in the phenotypic conversion of the host, including 
loss of polysaccharide coat, flagella, motility and the acquisition of a yellow 
pigmented appearance (Thompson et al., 1980a). Subculture of these strains 
led to the loss of phage A21 production but retention of their phenotypic 
differences (Thompson et al., 1980b). Similarly, Ripp and Miller (1997) 
reported that a phage genome had stabilised in Pseudomonas aeroginosa but 
was no longer able to replicate along with host genome replication and cell 
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division. The same investigators showed that pseudolysogeny played an 
important role in the long-term survival of bacteriophage in a natural 
freshwater environment under nutrient limitation. Additionally, establishment 
of pseudolysogeny in P. aeroginosa infected with either phage F116 or UT1 
was increased when the bacterial cells were starved leading to decreased phage 
numbers and followed by an increase in the number of bacteria containing 
phage DNA (Ripp and Miller, 1998).  Burst sizes of phages decreased when 
bacteria were starved resulting in higher occurrence of pseudolysogens, which 
was probably due to the fact that the starved cells did not supply sufficient 
energy for phage to initiate either a lysogenic or lytic life cycle (Miller and 
Ripp, 2002). A pseudolysogenic-like interaction between Ɏ HSIC virus and 
Listonella pelagia, showing a high rate of spontaneous induction under 
stimulated growth and low titres under unsuitable growth conditions was 
reported by Williamson et al. (2001) and Williamson and Paul (2006). Los et 
al. (2003) reported formation of T4 pseudolysogens of Escherichia coli in 
slowly growing cells in carbon-limited chemostats. Phage Ɏ$VS of an 
Actinoplanes strain SN223 was able to form a putative pseudolysogenic state 
based as the presence of phage DNA and the observation of phage particles 
present in bacterial cells by electron microscopy (Jarling et al., 2004). 
Pseudolysogeny was also reported in sporulating Bacillus subtilis where the 
phage genome survived storage in endospores (Sonenshein, 2005).  Vibrio 
harveyi infected with Siphoviriae-like phage (VHS1) exhibited pseudolysogens 
where the VHS1 DNA was carried on non-phage producing progeny but no 
longer in daughter cells (Khemayan et al., 2006).   A characteristic of 
pseudolysogens is that they are able to produce viable phage particles along 
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with a population of bacterial cells but do not produce phage as a result of 
induction with a mutagenic agent such as mitomycin C and that they lack 
integration of their nucleic acid (Williamson et al., 2001).  In conclusion the 
literature suggests that many bacteria are able to form pseudolysogens 
particularly where conditions for bacterial growth are limited, such as nutrition 
limitation or on sporulation. Pseudolysogeny is often associated with 
conversion phenotypes that distinguish them from the original bacteria. These 
phenotypes can be beneficial for the survival of the host bacteria under stress 
conditions. Bacteriophage associated with the surviving bacteria remain with 
their host offering shelter but retain the ability to undergo lysis at a later time. 
Pseudolysogens therefore play an important role in the maintenance and 
evolution of bacteriophages in natural environments.  
 
1.6 Campylobacter Bacteriophages  
1.6.1 Characteristics of Campylobacter bacteriophages 
The majority of phages that have been isolated with specificity to 
Campylobacter strains are virulent few being reported as temperate (Sails et 
al., 1998). Campylobacter bacteriophages are typically found in poultry and 
pig products, and sewage effluent (Frost et al., 1999; Atterbury et al., 2003b; 
El-Shibiny et al., 2005; Hansen et al., 2007; Tsuei et al., 2007). In the 1970s, 
temperate bacteriophage isolates were reported from Vibrio fetus, a species that 
is currently known as Campylobacter fetus var. intestinailis (Firehammer and 
Boder, 1968; Bryner et al., 1973; Hallett et al., 1977).  Campylobacter phages 
that have been extensively characterised belong to either the Myoviridae or 
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Siphoviridae families (Atterbury et al., 2003b; Loc Carillo et al., 2005; Timms 
et al., 2010). The Myoviridae family is classified into three categories of 
bacteriophages specific to Campylobacter based on genomic size: Class I-a 
genome size of approximately 320 kb, head 140 nm; Class II-a genome size of 
approximately 194 kb, head 99 nm and refractory to digest with HhaI; Class 
III-a genome size of approximately 140 kb, head 100 nm and digestible by 
HhaI (Table 1.1) (Sails et al., 1998; El-Shibiny et al., 2009; Timms et al., 
2010). Electron microscopy showed these phages have icosahedral heads and 
long contractile tails with average head sizes in the range of 92-100 nm and 
overall lengths of 190-200 nm (Sails et al., 1998; Loc Carrillo et al., 2005; 
2007; Figure 1.6). The group III phage of Campylobacter (virulent phages) 
were typically isolated from chicken, (El-Shibiny et al., 2005; Loc Carrillo et 
al., 2005, 2007).  
 
Bacteriophage can alter or provoke the succession of Campylobacter types 
colonising broiler chickens during production where environmentally exposed 
birds can be exposed to multiple Campylobacter types over the rearing cycle 
(El-Shibiny et al., 2005; El-Shibiny et al., 2007). The selection of the dominant 
type may be influenced by the presence of bacteriophages as observed in 
longitudinal studies of broiler houses demonstrating strain and bacteriophage 
carry over from one flock to another (Connerton et al., 2004).  This was further 
demonstrated experimentally by Scott et al. (2007b) in a broiler chicken 
colonisation model, who showed that in the absence of bacteriophage, a 
bacteriophage-sensitive strain out competed a bacteriophage insensitive strain 
to become the dominant strain. However, when bacteriophage were 
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administered to birds co-infected with both strains, the situation was reversed, 
with the insensitive strain becoming dominant and the sensitive strain being 
reduced to a minority population. Individually the strains were equally able to 
colonise birds but it was clear that the strain insensitive to the bacteriophages 
was associated with a competitive fitness disadvantage in the absence of 
bacteriophages but not in their presence. These findings have implications 
regarding the types of strains isolated from different sources as the presence of 
bacteriophages may bias the isolation rates of different strains colonising the 
same intestinal environment. Overall the role of bacteriophage on 
Campylobacter population dynamics depends on the proportion of insensitive 
and susceptible bacteria and the fitness of these bacteria in the environmental 
niche in which they are challenged (Cairns et al., 2009). 
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Table 1.1-Campylobacter bacteriophage (Myoviridae family) classification and 
sources 
Groups Sources Phages References 
I NCTC Ɏ4 (NCTC 12676) 
Ɏ12 (NCTC 12677) 
Sails et al. (1998) 
Coward et al. (2006) 
II Chicken 
 
NCTC 
 
CP220 
CPt10  
Ɏ10 (NCTC 12683) 
Ɏ14 (NCTC 12675) 
Ɏ8 (NCTC 12681) 
Ɏ3 (NCTC 12682) 
Ɏ15 (NCTC 12684) 
El-Shibiny et al. (2009) 
Timms et al. (2010) 
Sails et al. (1998) 
Coward et al. (2006) 
III Chicken 
 
NCTC 
CP1-8, CP34  
CP30, CP81 
Ɏ1 (NCTC 12673) 
Ɏ9 (NCTC 12669) 
Ɏ16 (NCTC 12670) 
Ɏ7 (NCTC 12671) 
Ɏ13 (NCTC 12672) 
Ɏ2 (NCTC 12674) 
Ɏ5 (NCTC 12678) 
Ɏ11 (NCTC 12679) 
Ɏ6 (NCTC 12680) 
Loc Carrillo et al. (2005, 
2007) 
Scott et al. (2007a); Hammerl 
et al. (2011) 
Sails et al. (1998) 
Coward et al. (2006) 
Ɏ-ɎDUHXVHGLQSKDJHW\SLQJIRUGLVFULPLQDWLRQRIC. jejuni and C. coli  
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Figure 1.6-Electron micrographs of bacteriophages CP8 (A), Bars, 0.1 µm. 
(Loc Carrillo et al., 2005) and CP30 (B). 
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1.6.2 Influence of bacteriophage on genomic diversity of Campylobacter 
Campylobacter prophage have been reported to have an effect on the genomic 
diversity of Campylobacter. Fouts et al. (2005) reported that there were three 
insertion sequences of phage DNA into the genome of C. jejuni RM1221 
including Campylobacter jejuni insertion element 1 (CJIE1)  containing a Mu-
like phage, CJIE2 encoding phage-related endonuclease, methylases or 
repressors and CJIE4-phage structural proteins. Parker et al. (2006) showed 
through the use of a PCR screen and DNA microarray hybridisation that 
several C. jejuni isolates carry inserted sequences with one or two being similar 
to CJIE of C. jejuni RM1221.  Bacteriophages affect Pulsed Field Gel 
Electrophoresis (PFGE) patterns of C. jejuni because of insertions or deletions 
of bacteriophage genes (Barton et al., 2007).  Genomic rearrangements were 
identified in phage-treated isolates from chickens, resulting from 
recombination by Mu-like prophage DNA sequences in the Campylobacter 
genomic DNA (Scott et al., 2007b).  Furthermore, the genomic DNA of C. 
jejuni HPC5 was found to carry on insertion of Mu-like phage DNA (CJIE1) 
similar to these seen in C. jejuni RM1221 (John et al., 2011). The prophages 
might have a role in the biology and virulence of bacteria. Clark and Ng (2008) 
provided further evidence for recombination of prophages in the DNA of 
several C. jejuni isolates by southern blotting using probes designed from three 
putative prophages of C. jejuni RM1221. Scott et al. (2007a) reported that 
phage resistance/insensitivity could be acquired by horizontal gene transfer 
between the C. jejuni phage sensitive and phage resistant strains that lead to the 
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creation of a new phenotype; however, the phage resistant strains were less 
capable of colonising broiler chickens.  
 
1.6.3 Phage genome sequences  
Whole genome sequences of Campylobacter phage CP220, CPt10 NCTC 
12673 and CP81 have been lodged in the database (Genebank no: FN667788.1, 
FN667789.1, GU296433.1, and EMBL: FR823450, respectively).  These 
genomic sequences represent group II and group III Campylobacter specific 
bacteriophages (Table 1.2). Interestingly, the CP220 and CPt10 genomes 
contained many copies of radical S-adenyl-methionine genes that may play a 
role in expanding bacterial metabolism during infection through enhanced 
biosynthesis of metal containing oxidoreductases (Timms et al., 2010; 
Connerton et al., 2011).     Additionally, phage CP81 (group III) showed a 
relationship with group II CP220 and Cpt10 resulting in the presence of a 
number of similar proteins relating to capsid structure, DNA replication and 
recombination; however these virion-related modules are scattered throughout 
the phage genome and are not conserved as they are in other T4 related 
bacteriophage (Hammerl et al., 2011). Notably the CP81 phage genome does 
not  contain the metabolic enzymes present in CP220/CPt10 that include 12 
proteins with S-adenosylmethionine domains, transposases and membrane 
proteins (Hammerl et al., 2011). Interestingly, the vB_Ccom-IBB_35 phage 
(Genebank no: HM246720- HM246724) contains genes that encode 
carbohydrase enzymes that have the potential to degrade bacterial capsular 
polysaccharides (CPS) (Carvalho et al., 2012). The genome sequence of the 
group 2 bacteriophage CP21 (Genebank no: HE815464) is composed of large 
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modules separated by long DNA repeat regions which may trigger 
UHFRPELQDWLRQ DQG PRGXODU VKXIÀLQJ +RZHYHU WKH JHQRPH VHTXHQFHV RI
CP21 and vB_Ccom-IBB_35 bacteriophage are incomplete , with the former 
composed offive contigs (Hammerl et al. 2012). 
 
Table 1.2- The sequenced whole genome of Campylobacter phages 
Phages Group Length (bp) DNA %GC References 
CP220 II 177534 circular 27.4 Timms et al. (2010) 
CPt10 II 175720 circular 27.3 Timms et al. (2010) 
CP21 II 182833 unknown 27 Hammerl et al. (2012) 
vB_Ccom-
IBB_35 
II 172065 unknown 27 Carvalho et al. (2012) 
NCTC 12673 III 135041 circular 26 Szymanski et al. (2011) 
CP81 III 132454 unknown 26.1 Hammerl et al. (2011) 
 
1.6.4 Application of Campylobacter bacteriophage 
Phage can be exploited to detect bacterial pathogens or to reduce bacterial 
pathogens upon infection; as an antimicrobial agent in both medical and 
agricultural settings; as biotherapeutic agents and for biosanitation for food 
safety purposes (Kutter and Sulakvelidze, 2005; Hagens and Loessner, 2007; 
Mahony et al., 2011).Phage therapy has been applied in food animals such as 
cattle, sheep, pigs and poultry to reduce the microbial loads of food borne 
pathogens (Johnson et al., 2008). Campylobacter bacteriophages have been 
applied to both phage typing and phage therapy. Campylobacter phage typing 
was developed for discrimination of C. jejuni and C. coli (Grajewski et al., 
1985; Salama et al., 1990; Khakhria and Lior, 1992). There are 16 phages used 
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in the UK phage typing scheme to characterise C. jejuni and C. coli (Sails et 
al., 1998; Frost et al., 1999). The 16 phages were classified into three groups 
based on structure criteria and belong to Myoviridae family of phages. The 
phages were generally isolated from poultry faeces, poultry manure and 
sewage effluent (Sails et al., 1998).  Khakhria and Lior (1992) reported the 
application of Campylobacter phage typing using 19 typing phages to 
differentiate C. jejuni and C. coli isolated from human and non-human 
established 46 different phage types. Frost et al. (1999) reported the utilisation 
of phage typing in combination with serotyping to discriminate both species 
into subtypes. Phage typing may therefore be of epidemiological use in 
conjunction with serotyping (Frost et al., 1999). Coward et al. (2006) reported 
WKHW\SLQJEDFWHULRSKDJHVɎ-16 or PT1-PT16) could be assigned to four 
groups based on their reaction with spontaneous resistant mutants arising  from 
the Campylobacter typing strains using a spot lysis method.  
 
Bacteriophage therapy has been shown to be potentially useful to reduce 
Campylobacter in broiler chicken flocks (Wagenaar et al., 2005; Loc Carillo et 
al., 2005; El-Shibiny et al., 2005).  For instance, application of a group II 
Campylobacter bacteriophage (CP220) was able to reduce numbers of C. jejuni 
and C. coli colonizing broiler chickens (El-shiny et al., 2009). Campylobacter 
phages have been used for biological control on food products, for instance, 
phages infecting C. jejuni could inactivate their host strains on raw and cooked 
beef (Bigwood et al., 2008). Goode et al. (2003) showed that Campylobacter 
EDFWHULRSKDJH 1&7&  RU Ɏ RQ SKDJH W\SH VWUDLQ WUHDWPHQW RQ C. 
jejuni C222, on chicken skin at a multiplicity of infection (MOI) of 1, reduced 
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the bacteria less than 1 Log10 unit and at a higher dose the phage led to 
reduction in the number of bacterial cells to lower than the control. Atterbury et 
al. (2003a) reported that the application of bacteriophage on chicken skins was 
able to reduce the recovery number of Campylobacter approximately 1 Log10 
CFU at 4 °C. The optimal conditions for phage treatment of food products 
were dependent on the interaction of both Campylobacter phage and 
concentration of host (Bigwood et al., 2009). The same investigators suggested 
that the application of phage on food products was dependent on host 
concentration and phage concentration. Hwang et al. (2009) showed that in 
vitro, the phage CPS2, when had been isolated from chickens in Korea, was 
able to reduce the growth of C. jejuni in liquid culture. Carvalho et al. (2010) 
reported a reduction of C. coli and C. jejuni numbers in chicken faeces of an 
approximately 2 Log10 CFU/g following treatment with a phage cocktail. These 
findings suggest the feasibility of exploiting bacteriophage to control 
Campylobacter in the food chain and therefore a reduction in transmission to 
humans.   
 
1.6.5 Acquisition of phage resistance 
The acquisition of phage resistance is a problem that may affect any 
bacteriophage therapy application. Loc Carrillo et al. (2005) reported that 97% 
of isolates after phage treatment of chicken experimentally infected with 
campylobacter remained phage sensitive, and that those that were phage 
resistant were unable to colonise chickens efficiently. Furthermore the resistant 
types were found to revert to bacteriophage sensitivity upon passage through 
chickens. Similarly, Carvalho et al. (2010) reported that 86% of bacteria 
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isolated from chickens colonised with resistant strains without phage treatment 
were susceptible to phage, while 54% of the resistant strains isolated from 
phage treatment on chicken reverted to susceptibility to phage sensitivity. Scott 
et al. (2007b) reported evidence that phage resistance in C. jejuni strain HPC5 
was associated with genomic rearrangements. Bacteriophage resistance 
mechanisms may therefore impact on the use of phage therapy.  Receptor 
modification to prevent phage entry to the host cells is one mechanism of 
phage resistance. Variation in the surface membrane structure of C. jejuni may 
therefore play a crucial role in the characteristics of phage-host range as well as 
the ability to colonise chickens. For instance, C. jejuni with defects in motility 
or capsular polysaccharide were reported to exhibit phage resistance (Coward 
et al., 2006). Restriction-modification systems are another mechanism by 
which bacterial cells prevent foreign DNA from replicating, in particular phage 
DNA leading to phage resistance. The diversity of the DNA restriction and 
modification systems encoded by C. jejuni strains had been recently studied. 
For example, C. jejuni 81-176 encodes both type I and type II DNA restriction 
and modification systems, in contrast, the sequenced strains, NCTC 11168 and 
RM1221 have only the type II restriction and modification system (Hofreuter 
et al., 2006). However, phage DNA may avoid restriction enzymes, leading to 
the process of the lytic life cycle (reviewed by Labrie et al., 2010). Many 
bacteria and Achaea contain clustered regularly interspaced short palindromic 
repeats (CRISPRs) that are responsible for resistance to invasive genetic 
elements (Haurwitz et al., 2010).  The CRISPR/Cas system mediates phage 
resistance by acting in at least two general ways: the adaptation stage and the 
interference stage (Deveau et al., 2010). Additionally, other mechanisms of 
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phage resistance are by blocking the entry of phage DNA into host cells and 
through abortive infection mechanisms (Sturino and Klaenhammer, 2006).  
 
1.7 Bacteriophage dispersal of biofilm  
The persistence of foodborne pathogens on contact surfaces will negatively 
affect the quality and safety of food products. The presence of biofilms forms 
harbourage for pathogens where several outbreaks of foodborne disease have 
been attributed at least in part to the presence of biofilms (Jahid and Ha, 2012). 
Pathogenic microorganisms can be found in mono- and mixed-biofilms which 
have proved difficult to remove, increasing pathogen survival and enabling 
dissemination during processing (Simuões et al., 2010).  The application of 
disinfectants and other antimicrobial agents to treat bacteria within biofilms are 
often of limited success with compounds such as chlorine, commercial 
chlorinated sanitizer, sodium hyprochlorite, quanternary ammonium 
compounds having to be applied at increasing concentrations (Simuões et al., 
2010). These stringent conditions are necessary for high risk food production 
facilities but increase the risk of antimicrobial resistance emerging, and making 
WKH FRQWURO RI SDWKRJHQV ZLWKLQ ELRILOPV GLIILFXOW 0DK DQG 2¶7RROH 
The necessity to identify alternative methods to control pathogens has led to 
the discovery that bacteriophages are a potentially useful biological agent to 
control biofilm formation and the control of pathogenic bacteria within 
biofilms. Hibma et al. (1997) suggested that phage could inhibit the L-form of 
L. monocytogenes biofilms on stainless steel and also reduce viable cell 
numbers. Hughes et al. (1998) also reported that bacteriophage isolated from 
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sewage could be used to treat biofilms produced by two Enterobacter 
agglomerans strains and an exopolysaccharide (EPS)-producing pseudomonad, 
resulting in production of very large plaques in the biofilm. The clearing of the 
biofilm by bacteriophage has been linked with the production of a 
polysaccharide depolymerase that can degrade the exopolysaccharide. For 
instance, phage ĳ15, a T7-like bacteriophage; has a virion-associated 
expolysaccharide depolymerase that was able to degrade single-species 
Pseudomonas putida biofilms of strains PpG1 and RD5PR2 (Cornelissen et al., 
2011).   The same authors also confirmed that the ĳ15 tail spike protein (Gp17) 
showed similarity to pectin lyases with the potential to bind and degrade EPS. 
Sillankorva et al. (2004) reported that bacteriophage ) S1, at a multiplicity of 
infection (MOI) of 0.5, infected both planktonic cells and biofilms of 
Pseudomonas fluorescens resulting in reduction in culturability by 
approximately 85% in both cases.  However, when Escherichia coli O157:H7 
attached to stainless steel was treated with bacteriophage, there was a reduction 
in viability of the attached cells but not in the number of cells in the biofilm 
(Sharma et al., 2005). Additional examples of bacteriophage trials with 
biofilms are shown in Table 1.3. Generally research has indicated that 
bacteriophage may be useful in the reduction of attached cells and cells in 
biofilms on food surfaces and food-contacted surfaces. 
An alternative approach was suggested by Whitchurch et al. (2002), who 
attempted to use DNase I to inhibit Pseudomonas biofilm formation due to the 
requirement for extracellular DNA to be present for the establishment of the 
biofilm. The developments of other novel agents that inhibit biofilm formation 
including inhibitors of inter- and intracellular signals have been reviewed by 
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Kaplan (2010). Quorum sensing inhibitory compounds have been suggested as 
agents to prevent biofilm formation, such as AHL antagonist inactivation of 
LuxR homologs, inhibition synthesis of AHL and degradation of AHL 
(Hentzer et al., 2002).  The use of an engineered BdcA gene in the initial 
colonizer cells could be able to reduce c-di-GMP levels, resulting in an 
increase in motility and reduction in adhesion leading to dispersion of the 
initial colonising cells (Ma et al., 2011).  
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Table 1.3-Examples of bacteriophage trials with biofilms 
Bacteria Phages Main Outcome References 
Escherichia coli K29 Ability of phage to penetrate the 
polysaccharide capsule of E. coli. 
Bayer et al. (1979) 
E. coli T4 E. coli in biofilms was successfully lysed 
with phage. 
Dolittle et al. (1995) 
E. coli Modified T7 Engineered phage reduced biofilm cell 
counts by over 99%. 
Lu and Collins (2007) 
E. coli OP7061, 
OP10081 
Exposure of E. coli to phage resulted in 
the phage-tolerant subpopulation 
exhibiting stimulation of biofilm 
formation. 
Lacqua et al. (2006) 
E. coli T4 The phage reduced bacterial biofilms by 
approximately 90% 
Carson et al. (2010) 
Staphylococcus 
aureus 
K Reduction in biofilm mass varied 
depending on strain tested. 
Cerca et al. (2007) 
Listeria 
monocytogenes 
H387,H378A, 
2671 
Synergistic effect found with a quaternary 
ammonium compound and phage. 
Roy et al. (1993) 
Enterobacter 
cloace 
11229, 
Ɏ(QWɎ 
Blackburn, 
Philipstown 
Three phages successfully removed the 
VLQJOHVSHFLHVELRILOPV7KHSKDJHɎ
enzyme was capable of depolymerising 
the extracellular polysaccharide. 
Tait et al. (2002) 
 
   
Pseudomonas 
aeruginosa 
F116 Phage caused 1-2 Log10reduction in 
biofilm viable count dependent on the 
ratio of phage per cell.  
Hanlon et al. (2001) 
P. aeruginosa Phage cocktail The phage cocktail reduced the biofilm 
cell density by 99.9% 
Fu et al. (2010) 
P. fluorescens ĳ,%%-PF7A Biomass removed by 63-91% depending 
on the biofilm age and biofilm forming 
condition 
Sillankova et al. 
(2008) 
Proteus 
mirabilis, 
 
Coli-proteus, 
 
The phage reduced bacterial biofilms by 
approximately 90% 
Carson et al. (2010) 
Modified and adapted IURPWKHUHYLHZE\2¶Flaherty et al. (2009) 
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1.8 Objectives of this study 
Campylobacter species are of great concern as a cause of food borne disease 
and are harmful to human health. Knowledge of the mechanisms of prolonged 
environmental survival of these bacteria and host cell virulence still remains 
unclear. The survival and persistence of Campylobacter spp. in the natural 
environment and on food surfaces may involve biofilm formation. The 
formation of Campylobacter biofilms may help these organisms to survive in 
harsh environments and in the persistence and colonization of animal digestive 
tracts leading to contamination of food, during processing. Thus, it is necessary 
to understand biofilm formation by C. jejuni and to better understand how 
biofilms respond to environmental factors in order to help eliminate them from 
food and food-contacted surfaces. Bacteriophages are an alternative treatment 
as bio-control agents to reduce or eliminate the biofilms from food and food 
contacted-surfaces. The effect of bacteriophage exposure on attachment of cells 
and on pre-formed biofilms by Campylobacter has not previously been studied.  
 
The specific objectives of this study are: 
1) To investigate the dispersal of Campylobacter biofilms by 
bacteriophage under microaerobic conditions. 
2) To evaluate the formation of the carrier state life cycle (CSLC) in 
Campylobacter biofilms after bacteriophage treatment and the 
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physiology of the CSLC cultures and parental bacteria under 
microaerobic, low oxygen (<1% O2), and atmospheric conditions. 
3) To demonstrate the characteristics of the CSLC phages compared to 
parental phages. 
4) To determine the transcriptomics of CSLC cultures and parent strains at 
early exponential phase of growth under microaerobic conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                                         Chapter 2 Materials and methods 
47 
 
CHAPTER 2 
MATERIALS AND METHODS 
2.1 Growth, storage media and chemical solutions 
2.1.1 Blood agar (BA) 
Blood agar base No. 2 (Oxoid, Basingstoke, UK) was prepared according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV )ROORZLQJ VWHULOLVDWLRQ GHILEULQDWHG KRUVH EORRG
(TCS, Buckingham, UK) was added to a final concentration of 5% (v/v) before 
dispensing into Petri dishes. A 1 Litre of BA contained 40 g of blood agar No. 
2 and 50 ml of defbrinated horse blood.Typical formula of blood agar base No. 
2 contains substances as shown below. 
  
Typical Formula g/litre 
Proteose peptone 15.0 
Liver digest 2.5 
Yeast extract 5.0 
Sodium chloride 5.0 
Agar 12.0 
pH 7.4 ± 0.2 @ 25°C   
 
2.1.2 Campylobacter blood-free selective agar (CCDA) 
Campylobacter blood-free selective agar (Oxoid), supplemented with 2% (w/v) 
bacteriological DJDU1R 2[RLGZDVSUHSDUHGDFFRUGLQJ WRPDQXIDFWXUHU¶V
instructions.  A 1 Litre of CCDA contained 55 g of Campylobacter blood-free 
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selective agar and 20 g of agar No. 1. Typical formula of CCDA contains 
substances as shown below. 
Typical Formula g/litre 
Nutrient Broth No.2 25.0 
Bacteriological charcoal 4.0 
Casein hydrolysate 3.0 
Sodium desoxycholate 1.0 
Ferrous sulphate 0.25 
Sodium pyruvate 0.25 
Agar 12.0 
pH 7.4 ± 0.2 @ 25°C  
 
2.1.3 New Zealand casamino yeast medium (NZCYM) basal agar 
'LIFR1=&<0 broth (Becton, Dickinson and Company, Sparks, MD, USA), 
supplemented with bacteriological agar No. 1 (Oxoid) to a final concentration 
RIZYZDVSUHSDUHGDFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQV$/LWUH
of NZCYM basal agar contained 22 g of NZCYM broth and 15 g of agar No.1. 
Typical formula of NZCYM broth contains substances as shown below.  
Typical Formula g/litre 
Pancreatic Digest of Casein 10.0 
Casamino acids 1.0 
Yeast extract  5.0 
Sodium chloride 5.0 
Magnesium sulfate (anhydrous) 0.98 
pH 7.0 ± 0.2 @ 25°C  
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2.1.4 NZCYM overlay agar 
'LIFR 1=&<0 EURWK VXSSOHPHQWHG ZLWK EDFWHULRORJLFDO DJDU 1R  WR D
ILQDO FRQFHQWUDWLRQ RI  ZY ZDV SUHSDUHG DFFRUGLQJ WR PDQXIDFWXUHU¶V
instructions. Following sterilisation, 6 ml aliquots were aseptically dispensed to 
sterile glass universals and stored at 4°C for a maximum of 8 weeks. 
Immediately before use the agar was melted in a microwave and cooled to 
50°C. A 1 Litre of NZCYM overlay agar contained 17.6 g of NZCYM broth 
and 6 g of agar No.1. 
2.1.5 Mueller-Hinton (MH) Broth and Agar 
Mueller-+LQWRQ EURWK 2[RLG ZDV SUHSDUHG DFFRUGLQJ WR PDQXIDFWXUHU¶V
instructions. Following sterilisation, MH broth was stored at room temperature 
in the dark for a maximum of 8 weeks. Addition of 1.5% (w/v) of 
bacteriological agar No.1 (Oxoid) was prepared to obtain the MH agar. A 1 
Litre of  MH broth contained 21 g of MH broth and 15 g of agar for MH agar 
No. 1. Typical formula of MH broth contains substances as shown below. 
 
Typical Formula g/litre 
Beef, dehydrated infusion from 300.0 
Casein hydrolysate 17.5 
Starch 1.5 
Agar (MH Agar) 15 
pH 7.3 ± 0.1 @ 25°C   
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2.1.6 Campylobacter motility agar 
Mueller-Hinton (MH) broth (Oxoid), supplemented with bacteriological agar 
No. 1 to a final concentration of 0.4% (w/v) was prepared according to 
PDQXIDFWXUHU¶V LQVWUXFWLRQV$/LWUHRIPRWLOLW\DJDUFRQWDLQHGJRI0+
broth and 4 g of agar No. 1.  
2.1.7 Bacterial storage medium  
1XWULHQWEURWK1%1R2[RLGZDVGLVSHQVHGDFFRUGLQJWRPDQXIDFWXUHU¶V
instructions and dissolved in RO water supplemented with 20% (v/v) glycerol 
(Fisher Scientific, Loughborough, UK). This was dispensed in 30 ml aliquots 
to sterile glass universals and, following sterilisation, stored at room 
temperature for a maximum of 8 weeks. A 1 Litre of bacterial storage medium 
contained 23 g of nutrient broth and 200 ml of glycerol. Typical formula of NB 
No.2 contains substances as shown below. 
Typical Formula g/litre 
`Lab-/HPFR¶SRZGHU 10.0 
Peptone 10.0 
Sodium chloride 5.0 
pH 7.5 ± 0.2@ 25°C   
 
2.1.8 Maximal Recovery Diluents (MRD) 
0D[LPXPUHFRYHU\GLOXHQW2[RLGZDVSUHSDUHGDFFRUGLQJWRPDQXIDFWXUHU¶V
instructions. Following sterilisation, MRD was stored at room temperature for 
a maximum of 8 weeks. A 1 Litre of MRD contained 9 g of MRD. Typical 
formula of MRD contains the substances as shown below. 
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Typical Formula g/litre 
Peptone 1.0 
Sodium chloride 8.5 
pH 7.0 ± 0.2 @ 25°C   
 
2.1.9 Phosphate Buffer Saline (PBS) 
3KRVSKDWH EXIIHUHG VDOLQH 2[RLG ZDV SUHSDUHG DFFRUGLQJ WR PDQXIDFWXUHU¶V
instructions. Following sterilisation, PBS was stored at room temperature for a 
maximum of 8 weeks. The PBS contains the chemical agents as shown below. 
Formula g/litre 
Sodium chloride 8.0 
Potassium chloride 0.2 
Disodium hydrogen phosphate 1.15 
Potassium dihydrogen phosphate 0.2 
pH 7.3  
 
2.1.10 10 mM Tris-HCl, 1 mM disodium ethylene diamine tetraacetic acid 
(EDTA), pH 8 (TE buffer) 
 
TE buffer was prepared by addition 1.214 g/l of 2-Amino-2-(hydroxymethyl)-
1,3-propanediol Tris (hydroxymethyl) aminomethane (Trisma® base, Sigma-
Aldrich, St Louis, MO, USA), 0.3722 g/l of disodium ethylene diamine 
tetraacetic acid (EDTA, Sigma-Aldrich), and adjusting the pH to 8.0 by adding 
HCl (Acros Organics, New Jerseys, USA). Following sterilisation, TE buffer 
was stored at room temperature for a maximum of 8 weeks.  
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2.1.11 50X Tris-acetrate, EDTA buffer (TAE buffer) 
A stock solution of 50X TAE buffer was prepared by dissolving 242 g/l of 
Trisma® base (Sigma-Aldrich), 57.1 ml/l of glacial acetic acid, 18.61 g/l of 
EDTA to final concentration and adjusting the pH to 8.0 by adding NaOH 
(Fisher Scientific). Following sterilization, TAE buffer was stored at room 
temperature for a maximum of 8 weeks.  
2.1.12 Salt Magnesium buffer (SM buffer) 
SM buffer was prepared by dissolving sodium chloride (Fisher Scientific) to a 
final concentration of 5.8 g/l, magnesium sulphate heptahydrate (Sigma-
Aldrich) to a final concentration of 2 g/l, Trisma® base (Sigma-Aldrich)  to a 
final concentration of 6 g/l, and gelatin (Sigma-Aldrich) to a final 
concentration of 0.01% w/v in RO water. The pH was adjusted to 7.5 using 
HCl (Acros Organics). This was dispensed in 30 ml aliquots to sterile glass 
universals and, following sterilisation, stored at room temperature for a 
maximum of 8 weeks. 
2.1.13 Magnesium sulphate 
Magnesium sulphate (1 M) was prepared by dissolving of magnesium sulphate 
heptahydrate (Sigma-Aldrich) to final concentration 246.7 g/l. To obtain 10 
mM MgSO4 was performed by dilution with sterile RO water. 
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2.2 Campylobacter 
2.2.1  Bacterial strains and growth conditions  
Campylobacter strains (Table 2.1) were stored in Nutrient Broth no.2 (Oxoid) 
supplement with 20 % glycerol (2.1.6) at -80 °C. For routine growth they were 
subcultured on Blood Agar base no. 2 (Oxoid) supplemented with 5% 
defibrinated horse blood (TCS) as described in 2.1.1 and incubated at 42 °C in 
a gas jars (Oxoid) under microaerobic conditions achieved by gas replacement 
(85% N2, 5% O2 and 10% H2) for approximately 18-20 h. 
 
2.2.2 Enumeration of Campylobacter 
Campylobacter enumeration was carried out using a modification of the 
technique described by Miles and Misra (1938). Campylobacter suspensions 
were enumerated by performing ten-fold serial dilutions using MRD using 900 
µl of MRD (2.1.8) and 100 µl of suspension. Multiple 10 microlitre spots of 
each dilution were dispensed onto Campylobacter Blood-Free Selective Agar 
(CCDA; Oxoid) containing addition of agar to 2% (w/v) (2.1.2) to prevent 
swarming and allowed to dry for 20 min. The use of the multiple spot 
methodology was adopted to ensure dispersal of the Campylobacter colonies 
and reduce swarming that is evident when using spread plates to obtain reliable 
colony counts. The plates were then incubated under microaerobic conditions 
at 42 oC for 48 h and the colonies counted.  
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 Table 2.1-Campylobacter Strains used in this thesis 
Strains Sources Reference 
NCTC 11168 Human NCTC Parkhill et al., 2000 
HPC5 Chicken (caeca) Loc Carrillo et al., 2005 
PT14 HPA Collindale UK Frost et al., 1999 
HPC5CP8PL Campylobacter biofilms In this thesis 
HPC5CP30PL Campylobacter biofilms In this thesis 
PT14CP8PL Campylobacter biofilms In this thesis 
PT14CP30PL Campylobacter biofilms In this thesis 
11168GFP Laboratory Karlyshev and Wren, 2005  
11168YFP Laboratory Karlyshev and Wren, 2005  
PT14GFP Laboratory Laboratory Stock 
PT14YFP Laboratory Laboratory Stock  
PT14YFPCP8PL Planktonic phage-treated In this thesis 
PT14YFPCP30PL Planktonic phage-treated In this thesis 
 
2.3 Bacteriophage 
2.3.1 Bacteriophage propagation 
The propagating Campylobacter strains were sub-cultured onto blood agar 
plates over night (2.2.1). One hundred microlitres of bacteriophage suspension 
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109 PFU/ml (Table 2.2) was mixed with Campylobacter cells (109-1010 
CFU/ml) that were harvested into 2 ml of sterile 10 mM MgSO4 (2.1.13) with 
the aid of sterile swab. The propagating strain suspension was incubated for 40 
min at 42 oC in order to allow bacteriophages to adsorb. Five hundred 
PLFUROLWHUV RI WKH VXVSHQVLRQ ZDV WKHQ DOLTXRWHG WR  PO RI PROWHQ 'LIFR
NZCYM supplemented with 0.6 %(w/v) agar bacteriological No.1 (Oxoid) 
overlay agar (2.1.4) and then applied to the surface of NZCYM basal plates 
(2.1.3) (Sambrook et al., 1989). The overlay agar plates were left to set at room 
temperature for 20 min and then incubated under microaerobic conditions at 42 
oC for 48 h. Five mililitres of MRD (2.1.8) was added to the surface of each 
plate and the bacteriophage allowed to elute onto the buffer by shaking gently 
overnight at 4 oC on a gyratory shaker at 60 cycles / min. The final harvested 
bacteriophage suspension was filtered through 0.2 Pm Minisart® filters 
(Satorious Stedim Biotech, Surrey, UK) and the phage stock titres 109 PFU/ml 
and transferred to a thick wall universal bottle and stored at 4 oC in the dark. 
These phage stocks retained their titres for at least two years. 
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Table 2.2-Bacteriophages used in this thesis and their propagating strains 
Bacteriophages Propagating strains Sources 
CP8 NCTC 11168 or PT14 or HPC5 Dr. C. Loc Carrillo 
CP30 NCTC 11168 or PT14 or HPC5 Dr. P. Connerton 
CP8PL PT14CP8PL or HPC5CP8PL This thesis 
CP30PL PT14CP30PL or HPC5CP30PL This thesis 
CP220 PT14 or HPC5 Dr. P. Connerton 
 
2.3.2 The carrier state life cycle (CSLC) phage propagation 
For propagation, the CSLC strains (Table 2.1) were sub-cultured on blood agar 
at 42 oC under microaerobic conditions for 18-20 h. The growth from the 
whole plate (109-1010 CFU/ml) was resuspended into 5 ml of sterile 10 mM 
MgSO4 (2.1.13) and an aliquot of 0.5 ml of this suspension was added into 4 
ml of molten NZCYM (2.1.4) and then carried on the same as described in 
2.3.1.  
2.3.3 Bacterial lawn preparation 
Cultures of C. jejuni (2.2.1) were resuspended in 10 ml of 10 mM MgSO4 
(2.1.13). Five hundred microlitres of bacterial suspensions (109 CFU/ml) were 
added to 4 ml of molten NZCYM containing 0.6% (w/v) agar as overlay agar 
(2.1.4) and then dispensed on the basal NZCYM plates (2.1.3). The overlay 
agar plates were left to set at room temperature for 20 min. The lawns were 
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used for the phage titration. Ten microlitre spot assays were used to locate the 
phage on the plates and minimise the adsorption times for phage suspension 
into the agar plate to prevent spread. This procedure enable the comparison of 
phage titres between wild type host Campylobacter strains and those carrying 
bacteriophage that give rise to background plaque formation.  
2.3.4  Bacteriophage titration 
To enumerate bacteriophage suspension, ten-fold serial dilutions were 
performed in 900 of MRD (2.1.8) using 100 µl of suspension and subsequently 
10 µl aliquots dispensed, in triplicate, onto bacterial lawns (2.3.3), a volume 
that would readily adsorb before placing in a microaerobic environment. The 
plates were incubated at 42 oC under microaerobic conditions for 18-20 h. The 
plaques were counted and used to calculate the plaque forming unit (PFU)/ml.  
 
2.4 Biofilm formation and bacteriophage treatment 
2.4.1 Initial culture for biofilm formation  
Campylobacter jejuni cultures (2.2.1) were resuspended in Mueller-Hinton 
(MH) broth (2.1.7) at OD600nm 0.3-0.4, using a sterile swab and then incubated 
at 42 °C under microaerobic conditions to use as inocula. The microaerobic 
DWPRVSKHULF ZDV DFKLHYHG XVLQJ HLWKHU  [  / 2[RLG &DPS\*HQ JDV
packs placed in sealed incubation boxes or using gas jars employing gas 
replacement (85% N2, 5% O2 and 10% H2) .  
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2.4.2 Attachment and biofilm formation 
The Campylobacter cultures (2.2.1) were diluted to contain approximately 105 
CFU/ml with fresh MH broth. Approximate Campylobacter count was 
estimated using the empirical equation:  
Campylobacter count in CFU/ml = (OD600 * 2 x 109) ± 6 x 106 
The equation was derived from a standard Campylobacter dilution series 
(Scott, 2006). A 10 ml aliquot of each culture was dispensed into a Petri dish 
containing six glass cover slips (18x18 mm, Scientific Laboratory Supplies 
Ltd, Nottingham, UK) on which the biofilms were to be formed. The Petri 
dishes were then incubated at 37 oC under microaerobic conditions for 1, 2, 5 
and 7 days and followed the enumeration of Campylobacter as described in 
2.4.5.   
2.4.3 Effect of temperature on attachment and biofilm formation 
The attachment and biofilm formation by C. jejuni NCTC 11168 was 
performed by method described in 2.4.1 and 2.4.2 following incubation at 37 or 
42 oC for 1, 2, 5 and 7 days. The viability of attached and planktonic cells was 
determined by method described in 2.4.5. 
2.4.4  Bacteriophages treatment of biofilms 
Biofilms of C. jejuni NCTC11168, PT14 and HPC5 were allowed to form 
under microaerobic conditions over 5 days at 37 oC. Glass cover slips covered 
with these Campylobacter biofilms were moved to a clean Petri dish for phage 
treatment and 1 ml of the residual unattached cells (approximately 90%) 
collected in a tube for independent treatment with phage. Bacteriophage stock 
suspensions (2.3.1) were diluted in fresh MH broth to final concentration of 106 
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or 109 PFU/ml, from which 100 µl of bacteriophage suspension was placed 
onto each coverslip surface and added to the corresponding planktonic phase in 
a microcentrifuge tube. The coverslips and tubes were incubated at 37 oC, 
under microaerobic conditions for 0, 2, 4, 7, and 24 h in a petri dish containing 
a buffer reservoir to maintain a water saturated environment.  Control samples 
were mock-treated with fresh sterile MH broth instead of phage suspension. 
Three slides of each treatment at each sampling time were removed and 
processed for the determination of the viable bacterial count (2.4.5) and 
bacteriophage titration (2.4.6). The remaining glass slides were left to incubate 
undisturbed until the next sampling time point. All experiments were 
performed using triplicate slides with a minimum of three independent 
biological replicates. The data were presented as mean counts (± standard 
deviation) and their significance determined using T-test (P<0.05).   
2.4.5 Enumeration of viable bacterial cells 
After gently washing with 2 ml of MRD, bacterial cells attached to the glass 
surfaces were resuspended in 2 ml of MRD (2.1.8) using a repeated pipetting 
action up and down 20 times to detach bound cells. The campylobacters were 
enumerated as described in 2.2.2. Planktonic cells were serially diluted and 
enumerated in the same way. The limit of detection for the enumeration of 
bacterial populationsfrom biofilm and planktonic cultures was 1 log CFU/cm2 
and 2 log CFU/ml, respectively. Recovery (efficiency of detachment) of the 
cells from the glass slides was monitored by repetition of the steps with 
subsequent enumeration to establish no significant changes in the viable count.    
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2.4.6 Enumeration of bacteriophage  
Bacterial lawns of C. jejuni PT14 or HPC5 or 11168 were prepared as 
described in 2.3.2. Serial dilutions of the recoverable attached phage 
populations in MRD were retained over night at 4 ºC before titering of the 
bacteriophage as described in 2.3.3. After washing with 2 ml of MRD, the 
unattached bacteriophage on biofilms were eradicated. The recoverable 
attached phage numbers of plaque forming units (PFU) per cm2 of surface area 
of glass cover slip were calculated by The recoverable attached phage numbers 
of plaque forming units (PFU) per cm2 of surface area of glass cover slip were 
calculated by dividing the plaque forming units determined per coverslip with 
surface area (cm2) of the glass coverslip. The limit of detection for the 
enumeration of bacteriophage in biofilms and planktonic phases was 1 log 
PFU/cm2 and 2 PFU/ml, respectively. 
2.4.7 Crystal violet staining for quantity of biofilms  
Crystal violet is a vital dye which binds to carbohydrate, protein and nucleic 
acid and is therefore useful for staining and quantifying biofilm material (Kim 
and Wei 2007). Campylobacter biofilms attached to glass cover slips were 
washed twice with 2 ml of MRD (2.1.8) at ambient temperature prior to 
staining. One hundred microlitres of 0.1% (w/v) crystal violet (Sigma-Aldrich) 
was added to the surface of each glass coverslip and allowed to stain for 1 h. 
The biofilms were then washed three times with sterile RO water. The bound 
crystal violet was extracted from biofilms by dissolving in 2 ml of 95% 
ethanol. The absorbance of the extract was measured at 570 nm by Pharmacia 
Biotech Ultrospec®2000 UV/Visible Spectrophotometer. Efficiency of  the 
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crystal violet stained on biofilm was monitored by repetition of the method to 
prove no significant different. 
2.4.8  Determination of the frequency of phage resistance 
The 30-100 colonies produced by viable cells recovered from biofilms post-
treatment with either bacteriophage CP8 or CP30 were sub-cultured on blood 
agar plates (2.2.1). Bacterial lawns were prepared from these sub-cultures to 
test for bacteriophage sensitivity (2.3.2). Phage stocks were applied to the 
bacterial lawn as 10 µl aliquots at the routine test dilution (105 PFU/ml; Frost 
et al., 1999). Bacteriophage stocks included bacteriophage CP8 and CP30 
propagated on different host strains. Phage resistance was identified on the 
basis of the inability of the phage stock to produce confluent lysis or generate 
any plaques on the bacterial lawn. The frequency of phage resistance was 
calculated as the percentage of resistant isolates per total number of isolates 
tested.  
2.4.9 Motility (swarming) determination 
The motility of Campylobacter isolates was assessed by centre-inoculating 
0.4% (w/v) Muller-Hinton agar plates (2.1.6) and subsequently incubating 
them under microaerobic conditions for 48 h according to Goossens et al. 
(1989). The diameter (cm) of the growth was measured as the degree of 
swarming. 
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2.5 DNA preparation and analysis 
2.5.1 Campylobacter jejuni genomic DNA extraction 
Campylobacter jejuni genomic DNA was extracted and purified by using 
*HQ(OXWH%DFWHULDO*HQRPLF'1$NLWIROORZLQJPDQXIDFWXUHU¶VLnstructions 
(Sigma-Aldrich). Briefly, the Campylobacter cultures (2.2.1) were resuspended 
in 1.5 ml of PBS (2.1.9) and centrifuged at 13,000 x g for 1 min. Pellets were 
harvested and resuspended in 180 µl of lysis solution T (EDTA disodium [0.5 
M solution], 1-S-Octyl-beta-D-thioglucopyranoside [9-8%], NaCl, Tris-HCl 
[pH 8.0, 1.0 M stock solution]). The 20 µl of RNase A (20 mg/ml) was mixed 
and incubated at room temperature for 2 min to get RNA free DNA. Cell lysis 
was carried out by the addition of 20 µl of 20 mg/ml of Proteinase K solution, 
incubation for 30 min at 55 oC followed by the addition of 200 µl of lysis 
solution C (guanidine hydrochloride, Tris-HCl [pH 7.0, 1.0 M sock solution], 
EDTA disodium [0.5 M solution], Tween® 20, p-tertiary-Octylphenoxy 
polyethyl alcohol, hydrochloric acid, water), incubated for 10 min at 55 oC to 
obtain the lysate. The mixture of the entire lysate suspension and 200 µl of 
100% ethanol were transferred into prepared binding column using a wide bore 
pipette tip, then centrifuged at 6,500 x g for 1 min. The washing step was 
performed firstly by addition of 500 µl of washing solution 1 (ethanol), 
centrifugation at 6,500 x g for 1 min and subsequently by addition of 500 µl of 
wash concentration solution (withheld as a trade secret of the manufacturer), 
centrifugation at 13,000 x g for 3 min to dry the column. The DNA was eluted 
by addition of 200 µl of the elution solution (10 mM TrisHCl, 0.5 mM EDTA, 
pH 9.0) directly onto the centre of the column, incubation at room temperature 
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for 5 min and then centrifugation at 6,500 x g for 1 min. The DNA solution 
was kept at 4 °C or -20 oC.  
2.5.2  Bacteriophage DNA extraction 
Two hundred microlitres of phage suspension (approximately 109 PFU/ml) was 
mixed with 200 µl of detergent solution containing 20 mM Tris-HCl (pH 8), 
200 mM EDTA (pH 8), 2% (w/v) N-lauroyl sarcosine (Sigma-Aldrich) and 
0.4% (w/v) sodium dodecyl sulphate (SDS, Sigma-Aldrich).  Twenty 
microlitres of 10 mg/ml of proteinase K (Sigma-Aldrich) was then added and 
incubated at 55 °C 2 h to digest capsid proteins. Phenol solution (Fisher 
Scientific) was added (0.5 ml), mixed by inverting, and centrifuged at 13,000 x 
g for 1 min. The top phase was collected and transferred to a new tube. 
Chloroform (Sigma-Aldrich) was added (0.5 ml) in the new tube and the tube 
was mixed by inverting, and then centrifuged at 13,000 x g for 1 min. This step 
was repeated once and then a 1: 10 volume of 7.5 M ammonium acetate 
(Sigma-Aldrich) was added. Two volumes of 100% ice cold ethanol was added 
and mixed gently by inverting. The tube was then kept at -20 °C overnight. The 
sample was centrifuged at 13,000 x g for 10 min. The pellet was collected and 
washed with 70% ethanol and then centrifuged at 13,000 g for 10 min. the 
pellet was resuspended in 50 µl of TE buffer (2.1.10) and kept at 4 °C until use. 
The DNA content was measured by using a Nanodrop ND-1000 
spectrophotometer (Fisher Thermo Scientific) and by agarose gel 
electrophoresis (2.5.4).   
2.5.3 Agarose Gel Electrophoresis 
DNA was routinely analysed using agarose gel electrophoresis. A solution 
containing 0.8% or 1.0% (w/v) agarose (Melford Laboratories Ltd., Ipswich, 
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UK) in TAE buffer (2.1.11) was melted in a microwave and allowed to cool to 
70 ºC. Ethidium bromide was added to a final concentration of 0.4 µg/ml and 
the solution poured into casting trays and allowed to set for 30 min at room 
temperature. DNA samples were mixed with 0.2 volumes of 6 x blue/orange 
loading dye (Promega UK, Southampton, UK) and loaded to wells in the gel. 
Standard DNA for comparison was the 1 kb ladder and 100 bp ladder markers 
(Promega). The samples were electrophoresised for 1 ± 2 h at 80 V in 1x TAE 
buffer (2.1.11) before visualisation using a Molecular Imager Gel Doc system 
(Bio-Rad Laboratories, Inc, Hercules, CA, USA). 
2.5.4 Pulsed Field Gel Electrophoresis 
Macro restriction profiling of Campylobacter genomes was performed 
according to the protocol of Ribot et al. (2001). PFGE was used to determine 
Campylobacter and CSLC bacteriophage-associated genomic DNA fragments 
from 20 ± 1000 kb in size. Campylobacter genomic DNA plugs were made by 
collecting the growth from a blood agar plate into 1.5 ml of PBS (2.1.9) using a 
sterile swab. The suspensions (400 µl) were then mixed with 400 µl of molten 
1% (w/v) ultra-pure PFGE agarose (Bio-Rad) in 1X TE buffer (2.1.10) and 
dispensed to plug moulds (Bio-Rad) to set. The genomic DNA plugs were 
incubated in freshly prepared cell lysis buffer (50mM Tris-HCl [pH 8.0], 
50mM EDTA, 1% (w/v) N-lauroyl sarcosine, 0.1 mg/ml proteinase K) at 55°C 
without shaking for 20 min. The plugs were then washed by incubating at 55 
°C in RO water for 20 min, followed by three incubations in TE buffer at 55 °C 
without shaking for 15 min. DNA plugs were stored at 4°C in TE buffer until 
use. 
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Campylobacter genomic DNA plugs were digested with SmaI to produce 
fragments of 20 ± 1000 kb size. The plugs were cut into 2 mm slices using a 
sterile scalpel and separately placed into 100 µl of SuRE/cut buffer A (33 mM 
tris-acetate adjusted with glacial acetic acid to pH 7.9, 10 mM magnesium 
acetate, 66 mM potassium acetate, 0.5 mM dithiothreitol) for 15 min at room 
temperature. This was replaced with 100 µl of fresh SuRE/cut buffer A and 
SmaI (Roche) was added to a final concentration of 0.4 U/µl. This was 
incubated for 2 h at 30 °C without shaking, when the buffer/ SmaI mixture was 
removed and replaced by 100 µl of TE buffer (2.1.10).  
The digested DNA plugs were inserted into the PFGE 1% (w/v) of ultra-pure 
agarose (BioRad) gel in TAE (2.1.11). Electrophoresis was performed for 18 h 
at 14°C in a CHEF-DRII PFGE apparatus (Bio-Rad) in 1X TAE buffer with an 
initial switch time of 6.8 s and a final switch time of 38.4 s (gradient of 6 V/cm 
and an included angle of 120°). Following electrophoresis the gel was 
immersed in a 50 µg/ml ethidium bromide solution for 30 min followed by two 
washes in RO water for 30 min each and visualized under UV illumination. 
2.5.5  Southern blotting of pulsed field gel electrophoresis (PFGE) 
Southern blotting of PFGE was used to identify the bacteriophage genomes 
associated with the CSLC strains. The PFGE gel was transferred to 200 ml of 
0.25 M HCl for 10 min at room temperature and washed with RO water. The 
gel was soaked twice in 200 ml of denaturation solution (0.5 M NaOH, 1.5 M 
NaCl) for 15 min and washed with RO water. Subsequently, the gel was 
soaked twice in 200 ml of neutralization solution (0.5 M Tris-HCl, pH 7.5 and 
3 M NaCl) for 15 min and washed with RO water. The southern blot was 
performed as described by Sambrook et al. (1989) using Hybound-N+ nylon 
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membrane (GE healthcare, Buckingham, UK). After transfer the DNA was 
cross-linked on the membrane using UV light for 2 min. The membrane was 
kept in TE buffer (2.1.9) at 4 oC.  
2.5.6  Hybridization  
Hybridization was performed by using Digoxigenin (DIG) high prime DNA 
labeling and detection starter kit (Roche Applied Science, Mannheim, 
*HUPDQ\DVGHVFULEHGLQPDQXIDFWXUHU¶VLQVWUXFWLRQ 
The preparation of DIG probes was carried out as following: Template DNAs 
(0.5-1 µg) were denatured by heating in a boiling water bath in a 1.5 ml 
microfuge tube for 10 min and quickly chilling on ice. Four microliter of DIG-
High prime (vial 1) was mixed with the denatured DNA and incubated 
overnight at 37 ϶C. Reaction was stopped by heating at 65 ϶C for 10 min. The 
denatured DIG-labeled DNA probe was added into 7 ml of pre-heated DIG 
Easy Hyb buffer at 42 ϶C as a probe mixture and carried on hybridization.  
Pre-hybridization the blot was performed by adding 20 ml of pre-heated DIG 
Easy Hyb at 42 ϶C for overnight with gentle agitation.  The pre-hybridization 
solution was poured off and then added the probe mixture to the blot. 
Hybridization was performed overnight with gentle agitation at 42 ϶C. The 
membrane was washed subsequently twice in 100 ml of 2X SSC, 0.1 % SDS at 
25 ϶C for 5 min under constant shaking. The blot was washed twice in pre-heat 
100 ml of 0.5X SSC, 0.1% SDS at 65 ϶C for 15 min under constant agitation at 
65 ϶C. After that the blot was washed briefly with washing buffer [0.1 M 
Maleic acid, 0.15 M NaCl, pH 7.5 and 0.3% (v/v) Tween 20] for 2-5 min at 25 
϶C under constant agitation. The blocking buffer [1: 10 blocking solution 
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(bottle 6) and Maleic acid buffer (0.1 M Maleic acid, 0.15 M NaCl, pH 7.5)] 
was added to block the blot for 60 min at 25 ϶C under constant agitation. The 
diluted 1:5000 Anti-Digoxigenin-Alkaline phosphatase conjugate (vial 4) with 
blocking buffer was added on the blot and incubated under constant agitation 
for 60 min at 25 ϶C. The membrane was washed twice with washing buffer for 
15 min under the same conditions. Subsequently, the membrane was 
equilibrated with detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5) for 2-
5 min at room temperature. The mixture of 200 µl of NBT/BCIP stock solution 
(vial 5) and 10 ml of detection buffer was added to the blot and then incubated 
in the dark until the band visible (2-3 hours). The reaction was stopped by 
transferring to TE buffer.    
 
2.6 Transduction of chloramphenicol resistance gene via 
phages and the carrier state life cycle (CSLC) phages 
 
Campylobacter jejuni 11168 GFP, 11168YFP, PT14GFP and PT14YFP strains 
that contained a plasmid which expressed green fluorescence protein (GFP) or 
yellow fluorescence protein (YFP) and camR (chloramphenicol resistance 
gene) were used for phage propagation. The CSLC phages were propagated 
from C. jejuni PT14YFPCP8PL and PT14YFPCP30PL obtaining from phage 
treatment on C. jejuni PT14YFP. The phages and CSLC phages (109-1010 
PFU/ml) were added to suspensions of C. jejuni 11168 and PT14 (107 CFU/ml) 
at 42 °C under microaerobic conditions for 1 h. The viable Campylobacter 
counts were performed by using Muller-Hinton plates (2.1.7) supplemented 
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with 5 % horse blood (TCS) and 10 µg/ml chloramphenicol (2.2.1). The 
resistant colonies were enumerated and the transduction rate calculated by 
division of transductant cells by the bacteriophage density. 
 
2.7 Characteristics of CSLC strains and phages 
2.7.1 Growth curve of Campylobacter jejuni and CSLC strains 
Campylobacter jejuni and CSLC isolates were sub-cultured as previously 
described (2.2.1). The cultures were inoculated into 50 ml of sterile MH broth 
to a concentration of approximately 105 CFU/ml as described in 2.4.2 and 
subsequently determined by viable count to obtain the initial Campylobacter 
counts. Samples were incubated in a shaking incubator selecting an orbital 
rotating speed of 100 rpm (IS-971R, Fishers Scientific, UK) at 42 °C using 
either microaerobic conditions, or low oxygen (<1% O2)  conditions generated 
by $QDHUR*HQ JDV SDFNV 2[RLG RU DWPRVSKHULF R[\JHQ DHURELF
conditions). A 100 µl aliquot was removed every 2 h for 24 h for microaerobic 
and low oxygen (<1% O2) conditions or 1 h for aerobic conditions. The 
samples were immediately ten-fold serially diluted using MRD. The number of 
viable Campylobacter and bacteriophages were enumerated by following the 
method as described above (2.2.2 and 2.3.4).  All experiments were performed 
in triplicate at least twice.    
2.7.2 Survival of Campylobacter jejuni and CSLC strains 
Campylobacter jejuni and CSLC isolates were sub-cultured as previous 
described (2.2.1). The cultures were inoculated into 50 ml of sterile MRD to 
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final concentration approximately 105 CFU/ml as described in 2.4.2 and 
subsequently determined by viable count to obtain the initial Campylobacter 
counts. The cultures were incubated in a shaking incubator at 100 rpm (Fishers 
Scientific) at 42 °C under either under microaerobic conditions, or low oxygen 
(<1% O2 FRQGLWLRQV DFKLHYHG XVLQJ $QDHUR*HQ 2[RLG RU atmospheric 
conditions (aerobic). The number of viable Campylobacters and 
bacteriophages were enumerated by following the method described in 2.2.2 
and 2.3.4. Percentage of survival of Campylobacter and bacteriophage were 
calculated. All experiments were performed in triplicate.   
2.7.3  Effect of temperature on survival of C. jejuni  
Campylobacter jejuni parent strains and CSLC isolates were sub-cultured as 
previously described (2.2.1). The cultures were inoculated into 50 ml of sterile 
MRD to final concentration of approximately 107 CFU/ml as described in 2.4.2 
and subsequently determined by viable count to obtain the initial 
Campylobacter counts. The cultures were then incubated in an orbital shaking 
incubator set at 100 rpm at 42 °C under microaerobic conditions for 2 h. The 
cultures were then aliquoted (1 ml) into microcentrifuge tube and then 
incubated under ambient atmospheric conditions either at 4 °C for 1, 3, 5, 7 and 
9 days, or for 0.5, 1, 1.5 and 2 h using a water bath set at 50 °C . The survival 
of bacterial cells and bacteriophages were determined as described in 2.2.2 and 
2.3.3. Percentage of survival of Campylobacter and bacteriophage were 
calculated relative to numbers of bacteria and bacteriophages at the initial time. 
All experiments were performed in triplicate.   
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2.7.4 Comparison of the ability of parent phages and CSLC phages to 
form plaques on different hosts 
Lawns were prepared as described in 2.3.2. The routine phage concentrations 
(approximately 105 PFU/ml) of that were propagated from distinct strains were 
applied on the lawns. The ability of phages and CSLC phages to form plaque 
on the different hosts was evaluated.    
2.7.5  Efficiency of plating (EOP) of parent phages and CSLC phages 
The efficiency of plating (EOP) of phages and CSLC phages was determined 
by calculating from the phage titre when applied to the lawns of C. jejuni 
HPC5 and 11168 and comparing them to the type strain, C. jejuni PT14.  The 
lawns were prepared using the method described in 2.3.2. The phages and 
CSLC phages were serial-diluted and onto each lawn. Phage numbers were 
counted and the EOP calculated. All experiments were performed in triplicate.  
2.7.6 Host binding assay of bacteriophages 
Campylobacter jejuni NCTC 11168, PT14 and HPC5 were sub-cultured as 
previously described (2.2.1). The hosts were prepared in 10 ml of MH broth to 
give final counts approximately 109-1010 CFU/ml. Phages and CSLC phages 
were employed to a final phage titre of 105 PFU/ml.  The mixtures were 
incubated in a shaking incubator operating at 100 rpm (Fishers Scientific) at 42 
°C under microaerobic conditions, interval sampling every 30 min until 90 
min. Samples were centrifuged at 13,000 x g for 5 min and the supernatants 
collected for examining the phage number by following the method described 
above (2.3.3). The percentages of phage binding were calculated.  All 
experiments were performed in triplicate twice. The data were presented as the 
means and SD of the percentage of bound phage determined from triplicate 
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determinations of the residuals of the input titres less the free phage post 
centrifugation, and their significant determined using unpaired t-tests, ANOVA 
(P DQG IXUWKHU PXOWLSOH FRPSDULVRQ RI WKH PHDQV ZLWK 7XNH\¶V 
confidence intervals.  
 
2.8 Transmission Electron Microscope (TEM) 
Biofilms attached to glass coverslips (2.4.2) were fixed and the capsular 
material stained using 1% (w/v) alcian blue 8GX (Sigma-Aldrich) (Karvlyshev 
et al., 2001) and 3% (v/v) glutaraldehyde prepared in 0.075 M sodium 
cacodylate (Sigma-Aldrich) buffer, pH 7.4. They were post ±fixed in 1% (v/v) 
osmium tetroxide in the same buffer following this, a thin layer of 1% (w/v) 
molten agar (Oxoid) that had been cooled to 45 °C was applied to cover the 
fixed biofilms and allowed to solidify. The agar-encased biofilms were then 
removed from the glass cover slips and cut into 2-3 mm pieces to allow 
processing using standard procedures, by dehydration in ethanol, infiltration 
and embedding in resin (TAAB Laboratories, Aldermaston, UK). Ultra thin 
sections were stained with uranyl acetate (Sigma-Aldrich) and lead citrate 
(Sigma-$OGULFK EHIRUH REVHUYDWLRQ XVLQJ 7HFQDL %LRWZLQ WUDQVPLVVLRQ
electron microscope (FEI Company) operated at an accelerating voltage of 100 
kV.  
The CSLC strains were examined by using negative staining technique. 
Bacterial cultures were applied to a copper grid and then stained with uranyl 
acetate. The images were observed by TEM operated at an accelerating voltage 
of 100 kV.    
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2.9   RNA isolation and purification 
Campylobacter jejuni and CSLC isolates (Table 2.1) were sub-cultured as 
previously described in 2.2.1. Three independent experiments of each culture 
were inoculated into 150 ml of sterile MH broth to a final density 
approximately 105 CFU/ml as described in 2.4.2 and then incubated in a 
shaking incubator at 100 rpm (Fishers Scientific) at 42 °C under microaerobic 
conditions for 9 h. Seven independent cultures of C. jejuni HPC5 were grown 
in 150 ml of sterile Nutrient broth (Oxoid) using the same conditions, from 
which independent RNA extractions were prepared and then pooled to act as a 
control for normalization of the hybridization levels to oligonucleotide spots in 
the microarray experiments. After centrifugation at 12,000 x g for 15 min, at 4 
°C, in a Beckman JS-21 centrifuge using a JA14 rotor, the pellets were pooled. 
Total RNA were isolated by using TRIzol® 0D[%DFWHULDO51$LVRODWLRQNLW
,QYLWURJHQ 3DLVOH\ 8. IROORZLQJ PDQXIDFWXUHU¶V LQVWUXFWLRQV The pre-
heated Max Bacterial Enhancement Reagent at 95 °C was added by pipetting 
up and down to inhibit RNase activity and incubated at 95 °C for 4 min. 
TRizol® reagent was added to the lysate and incubated at room temperature for 
5 min. Phase separation was proceeded by adding cold chloroform (Sigma-
Aldrich) and mixed by shaking the tube vigorously by vortex for 15 sec. The 
mixture was incubated at room temperature and centrifuged at 12,000 g for 15 
min at 4 °C.  The mixture was separated into a lower red, phenol-chloroform 
phase, an interphase, and a colorless aqueous phase containing RNA. The 
aqueous phase (400 µl) was transferred into a fresh tube for proceeding to 
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precipitating RNA by adding 0.5 ml cold isopropanol (Fluka) and mixing by 
inverting the tube, incubated at room temperature for 10 min. After 
centrifugation at 12,000 g for 10 min at 4 °C, the supernatant was removed 
carefully without disturbing the RNA pellet. The pellet was resuspended in 1 
ml of 75% ethanol and centrifuged at 7,500 g for 5 min at 4 °C. The RNA 
pellet was resuspended in 50 µl RNase free water by pipetting up and down 
after air-dry.  The RNA was treated by DNase I (QIAGEN) to digest away 
contaminated DNA and purified by using the RNeasy mini kit (QIAGEN) 
IROORZLQJ PDQXIDFWXUHU¶V LQVWUXFWLRQV %ULHIO\ WKH 51$ ZDV FOHDQHG XS E\
buffer RLT (containing quinidine thiocynate) and subsequently with 96-100% 
of ethanol by using RNeasy mini spin column and centrifuge at 8000 x g for 15 
sec. each step. The RNA was then cleaned twice by buffer RPE (containing 
ethanol) using the mini spin column and centrifuge at 8000 x g for 15 sec. and 
2 min, respectively.  The RNA was collected into RNase free water. RNA 
concentration was determined by using Nanodrop ND-1000 spectrophotometer 
(Fisher Scientific).  The RNA was stored at -80 oC. 
 
2.10  cDNA synthesis, labeling and hybridization 
Reverse transcription and labeling with Alexa Fluor® AF555 and AF647 dyes 
(Molecular Probes, Invitrogen, Eugene, OR, USA) was carried out using a 
6XSHU6FULSW GLUHFW F'1$ ODEHOOLQJ NLW ,QYLWURJHQ DFFRUGLQJ WR WKH
PDQXIDFWXUHU¶V LQVWUXFWLRQV following an incubation for 3 h at 46 ºC, the 
K\GURO\VLVUHDFWLRQZDVSHUIRUPHGE\DGGLQJȝORI01D2+DQGLQFXEDWLQJLW
at 70 ºC for 15 min. Neutralisation of the reaction was performed by adding the 
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same quantity of 1 M HCl. Synthesised cDNA was purified by using QIA quick 
PCR purification kit (QIAGEN) and subsequently ethanol precipitation to 
concentrate samples. The eluted cDNA was precipitated with ethanol and was 
stored at -&SULRUWRODEHOOLQJ7RȝORIWKHF'1$ȝORI0RIVRGLXP
bicarbonate (Sigma Aldrich, UK) was added and Alexa Fluor (Fisher, UK) dyes 
ZHUHDGGHGE\GLVVROYLQJ LQȝORIGLPHWK\OVXOIR[LGH '0626LJPD$OGULFK
UK). This was incubated for 1 h in the dark, and the labelled cDNA was purified 
by using the QIA PCR Purification kit according to the PDQXIDFWXUHU¶V
instructions. The synthesized cDNA was quantified by using a Nanodrop 
spectrophotometer. Labelling efficiency was measured by calculating the 
frequency of incorporation (FOI) of the dye defined as the number of labeled 
nucleotides incorporated per 1000 nucleotides of cDNA (nucleotides / dye ratio 
= pmol dNTP / pmol dye) and should be >15. The experimental samples were 
competitively hybridized against pooled HPC5 cDNA control, prepared as 
described above (2.9), labelled with AF555.  
The arrays are composed of synthetic oligonucleotide 70-mers(Eurofins MWG 
2SHURQ*HUPDQ\7P&&ORFDWHGIURPƍHQGRIJHQH!ESSRO\
(N) tract <8 bp, stem length in potential hairpin <8 bp contiguous bases 
common to any non-self ORF <20 bp with cross-hybridisation identity to all 
other genes <70%. 7KH VOLGHV XVHG IRU WKH PLFURDUUD\ ZHUH Ȗ-
DPLQRSURS\OWULHWKR[\VLODQH Ȗ $36 FRDWHG $+ bar coded SCHOTT Nexterion® 
slides (Item number 1064875). The slides were printed according to a campy 
dense array gal file by Microgrid II GOD robot using TAS software version 
V2.4.03. The slides had 2500 pins with a 26 × 26 pin grid configuration. The 
spacing between the spots was 0.165 mm and the slides were prepared at 60% 
                                                                         Chapter 2 Materials and methods 
75 
 
humidity. The slides were rehydrated by incubation at room temperature in a 
humidity chamber for 30 min followed by 30 min incubation at 60 °C to dry. 
The slides were blocked in a solution containing 100 mM ethanolamine, 1 M 
Tris (pH 9.0), and 0.1% SDS (Sigma Aldrich) for 15 min at 50 °C, then 
thoroughly rinsed with water and spun dry before use. Hybridizations of 
microarray slides were performed at the Queens Medical Centre, University of 
Nottingham.The slides represent oligonucleotide microarray contains the gene 
repertoires (locus tags) from C. jejuni 11168 (Gundogdu et al., 2007; Parkhill 
et al., 2000), C. jejuni RM1221 (Fouts et al., 2005), C. coli RM2228 (Fouts et 
al., 2005), and all new non-redundant locus tags associated with C. jejuni and 
C. coli genomes available in the GenBank database at the time of construction 
(May 2009). In addition, oligonucleotides representing all the Campylobacter 
bacteriophage genes for representative class II (CP220 Accession No: 
FN667788.1; Timms et al., 2010) and class III (CPX Accession No: 
JN132397.1; Al-kandari et al., unpublished) bacteriophage.  
The microarray slides were printed in triplicate and each of the hybridizations 
were repeated to yield two technical replicates for each sample containing three 
independent spots for each oligonucleotide probe. The microarray slides were 
scanned using Axon Genepix 4200AL scanner (Molecular Devices 
Corporation, Sunnyvale, CA, USA). Fluorescent spot intensities were analyzed 
using Genespring GX11 software (Agilent Technologies UK Ltd, Wokingham, 
UK) and the data normalized against the AF555-labelled controls (Lowess), 
merged and expressed in Log2 values. The normalized data were compared 
between wild type and the CSLC strains. Differentially expressed genes were 
identified on the basis of P<0.05 by ANOVA and using the Benjamini 
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Hochberg False Discovery Rate correction (Benjamini and Hochberg, 1995) 
and exhibiting a minimum of a two-fold change in transcript abundance in all 
three independent biological replicates. At the time of writing these microarray 
data have not been published are not available in the Gene Expression 
Omnibus (GEO) database. 
 
2.11 Identification CSLC phage DNA in CSLC strains 
To identify the CSLC phage DNA in the CSLC strains, DNA of the CSLC 
strains was prepared as described in 2.5.1.  Primers were designed on a non-
coding region of CP30 that distinguish the DNA from other phages and 
synthesized by Eurofins MWG Operon (Ebersberg, Gemany) and the sequence 
of  the  primers shown below:   
 
Name Sequence 
CP30tp-Frd ¶-GAAATTGCATGAATCAATGCGG-¶ 
CP30tp-Rev ¶-GTTTGTCACTTTTTATGGAACTAC-¶ 
 
PCR reactions were performed in a total volume of 50 µl consisting of 1 µl of 
DNA template (100 ng/µl), 5 µl of 2.5 mM dNTPs (Promega), 5 µl of 25 mM 
MgCl2, 1 µl of each primer (listed above), 5 µl of 10 x buffer (500 mM tris-
HCl [pH 9.2], 140 mM ammonium sulphate, 17.5 mM magnesium chloride), 
variable volume of RO water and  1 Unit of Taq DNA polymerase (Thermo 
Scientific) in a thin-walled 0.5 ml PCR tubes (Fisher). PCR conditions were as 
follows: predenaturation at 96 °C for 3 min for 1 cycle and 30 cycles of 
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denaturation at 96 °C for 0.5 min, annealing at 60 °C for 0.25 min and 
elongation at 72 °C for 1 min before a final elongation at 72 °C for 7 min and 
storage of the PCR products at 4°C for analysis. 
 
2.12 Analysis of different DNA sequences of CP8 and CP30 
DNA sequences discriminating between bacteriophage CP8 and CP30 were 
identified to confirm the identities of the initial phages used for treatment with 
those produced by the CSLC cultures. The primers were designed on a unique 
region in the CP8 DNA sequence that distinguishes it from other phage 
sequences available. The oligonucleotides were synthesized by Eurofins MWG 
Operon (Ebersberg, Germany) and the sequence of primers shown below:   
Name Sequence 
CP853B ¶-TCG TTA TAC CAC GGA TAT AG-¶ 
CP854B ¶-TAT AGG AGG GTT GTG AAA TG-¶ 
 
Phage DNA was prepared as described in 2.5.2. PCR reaction mixtures were 
performed by following in total 50 µl consisting of 1 µl of DNA template (100 
ng/µl), 5 µl of 2.5 mM dNTPs (Promega), 5 µl of 25 mM MgCl2, 1 µl of each 
primer (above list), 5 µl of 10 x buffer (500 mM tris-HCl [pH 9.2], 140 mM 
ammonium sulphate, 17.5 mM magnesium chloride), variable volume of RO 
water and 1 U of Taq DNA polymerase (Thermo Scientific) in thin-walled 0.5 
ml PCR tubes (Fisher). PCR conditions were as follows: predenaturation at 96 
°C for 5 min for 1 cycle and 30 cycles of denaturation at 96 °C for 1 min, 
annealing at 52 °C for 0.5 min and elongation at 72 °C for 5 min before a final 
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elongation at 72 °C for 10 min and storage of the PCR products at 4°C for 
analysis. Sequencing of DNA 
DNA sequencing was performed on the PCR products after purification using a 
PCR purification kit (Qiagen). DNA sequencing was performed by MWG 
Biotech AG (Ebersberg, Germany) using their ValueRead service (dye 
terminator chemistry). 
DNA sequencing results were received as chromatograms. These were 
analysed using Chromas v1.45 (Conor McCarthy, Griffith University, Australia 
- the latest version of this program can be obtained from 
http://www.technelysium.com.au/chromas.html) and the raw sequence data 
exported to the BioEdit sequence alignment tool (Hall, 1999) for further 
analysis. Sequences were compared to database sequences using the BLAST 
suite of tools (Altschul et al., 1997) which was located at 
http://www.ncbi.nlm.nih.gov/blast/. 
 
2.13 Analysis of the inactivation of CP8 with antiserum 
The C. jejuni, CP8PL (CSLC phage) and CSLC cultures were treated with 
either rabbit pre-immune serum or serum raised against bacteriophage CP8 
following dilution with PBS buffer at a final concentration 1:15. Viable 
Campylobacter counts and bacteriophage titres were determined post 
treatments as described above in sections 2.2.2 and 2.3.4 respectively.   
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CHAPTER 3 
BACTERIOPHAGE-MEDIATED DISPERSAL OF 
CAMPYLOBACTER JEJUNI BIOFILMS 
 
3.1  Introduction 
Campylobacter jejuni is a Gram-negative thermotolerant microaerobic 
pathogen that causes human gastroenteritis worldwide. In the United States, it 
is estimated there are 2 to 3 million people infected each year 
(http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/technical
.html#incidence), whereas over 190,000 cases were reported in the European 
Union (www.efsa.europa.eu/de/scdocs/doc/1533.pdf). Infection usually causes 
self-limiting diarrhoea but can occasionally lead to serious illnesses such as 
Guillain-Barré syndrome and reactive arthritis (Stern, 2001). The majority of 
human disease is attributed to C. jejuni whilst infection by other members of 
the Campylobacter genus is relatively infrequent. Consumption of 
undercooked or contaminated meat or poultry is generally believed to be the 
cause of a significant proportion of the total number of infections (Wilson et 
al., 2008). 
 
Bacteria in their natural environments frequently form biofilms that are 
composed of single or multiple bacterial species embedded in a surface extra-
cellular polymeric matrix, which can include polysaccharides, protein, nucleic 
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acid, phospholipid and teichoic acid (Chmielewski et al., 2003; Costerton et 
al  2¶7RROH et al., 2000; Sutherland, 2001). Thermophilic 
campylobacters may be considered as part of the commensal communities of 
poultry (Hendrixson and DiRita, 2004) and many other wild and farmed 
animals. Typically these bacteria form densely packed parcels of cells within 
the luminal crypts, attached to the mucus but not directly to the epithelium 
(Beery et al., 1988). In the laboratory, Campylobacter has been shown to be 
capable of forming three distinct types of biofilm (Joshua et al., 2006): the 
surface-attached type, a pellicle type in liquid culture and an unattached 
aggregate or floc type, probably similar to that observed in the luminal crypts 
in vivo. Biofilm formation may help the bacteria to overcome environmental 
stresses such as aerobic conditions, desiccation, heating, disinfectants and 
acidic conditions (Murphy et al., 2006; Reeser et al., 2007), and thereby 
increase their potential to cause disease. Campylobacter strains have been 
demonstrated to attach or associate with biofilms containing multiple 
organisms such as Gram-positive bacteria. For example, campylobacters 
comprise part of the mixed microflora of biofilms present in water lines and on 
many types of surface, including materials commonly used in industrial 
settings such as polyvinyl chloride (PVC) and stainless steel (Buswell et al., 
1998; Sanders et al., 2007; Sanders et al., 2008; Trachoo et al., 2002; Zimmer 
et al., 2003). Campylobacters have also been demonstrated to form 
monoculture biofilms on various surfaces under microaerobic (Dykes et al., 
2003; Gunther IV et al., 2009; Joshua et al., 2006; Kalmokoff et al., 2006; Moe 
et al., 2010; Reeser et al., 2007) and aerobic conditions (Reuter et al., 2010). 
Under conditions of biofilm formation Campylobacter strains have been 
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reported to be enhanced in their ability to resist antimicrobial agents (Joshua et 
al., 2006; Kalmokoff et al., 2006). Sessile cells of C. jejuni within biofilms 
exhibit a greater resistance to treatments with the anitbiotics ciprofloxacin or 
erythromycin compared to non-biofilm planktonic cells, possibly because these 
antibiotic agents do not diffuse through C. jejuni biofilm EPS (Lu et al., 2012). 
The formation of biofilms has therefore been suggested as a mechanism by 
which Campylobacter are able to survive harsh environments, and is probably 
a contributing factor in their persistence and colonization of the digestive tracts 
of poultry and other animal species. 
 
Bacteriophages represent an alternative to conventional antimicrobial agents to 
control food-borne microorganisms. The abilities of bacteriophages to reduce 
food-borne bacteria as a means of bio-sanitization and phage therapy have been 
investigated. Campylobacter bacteriophages have been shown to reduce viable 
Campylobacter cells on chicken skin (Atterbury et al., 2003; Goode et al., 
2003) and on raw and cooked beef (Bigwood et al., 2008). Bacteriophage 
therapy has been shown to reduce Campylobacter in the intestines of chickens 
(El-Shibiny et al., 2005; El-Shibiny et al., 2009; Loc Carrillo et al., 2005; Scott 
et al., 2007a; Wagenaar et al., 2005). Acquisition of bacteriophage resistance is 
commonly cited as a disadvantage of bacteriophage; however, implementation 
of the treatment of broiler chickens at the end of the rearing cycle should 
ensure maximal effect of the treatment and the removal of resistant survivors 
upon depopulation of the barn (El-Shibiny et al., 2009). Resistant 
Campylobacter isolates recovered from chickens treated with bacteriophage 
have been reported to be compromised in their ability to recolonize chickens 
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(Loc Carrillo et al., 2005), however alternative studies using bacteriophage 
cocktails  have been reported to lead to resistant types capable of re-
colonization (Carvalho et al., 2010).  
 
The application of bacteriophage to reduce biofilms of several different 
bacterial species has been demonstrated (Hibma et al., 1997; Hughes et al., 
1998; Sillankorva et al., 2004). Moreover, engineered bacteriophage enzymes 
have been employed to disperse biofilms by breaking down components of the 
extra-cellular polymeric matrix (Lu and Collins, 2007). However, when 
stainless steel adherent Escherichia coli O157:H7 were treated with 
bacteriophages there was a reduction in the viability of the exposed adhered 
cells but not in the cells within the biofilm itself due to inability of 
bacteriophage to gain access through the biofilm (Sharma et al., 2005).  
 
In this chapter the optimal conditions required for the formation of stable 
biofilms by C. jejuni have been investigated as a prerequisite to assess the 
impact of bacteriophage. The effect of bacteriophage treatment of 
Campylobacter biofilms had not previously been studied, and therefore this 
study was undertaken to assess the ability of Campylobacter specific 
bacteriophage to prey on bacteria in situ and disperse Campylobacter biofilms. 
Bacteriophage treatment of bacteria is known to involve non-linear kinetic 
phenomena which are independent of the concentration of bacteriophage 
applied on the bacteria population (Payne and Jansen, 2001). However, the 
bacteriophage treatment is dependent on the adsorption properties of the 
bacteriophage to the host. The phage infection cycle within a biofilm 
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environment has been considered to consist of three stages: settlement on the 
biofilm surface, production of phage progeny inside the biofilms and 
emigration of phage progeny out of the current focus infection (Gallet et al., 
2009). High adsorption rates are beneficial for phage settlement but could be 
detrimental to phage productivity and emigration (Gallet et al., 2009). How 
these factors influence the formation and maintenance of biofilms in vivo or in 
the environment will require further research. 
 
 
3.2 Results 
3.2.1 Attachment and biofilm formation 
The biofilm forming ability of the type strain C. jejuni NCTC 11168 has been 
examined at 37 and 42 ºC under microaerobic conditions over 7 days. The 
viability of attached cells on a glass surface at these temperatures were not 
significantly different (P>0.05, paired t-test) (Figure 3.1A).  The quantities of 
biofilm produced at both temperatures were assessed by staining with crystal 
violet and measuring the optical density of the stained material solubilised in 
ethanol. At 5 days post-inoculation the quantity of biofilm material recovered 
from the glass surface at 37 ºC was higher than that at 42 ºC (Figure 3.1B).  
Therefore, all subsequent experiments of biofilm formation by C. jejuni and 
bacteriophage treatment were performed at 37 ºC after 5 days incubation in 
Muller-Hinton broth under microaerobic conditions. 
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Figure 3.1-Viablity of C.jejuni NCTC 11168 attached on a surfaces at 37ºC and 
42ºC under microaerobic conditions (A) and the quantity of biofilm produced 
as measured by recording the optical density at 570 nm after ethanol 
solubilisation of crystal violet stained surfaces (B). 
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The abilities to attach and form biofilms of C. jejuni strains NCTC11168, PT14 
and HPC5 were investigated to monitor the development of Campylobacter 
biofilms at 37 ºC under microaerobic conditions (Figure 3.2).  Figure 3.2A 
shows that C. jejuni strains NCTC 11168, PT14 and HPC5 were able to initiate 
attachment on a surface after incubation for 24 h with an increase in the viable 
count (Figure 3.2A). Strains NCTC 11168 and PT14 showed no significant 
difference in viability over 5 days but at 7 days post-incubation, the cells began 
to detach from the surface, resulting in a loss of viability. On the other hand, 
the viability of the planktonic cells remained similar throughout the experiment 
(Figure 3.2B). The quantity of biofilm increased under microaerobic conditions 
at days 5, suggesting that C. jejuni produces extracellular polymeric materials 
to form mature biofilms, however a reduction in the recoverable biofilm was 
observed at 7 days. Interestingly, C. jejuni HPC5 has the least ability to 
produce extracellular matrix materials when compared to the other strains. 
Sulaeman et al. (2010) reported that 46 strains 
of C. jejuni and C. coli displayed different adhesion capabilities ranging from 
no adhesion to strong adhesion. The ability of C. jejuni to attach on surfaces 
varied depending on the surface charge and composition of the support 
(Nguyen et al., 2011).  
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Figure 3.2-Viable count of attachment (A) and planktonic cells (B) of 
Campylobacter jejuni NCTC 11168, PT14 and HPC5 at 37 ºC under 
microaerobic condition and biofilm formation determined by recording the 
optical density at 570 nm after ethanol solubilisation of crystal violet stained 
surfaces (C). 
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3.2.2 Viability of Campylobacter cells within biofilms following 
bacteriophage treatment 
 
Biofilms that were allowed to form on glass surfaces over 5 days (time of 
maximum observed attachment and biofilm formation) were treated with either 
bacteriophage CP8 or CP30, at a multiplicity of infection (MOI) of 
approximately 1 PFU per viable Campylobacter cell(Figure 3.3). Planktonic 
cultures from these biofilms were recovered and treated simultaneously at an 
equivalent MOI. Initial viable counts within biofilms of C. jejuni NCTC 11168 
were observed to vary batch to batch over the range Log10 4 CFU/cm2 to Log10 
6 CFU/cm2. A minimum of 5 independent experiments were therefore 
performed in which each experiment contained 3 replicate control and treated 
biofilms from the same batch of glass coverslips. The data are recorded as the 
means and standard deviations of replicates within these independent 
experiments. Viable cell counts from the C. jejuni NCTC 11168 biofilm were 
significantly reduced by 3 Log10 CFU/cm2 at 2 h post-infection by either of the 
phages compared to mock treated biofilms (P <0.05; Figure 3.4A). In contrast 
with the bacteriophage treated biofilms the control (mock treated) C. jejuni 
NCTC 11168 biofilms exhibited an increase in the viable count over the period 
to reach approximately Log10 5.5 CFU/cm2 at 8 h. The initial fall in the 
bacteriophage treated biofilms was followed by a rapid recovery in the number 
of attached viable cells that could not have occurred by normal cell division 
alone within the 2 h period. The observation may be associated with 
bacteriophage mediated detachment of Campylobacter containing biofilm from 
the glass surface and its loss in the primary surface washes before agitation to 
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recover the biofilm and enumeration of the bacteria. Later time points would 
have sufficient time for re-attachment of Campylobacter containing biofilm 
and therefore record higher viable counts. The CP8-treated culture experienced 
a further decline in the viable cell numbers over the next 24 h to barely 
detectable levels.  
 
Bacteriophage treatments of C. jejuni PT14 biofilms with CP8 resulted in a 
reduction of 1 Log10 CFU/cm2 in the viable count at 24 h compared to the 
mock-treated control (Figure 3.5A). Treatment of C. jejuni PT14 biofilms with 
bacteriophage CP30 by comparison produced a 2.5 Log10 CFU/cm2 reduction 
in the viable count 4 h post-infection, before experiencing a temporary 
recovery at 8 h. No significant reductions beyond that recorded for the control 
culture were observed over the 4 h post-infection for C. jejuni PT14 biofilms 
treated with CP8 bacteriophage (Figure 3.5A).  
 
Bacteriophage treatment of C. jejuni HPC5 biofilms with CP30 or CP8 resulted 
in reductions in the viable counts of approximately 1 and 1.5 Log10 CFU/cm2 at 
2 h and 7 h, respectively when compared to the mock infected control biofilms 
(Figure 3.6A). However, the counts recorded for the attached bacteria of 
experimental and control samples exhibited a reduction in viability at 24 h.  
The C. jejuni strain HPC5 notably produced less crystal violet stainable 
extracellular polymeric matrix material than the other C. jejuni strains used in 
this study. Over the course of the experiment bacteria embedded in this matrix 
could be more easily detached and afforded less protection from desiccation or 
atmospheric oxygen.  Planktonic cells removed from the liquid phase of the C. 
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jejuni NCTC 11168, PT14 and HPC5 static cultures were treated in parallel 
with bacteriophages CP8 and CP30 (Figure 3.4B; 3.5B and 3.6B). The C. 
jejuni PT14 treated with CP30 showed a significant reduction of 1 Log10 
CFU/ml (P <0.05) in the viable count at 4 h, before recovery to levels recorded 
for mock-treated controls. Otherwise, the C. jejuni HPC5 treated with CP8 and 
CP30 exhibited a reduction in viability of 2 Log10 CFU/ml at 24 h post-
infection (Figure 3.6B).  
 
Bacteriophage titres following application to the biofilms declined probably as 
a result of binding host cells but thereafter remained static over the 
experimental period (broken lines in Fig.3.4A and 3.5A). However, it is 
notable that bacteriophage CP8 and CP30 bind the C. jejuni NCTC 11168 host 
in the biofilm or planktonic phase to a greater degree than C. jejuni PT14 
(Figure 3.4A to 3.5B).  
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Summary of bacteriophage treatment of Campylobacter biofilms 
 
 
 
Figure 3.3-Flow diagram of the protocol adopted for the bacteriophage 
treatment of Campylobacter biofilms  
Biofilm formation
10 ml of culture was 
dispensed into Petri 
dishes containing 6 glass 
cover slips, incubated at 
37 oC under microaerobic
conditions for 120 h. 
Biofilms  on coverslips moved 
to clean Petri dishes
Residual culture collected for 
independent treatment with 
100 µl of bacteriophage 
solution 
Bacteriophage treatment
100 µl of bacteriophage solution 
was placed onto each coverslip 
surface. The coverslips and tubes 
were incubated at 37 oC, under 
microaerobic conditions for 0, 2, 
4, 7, and 24 h
Biofilms washed gently with 2 
ml of MRD X 2 to remove 
unattached viable bacteria and 
bacteriophage. 
Biofilms harvested in MRD by 
vigorous pipetting to  detach 
cells from coverslips.
Phage treated Control Mock treated (MH)
0 h
2 h
4 h
7 h
24 h
Phage treated Control Mock treated (MH)
0 h
2 h
4 h
7 h
24 h
Enumeration of planktonic 
bacteria and bacteriophage 
Enumeration of biofilm 
bacteria and bacteriophage 
3 coverslips 
per time 
point for 
both phage 
treated and 
controls
3 tubes per time 
point for both 
treated and controls
Bacteriophage Treatment of Campylobacter Biofilms
For each time point
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Figure 3.4-Viablity of C. jejuni NCTC11168 following bacteriophage treatment of biofilms (A) 
compared to that following treatment of planktonic cultures (B). The bar chart (C) compares 
the effect of bacteriophage treatment of biofilms, quantified using crystal violet staining. For 
the biofilm cultures the limit of detection is 1.3 Log10 CFU or PFU/cm2 and for planktonic 
cultures 2.4 Log10 CFU or PFU/ml.  
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Figure 3.5-Viability of C. jejuni PT14 following bacteriophage treatment of biofilms (A) 
compared to that following treatment of planktonic cultures (B). The bar chart (C) compares 
the effect of bacteriophage treatment of biofilms, quantified using crystal violet staining. For 
the biofilm cultures the limit of detection is 1.3 Log10 CFU or PFU/cm2 and for planktonic 
cultures 2.4 Log10 CFU or PFU/ml. 
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Figure 3.6-Viability of C. jejuni HPC5 following bacteriophage treatment of biofilms (A) 
compared to that following treatment of planktonic cultures (B). The bar chart (C) compares 
the effect of bacteriophage treatment of biofilms, quantified using crystal violet staining. For 
the biofilm cultures the limit of detection is 1.3 Log10 CFU or PFU/cm2 and for planktonic 
cultures 2.4 Log10 CFU or PFU/ml. 
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3.2.3  Evidence for reduction of biofilms following bacteriophage 
treatment  
Reductions in the biofilm matrix density following bacteriophage treatment 
were assessed by measuring the optical density of ethanol solubilized material 
after staining with crystal violet and comparing these with mock-treated 
controls. The results showed that bacteriophage-treatment of either C.  jejuni 
PT14 or 11168 significantly reduced the attached biofilm material at 2 to 24 h 
time points after treatment (P < 0.05; Figure 3.4C and 3.5C). Whereas, the C. 
jejuni HPC5 was not significantly different (P> 0.05; Figure 3.6C).  
 
Bacteriophage treated and untreated Campylobacter biofilms were examined 
by transmission electron microscopy (TEM). Alcian blue staining allowed 
visualization of the capsular polysaccharide surrounding vegetative cells within 
the biofilm matrix (Karlyshev et al., 2001). Examination of the TEM images 
revealed that the bacteriophage treatment disrupted the biofilms formed by 
both Campylobacter strains. The TEM images also allowed detailed 
examination of the structure the Campylobacter biofilms which revealed them 
to consist of few vegetative rod-shaped cells. There are many circular/oval 
imaged regions stained with alcian blue which could be coccoid or rods in 
transverse section, which could not be discriminated due to the sectioning of 
the biofilm embedded bacteria in these TEM images.  Interestingly, in the 
bacteriophage-treated biofilms it was possible to identify Campylobacter cells 
in longitudinal section where the membranes were distorted and swelling 
outwards as if on the point of lysis (indicated by arrows in Fig.3.7 b, c, e, and f) 
that were not observable in the non-bacteriophage treated biofilms (Figure 3.8a 
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and 3.8d). The crystal violet staining and TEM images showed that the 
biofilms after treated with both bacteriophages were decreased when increased 
incubation time.  The trends of decreasing quantities of biofilms were similar 
by both methods.   According to Djordjevic et al. (2002) reported that biofilm 
assay with crystal violet staining and quantitative epifluorescence microscopy 
showed similar trends. Reuter et al. (2010) also reported that the 
Campylobacter biofilms stained with crystal violet and Congo red resulted in 
the same trends.    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter
 3 B
a
cteriophage
-m
ediated disp
ersal
 of
 C
.
 jejuni biofilm
s
 
96 
   
 
 
Figure 3.7-Transmission microscopy to show the effect of treatment with bacteriophage CP8 and CP30 on biofilms of C. jejuni 
NCTC11168 (a, b, and c) and PT14 (d, e, and f): controls without phage treatment ( a and d), bacteriophage CP8 treatment after 2 h (b and 
e), and bacteriophage CP30 treatment after 2 h (c and f).  Section was thinned and stained with alcian blue, indicating the extracellular 
polysaccharide.  
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Figure 3.8-Transmission microscopy to show the effect of treatment with bacteriophage CP8 (b and e) and CP30 (c and f) on C. jejuni 
NCTC11168 (a, b, and c) and PT14 (d, e, and f) biofilms after 24 h compared to effects in controls without phage treatment ( a and d). 
Arrows indicate regions of Campylobacter cells showing membrane distortion. Section was thinned and stained with alcian blue, 
indicating the extracellular polysaccharide. 
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3.2.4  Frequency of phage resistance in bacteriophage treated biofilms.  
Viable cells recovered from the biofilms following bacteriophage treatment 
were tested for acquired resistance. There was very clear disparity between the 
sensitivity to bacteriophage of the three different strains of Campylobacter 
tested following bacteriophage treatment. All the isolated viable cells from the 
C. jejuni PT14 biofilms remained susceptible to either of the bacteriophages 
applied. For the C. jejuni HPC5 bacteriophage-treated biofilms 7% (2/30) of 
viable cells recovered were resistant to either bacteriophage CP8 or CP30.  In 
contrast, only 16 % (5/32) and 10 % (3/30) of the viable cells recovered from 
C. jejuni 11168 bacteriophage-treated biofilms remained susceptible to 
bacteriophages CP8 and CP30 respectively. This difference is not reflected in 
the planktonic replicates, in which the C. jejuni PT14 biofilms retained 8% 
(8/100) and 9% (9/100) susceptible bacteria for CP8 and CP30 bacteriophage 
respectively, with 9% (9/100) and 11% (being the 11/100) respective figures 
for C. jejuni 11168.  
 
The motility of the majority of post treatment isolates was not affected on the 
basis of their ability to swarm on 0.4% Mueller-Hinton agar (Figure 3.9). 
However, a few isolates recovered after bacteriophage treatment of C. jejuni 
strains PT14 and HPC5 were not motile, which prompted further 
characterisation, and are the subjects of study in Chapter 4 that determines their 
status as carrier state life cycle strains (see Table 3.1 and Figure 3.9).  
Three of each of the bacteriophage resistant types recovered post CP8 or CP30 
treatment of C. jejuni 11168 were selected and tested for their ability to make 
biofilms on glass cover slips. The C. jejuni 11168 isolates resistant to CP8 
(b) 
PP
P
(d
)  (e)
  (d
)  (f)
  
(e)
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were impaired in the ability to form biofilm based on the observation of 
significant reductions in the biofilm matrix density (estimated by staining with 
crystal violet and optical density measurements of the ethanol solubilized 
material; Figure 3.10A) when compared to the progenitor strain (P < 0.05). The 
C. jejuni 11168 isolates resistant to CP30 appeared to form biofilm but upon 
application of fresh MH broth these lost integrity such that the quantity of 
crystal violet stainable material recovered from the coverslip was reduced 
compared to wild type independent of any bacteriophage treatment (Figure 
3.10B). 
 
Table 3.1-Example of motility of wild type and isolates after treatment with 
bacteriophage 
Samples Diameter (cm) 
C.  jejuni NCTC11168 7.1 
 An isolate from C. jejuni NCTC 11168 treated with CP8 6.8 
An isolate from C. jejuni NCTC 11168 treated with CP30 7.0 
C. jejuni PT14 5.3 
An isolate from C. jejuni NCTC PT14 treated with CP8 4.5 
An isolate from C. jejuni NCTC PT14 treated with CP30 4.7 
An isolate from C. jejuni NCTC PT14 treated with CP8 0 (Non-motile)* 
An isolate from C. jejuni NCTC PT14 treated with CP30 0 (Non-motile)* 
C. jejuni HPC5 3.8 
An isolate from C. jejuni HPC5 treated with CP8 0 (Non-motile)* 
An isolate from C. jejuni HPC5 treated with CP30 0 (Non-motile)* 
* The carrier state life cycle strains  
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Figure 3.9-Motility of Campylobacter isolates recovered post treatment with 
bacteriophage on 0.4% MHA, (A) An isolate from C. jejuni NCTC 11168 
treated with CP8, (B) An isolate from C. jejuni NCTC 11168 treated with 
CP30, (C) An isolate from C. jejuni HPC5 treated with CP8, (D) An isolate 
from C. jejuni HPC5 treated with CP30. 
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Figure 3.10- Effect of bacteriophages on biofilm formation on glass slides by 
bacteriophage resistant C. jejuni NCTC 11168RCP8 (A) and C. jejuni NCTC 
11168RCP30 (B), compared to wild type C. jejuni NCTC 11168.  The bacterial 
isolates were allowed to form biofilms on glass coverslips at 37 ºC under 
microaerobic conditions over 5 days and the biofilms quantified using crystal 
violet staining at harvest and over the time course indicated. The wild type and 
control resistant type cultures were incubated MH broth whereas the resistant 
types marked CP8 and CP30 were incubated with MH broth containing the 
respective bacteriophage (106 pfu at an MOI of approximately 1).   
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3.3 Discussion  
Members of the genus Campylobacter represent a significant burden to public 
health, so novel treatments to reduce the spread of infection are of fundamental 
importance. Most bactericidal treatments are tested on the basis of their ability 
to kill planktonic cells, but their effects may be reduced where the target 
bacterium is protected within a biofilm. Bacteriophages have the potential to 
negate the protection afforded by biofilms either by direct penetration and 
infection of the cells at the biofilm surface or via infiltration of bacteriophage-
infected bacteria into the interior of the biofilm and their subsequent lysis to 
release bacteriophage in situ. 
 
The selection of a particular bacteriophage to use as a treatment is an important 
issue for phage therapy and bio-sanitization applications, since bacteriophages 
and their effects are diverse. Not least the bacteriophage should be virulent and 
not temperate if it is to have a significant effect. Virulent Campylobacter 
bacteriophage can be isolated from chicken excreta and from poultry meat 
(Atterbury et al., 2003; Connerton et al., 2004; El-Shibiny et al., 2005; Loc 
Carrillo et al., 2007). Bacteriophages CP8 and CP30 are virulent members of 
the Myoviridae with proven stability and efficiency in reducing Campylobacter 
numbers by 2 Log10 CFU/g in experimental Campylobacter-colonised chickens 
(Loc Carrillo et al., 2005; Scott et al., 2007a). These bacteriophages were 
therefore selected for this study in order to assess if bacteriophage application 
could reduce or eliminate either Campylobacter biofilms or the bacteria within 
them. 
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Treatment of Campylobacter biofilms attached to glass surfaces with 
bacteriophages CP8 or CP30 resulted in reductions of viable cells compared to 
levels in mock-treated controls. Interestingly, the response to bacteriophage 
treatment was dependent on the host strain forming the biofilm, with 
differences in both the speed and degree of reduction of the viable count. It is 
evident that the Campylobacter strains have differing capacities for biofilm 
formation and exhibit a range of cell viabilities, which could influence the 
effect of the bacteriophages.  
Difficulties in obtaining viable counts from biofilms of Campylobacter in 
monoculture have been reported (Reuter et al., 2010; Ica et al., 2012), whereas 
other authors have noted a range counts that are dependent on the strain, the 
incubation conditions and the substrate on which the biofilm is established 
(Reeser et al., 2007; Gunther and Chen, 2009). The batch dependent range 
reported in this thesis of Log10 4 CFU/cm2 to Log10 6 CFU/cm2 for the 
formation of a static biofilm on a glass surface. As an alternative to 
determining the viable counts from biofilms authors have either examined the 
shedding of viable bacteria from established biofilms (Reuter et al., 2010) or 
resorted to photomicrographic counting of live/dead stained bacteria (Ica et al., 
2012). In the latter case the inability to recover viable campylobacters but the 
continued ability to produce vital metabolic staining has been cited as evidence 
for a ³YLDEOH EXW QRW FXOWXUDEOH VWDWH´ 9%1& LQ ELRILOPV IRUPHG RI
Campylobacter monocultures (Ica et al., 2012). The VBNC state of 
Campylobacter has been the subject of debate for many years but essentially 
relates to the resuscitation of physiologically compromised bacteria (Rollins 
and Colwell, 1986; Bovill and Mackey, 1997). The failure of several authors to 
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recover viable campylobacters from monoculture biofilms would suggest that 
the viability of the bacteria is low and/or that the cells are physiologically 
impaired. In the experiments reported here were successful in recovering the 
bacteria but it is likely that the biofilms contain many more non-viable cells. 
 Two hours post-infection of C. jejuni NCTC 11168 biofilms a reduction in the 
viable count of 2.5 Log10 CFU/cm2 was recorded (Figure 3.1A). Bacteriophage 
CP30 was similarly effective at this time point against C. jejuni PT14 despite 
the increase in the biofilm matrix associated with this strain. However, 
treatment of C. jejuni PT14 with bacteriophage CP8 did not significantly 
reduce the viable Campylobacter count compared to that in the mock-treated 
control. At 24 h post-infection, CP8 treatment of C. jejuni NCTC 11168 
biofilm reduced the viable count below the detection limit but CP30 treatment 
results were not significantly different from the control. Bacteriophages CP8 
and CP30 significantly reduced the viable count compared to that in the mock-
treated control at 24 h post-infection of C. jejuni PT14 biofilm (P < 0.01). The 
initial fall in viable count at 2 h was followed by fast recovery at 4 to 8 h post-
infection. An increase >2 Log10 CFU/cm2 in 2 h was recorded for CP8-treated 
C. jejuni NCTC 11168. It is not likely that such a rapid recovery in the number 
of viable cells could occur by normal cell division alone, and therefore it may 
be associated with reattachment of Campylobacter-containing biofilm that had 
been detached by the bacteriophage treatment. To account for the recovery in 
the number of viable count, it may be postulated that not all of the 
campylobacters were compromised but remained viable and associated with 
sloughed biofilm material. If left undisturbed for longer periods, this material 
could become reattached, although in the long term, viability was reduced due 
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to the actions of the bacteriophage irrespective of the initial detachment. TEM 
images provide support for the contention that biofilms were dispersed in the 
presence of bacteriophage after 2 h (Figure 3.7). Higher-resolution TEM 
images at 24 h post-bacteriophage treatment also clearly show that 
campylobacters are subject to cell lysis within the biofilm matrix (Figure 3.8). 
Regardless of whether the viability of the campylobacters persists in the short 
term (4 h) the immediate effect of bacteriophage mediated biofilm dispersal 
would be to create a window of opportunity for the removal of Campylobacter 
biofilms. Bacteriophage could be used to initiate biofilm dispersion in 
industrial settings that could be followed by thorough pressure flushing to 
purge water conduits. 
 
The numbers of viable bacteriophage found in the biofilms and planktonic 
cultures showed an initial binding phase characterized by a decrease in 
numbers, then a recovery, followed by a period where numbers appeared to 
remain static. At first sight it might seem strange that the reduction in viable 
cells in the biofilms from 4 h to 24 h under treatment by phage CP8 should not 
be accompanied by a rise in phage numbers. This could be an example of what 
is called passive (or inundation) therapy (Payne and Jansen, 2000) in which 
weight of numbers of phage is sufficient to reduce cell counts without need for 
significant levels of phage replication. Even if this is not the case, phages that 
infect Campylobacter generally have a small burst size of around 2-3 (Cairns et 
al., 2009) and so it would only require a small extra loss of phage to prevent 
significant amplification of phage numbers. In should be noted that phage 
amplification depends not only on cell lysis, but also on the proportion of free 
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phage able to successfully reach and infect another susceptible bacterium, 
which in turn depends on the density of bacteria and the movement within the 
medium. Mean burst size could be attenuated by the fact that the majority of 
Campylobacter cells in the mature biofilms are likely to be in stationary phase 
and growing relatively slowly. Moreover, movement through the biofilm may 
be impaired by proximity to cell debris from the lysis event (Rabinovitch et al., 
2003), so that debris may be encountered and bound to at a higher rate than in 
planktonic systems. Experiments where phage were administered to 
Campylobacter colonized chickens also appear to confirm this stasis in phage 
titres, as there appears to be a threshold above which phage numbers do not 
increase despite being continually added to the system through replication (Loc 
Carrillo et al., 2005). It is perhaps not surprising that the phage-bacteria 
kinetics show somewhat different properties in biofilms compared to those 
observed for planktonic systems or in vivo. Clearly a formal mathematical 
model, based on more refined data, will need to be developed to properly 
understand the kinetic properties of the system. 
 
Bacteriophages have been shown to diffuse through the biofilms of other 
bacteria (Briandet et al., 2008), and it is also been reported that biofilm 
formation does not provide additional protection against bacteriophage attack 
(Sharma et al., 2005). Our data support these observations since 
campylobacters within the biofilm are subject to bacteriophage mediated lysis. 
However, it is also reported that the effects of bacteriophage on attached and 
planktonic cells are similar (Sharma et al., 2005). In contrast, our work 
indicates that bacteriophage were actually more effective at reducing numbers 
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of viable cells when campylobacters were associated in a biofilm compared to 
planktonic cells. However, caution is required in drawing mechanistic 
interpretations from these contrasting results: phage-bacteria kinetics are 
determined by density thresholds (Payne and Jansen, 2000) whereas in most 
empirical studies the standard practice is to control experiments using MOI 
(which is a ratio not a density). Further experiments, with control of the initial 
densities, will be needed to untangle the differing balances of processes in 
biofilm and planktonic populations. This will not be trivial, as it is anticipated 
that localized high densities of host and bacteriophage may arise within the 
biofilm, and these could give rise to physiological differences between the 
bacterial populations. Further, the planktonic cells in the overlaying static 
culture are likely to be in stationary phase, which may not support phage 
replication, and notably exhibit a high frequency of phage resistance in these 
experiments (82 to 92%). The propensity of campylobacters to 
aggregate/agglutinate in dense suspensions as encountered in the planktonic 
phase cultures will also impact on the adsorption and lysis by bacteriophage 
(Miller et al., 2000; Guerry et al., 2006). These conditions also effect the 
functional expression of the flagella that will also negatively impact phage 
replication (Guerry et al., 2006, Coward et al., 2006; Scott et al., 2007b).  
 
The mechanism by which the bacteriophages were able to break down the 
biofilm is unknown. It seems possible that bacteriophage CP8 and CP30 can 
reduce the extra-cellular matrix produced by C. jejuni in biofilms through 
enzymatic means. Bacteriophages have been shown to encode enzymes that 
can degrade exopolysaccharide which forms the major component of the 
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biofilm matrix (Hughes et al., 1998a; Hughes et al., 1998b). Carvalho et al. 
(2012) reported that the Campylobacter phage vB_cCom_IBB-35 contained 
genes encoding enzyme classes capable of extracellular polysaccharide 
depolymerisation. An alternative to phage-encoded enzymatic degradation is 
that the Campylobacter bacteriophages may break down biofilm indirectly, 
through bacterial cell lysis with the subsequent release of bacterial enzymes 
that degrade the biofilm matrix. The TEM images indicate that the 
bacteriophage not only lysed their targets but also caused a breakdown of the 
biofilm matrix, as evidenced by the density of the matrix polysaccharide 
stained by alcian blue in the phage treated biofilms compared with the control 
(presented in the lower resolution TEM images in Figure 3.7). 
 
In the laboratory, bacteria that survive bacteriophage infection often develop 
resistance to subsequent attack through mutation. Moreover, phage resistance 
of bacteria within biofilms has been reported to be due to the loss of phage 
receptor sites that become incorporated into the cell envelope (Donlan, 2009). 
This is contrary to what is observed for campylobacters surviving phage 
therapy in chickens, where the environment of the gut counter-selects resistant 
types that are physiologically compromised (Loc Carrillo et al., 2005; Scott et 
al., 2007b). It was therefore of interest to examine if the bacteria recovered 
from biofilms were resistant to the test bacteriophage. There were clear 
differences in the frequency of acquired bacteriophage-resistance dependant on 
the host strain used. All of the viable C. jejuni PT14 isolates recovered from 
the biofilm retained sensitivity to both bacteriophages. In contrast, only a 
minority (10 to 16%) of the viable C. jejuni NCTC 11168 isolates from the 
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treated biofilm retained sensitivity to the bacteriophages. Treatment of 
planktonic bacterial cells with bacteriophages in vitro results in the selection of 
resistant mutants (Adams, 1959). Resistant mutants selected following in vitro 
treatment of planktonic cells are often deficient in motility (Cairns et al., 
2009), and as a consequence would be unlikely to be able to survive outside the 
laboratory environment. The incidence of resistant phenotypes following 
bacteriophage treatment in vivo was found to be relatively low (4%) (Loc 
Carrillo et al., 2005; Scott et al., 2007b), where the isolates were noted to be 
motile probably due to the requirement of a competent motility phenotype for 
colonization (Handrixson et al., 2004). The frequency of resistance to 
bacteriophage in Campylobacter isolated from the biofilms of the two strains 
did not therefore match either the observations made for phage infection in 
vitro or in vivo. The incidence of resistance to bacteriophage was high for C. 
jejuni 11168 biofilms but unlike the survivors from in vitro planktonic 
infections, the isolates were fully motile. However, the bacteriophage resistant 
types recovered from C. jejuni 11168 biofilms were impaired in their ability to 
either form or maintain biofilms compared to the parental type strain. No 
resistant isolates were recovered from bacteriophage-treated biofilms of C. 
jejuni PT14, a pattern more reminiscent of that observed in vivo, during phage 
therapy of chickens (Connerton et al., 2004; Loc Carrillo et al., 2005; Scott et 
al., 2007b). Resistant bacteria can be resident within populations but there is no 
evidence that the stock Campylobacter cultures give rise to the frequency of 
non-motile types observed post phage replication in laboratory cultures. These 
non-motile types retain their phenotype through laboratory subculture implying 
the changes are not regulatory or otherwise temporary. The rates of phage 
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resistance have been reported recently by Fischer et al (2013) and the 
characterisation of phage resistant mutations in capsular polysaccharide 
encoding genes characterised by Sorensen et al. (2011 and 2012). 
 
3.4 Conclusion 
These results have shown the potential for use of lytic bacteriophages against 
campylobacters as a treatment to control biofilm formation. The viruses within 
the biofilm could not only effectively target and lyse campylobacters but were 
also able to disperse the extracellular matrix forming the biofilm. Further 
studies to identify the components involved in this action will allow further 
understanding of the interaction between bacteriophage and host within 
biofilms. More refined experiments, together with kinetic modelling, will be 
needed to better understand how the phage-bacteria interactions differ in 
biofilms and planktonic populations and the kinetic consequences of those 
differences. The preliminary results show promise, not only because the viruses 
within the biofilm effectively target and lyse campylobacters but also because 
they are able to disperse the extracellular matrix forming the biofilm. 
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CHAPTER 4 
FORMATION AND PHYSIOLOGICAL STUDIES OF 
CARRIER STATE LIFE CYCLE (CSLC) OF 
CAMPYLOBACTER JEJUNI  BACTERIOPHAGE 
 
4.1 Introduction 
Bacteriophage life cycles are generally ascribed to being either lytic or 
lysogenic. During the lytic cycle, following injection of nucleic acid, host 
metabolism is redirected towards the replication of phage nucleic acid and 
assembly of new phage particles, which are released during cell lysis. In the 
lysogenic cycle, injected nucleic acid integrates into the host genome or 
remains as a stable episome, replicating along with the host, but can still enter 
the lytic cycle following induction, or spontaneously, as a rare occurrence. In 
addition a spectrum of other types of life cycles, based on either of these two 
strategies exists (reviewed by Abedon, 2009).  A common feature amongst 
alternate life cycles is their inherent instability making their study problematic. 
Terminology of these variant life cycles is often confused but the two most 
documented types are; pseudolysogeny (false lysogeny) and the carrier state 
(Adams, 1959; Lwoff, 1953).   
The term pseudolysogeny has been used to define various different unstable 
bacteriophage-host interactions, including intersection with the carrier state 
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(reviewed by Abedon, 2009).  A specific definition was applied by Ripp and 
Miller (1997), where pseudolysogeny was defined as a phage-host cell 
interaction in which the nucleic acid of the infecting phage, neither establishes 
a long-term, stable relationship (lysogeny) nor elicits a lytic response but 
simply resides within the cell in a non-active state. This type of 
pseudolysogeny is usually associated with starvation conditions.  As nutrient 
supplies are replenished, the viral genome either establishes true lysogeny or 
becomes activated to produce and release viable bacteriophage following lysis 
of the cell (Ripp and Miller, 1998; Los et al., 2003).  A different definition of 
pseudolysogeny is used to describe a situation where the bacterial genome is 
carried as an unstable episome in the host that is both distinct from lysogeny 
and can be easily cured through subculture (Lood and Collin, 2011).  
The carrier state life cycle (CSLC) describes mixtures of bacteria and of 
bacteriophages which are in a more or less stable equilibrium (Lwoff, 1953). A 
proportion of bacteria are resistant; however, the presence of some sensitive 
variants appears to sustain the phage population so that both thrive.  The main 
difference to the state described as pseudolysogenic (Ripp and Miller, 1997 
definition), is that bacteriophage are constantly being generated within the 
culture at the expense of the sensitive cells. When first isolated, strains 
exhibiting CSLC, resemble lysogens, in that they appear to be resistant to 
superinfection and exhibit infrequent plaque formation in soft agar lawns but 
differ from the majority of lysogens as the nucleic acid does not appear to be 
integrated into the host.  Treatment with specific antiserum, which can inhibit 
infection by neutralisation with bacteriophage or repeated sub culture leads to 
the cessation of the CSLC, an important way in distinguishing the CSLC from 
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lysogenisation and possibly indicating that the majority of the active phage 
population exists externally to the phage-resistant elements of the host 
population.   The CSLC is usually observed in strictly lytic phage and there are 
numerous examples from various different genera (Li et al., 1961; Jones et al. 
1962; Baess, 1971; Pauling, 1982; Jarling et al., 2004; Bastías et al., 2010).  
Bacteriophage life cycle variations are sometimes confused with 
pseudolysogeny or the carrier state as noted by Abedon (2009). 
Biofilms, which comprise a polymeric matrix of extracellular polysaccharide, 
protein, lipid and nucleic acid to protect the embedded bacterial cells from 
stressful environments, commonly generate nutrient limiting conditions 
2¶7RROHet al., 2000; Flemming and Wingender, 2010). Chapter 3 describes 
the bacteriophage treatment of Campylobacter jejuni biofilms with virulent 
bacteriophage CP8 and CP30 isolated from chickens (Loc Carrillo et al., 2005; 
Scott et al., 2007a). Our studies on the effect of bacteriophage on biofilms 
(Siringan et al., 2011) during determination of frequency of phage resistance 
led to the discovery that CSLC was occurring in the biofilms.  
The phenomenon of CSLC is poorly understood, probably due to the instability 
of the relationship, with very few research articles available. In this chapter the 
isolation and characterization of the first examples of CSLC Campylobacter 
cultures are presented. It is postulated that the establishment of CSLC may 
grant a survival advantage to both bacteria and bacteriophage within biofilms. 
CSLC associated with biofilms has not previously been studied. This study 
therefore aims to investigate the formation and physiology of CSLC in C. 
jejuni. In addition, the phenotypic characteristics of CSLC phages have been 
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studied and compared to the characteristics of the parental phages produced by 
conventional host lysis.  
 
4.2 Results 
4.2.1 Formation of the carrier state life cycle (CSLC) of Campylobacter 
jejuni in biofilms  
 
Genomic DNA from single colonies of C. jejuni NCTC 11168, PT14 and 
HPC5 isolated from either biofilms or planktonic cultures that had been treated 
with either bacteriophage CP8 or CP30, were subcultured and prepared in 
agarose blocks as described in section 2.5.5. Uncut and SmaI restriction 
digested genomic DNAs were analysed by PFGE (Section 2.5.4). DNA bands 
of approximately 140 kb were identified in the genomic DNAs of C. jejuni 
isolates recovered from phage treated-biofilms and planktonic cultures of PT14 
and HPC5 strains but not NCTC 11168 (Figure 4.1). The DNA bands were of 
the size expected of the CP8 and CP30 phage genomes (Loc Carrillo et al., 
2005). This result indicated that the phage genomes may be present, but not 
incorporated, into the chromosome of bacterial cells present in biofilm and 
planktonic cultures. A southern blot of PFGE separated genomic DNAs was 
hybridized with CP8 bacteriophage DNA labelled by DIG random prime 
(Section 2.5.6).  This result confirmed that the 140 kb bands were indeed phage 
genomic DNAs (Figure 4.2). Furthermore, DNA sequencing of whole genomes 
of CSLC-HPC5 and - PT14 isolates did not contain the phage genome 
integrated into their genome.   
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Figure 4.1- Pulsed-field gel electrophoresis of genomic DNA from Campylobacter 
jejuni NCTC 11168 (a), PT14 (b) and HPC5 (c) recovered from biofilms with or 
without treatment with bacteriophages. C: Control biofilm cells without phage; A: 
Attached cells (biofilms); U: unattached cells (Planktonic); - : undigested; +: digestion 
with SmaI.  
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Figure 4.2- PFGE (A) and Southern blot (B) of genomic DNA from HPC5 
control and CSLC of biofilm isolates (U: undigested and SmaI digested) The 
Southern blot was hybridized with a bacteriophage DNA probe. 
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To further identify that the phage DNAs within the Campylobacter were 
derived from the infecting phage and not the result of prophage excision, 
DNAs extracted from phage containing cultures, wild type C. jejuni HPC5 and 
conventional CP30 propagated by lysis were PCR amplified using primers 
designed about a region distinguishable from all other available DNA 
sequences from Campylobacter bacteriophage (deposited in the GenBank 
database). Figure 4.3 shows the PCR products separated by agarose gel 
electrophoresis.  A contemporary preparation of Campylobacter genomic DNA 
did not constitute a template for the amplification and confirmed the extraction 
and PCR reagents did not contain CP30 or CP30 bacteriophage DNA but 
bacteriophage cultures derived from CP30 infection produced PCR amplicons 
of the correct size along with CP30 genomic DNA. The amplified DNA 
sequence of CSLC isolates were identical (presented in appendix 1) to confirm 
the persistence CP30 bacteriophage and not the excision of a prophage. 
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Figure 4.3- PCR products amplified from bacteriophage CP30 DNA (2), 
Campylobacter jejuni PT14CP30PL DNA (3), Campylobacter jejuni 
HPC5CP30PL DNA (4), Campylobacter jejuni HPC5 DNA (5) and DNA 
markers 1 kb (1), 100 bp (6) (Promega). Primers (CP30tp in section 2.11) were 
designed on genomic DNA of CP30. 
 
Bacteriophage CP8 and CP30 are classified within the family Myoviradae that 
have double-stranded DNA genomes of approximately 140 kb. In order to 
differentiate these bacteriophage and ensure the phage recovered from CSLC 
cultures were those used for the initial therapy, primer pairs were designed 
based on a region of the bacteriophage CP8 genome that contained a DNA 
sequence insertion as compared with all class III bacteriophage sequences 
available in all nucleotide sequence databases including CP30. The 
bacteriophage DNA preparations produced different sized PCR amplicons 
using the primer pair CP853B and CP854B (see section 2.12) of 200 and 280 
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bp respectively from CP30 and CP8 that are resolved by agarose gel 
electrophoresis in Figure 4.4A. PCR amplification of Campylobacter jejuni 
genomic DNAs extracted from PT14CP30PL and PT14CP8PL produced DNA 
fragments of 200 and 280 bp, which are consistent with the presence of phage 
DNAs corresponding with the phages used in the treatment of the biofilms that 
created them. Control C. jejuni PT14 DNA did not produce a DNA fragment 
corresponding with the size of either of the phage DNA amplicons using the 
same extraction and PCR amplification reagents within the same experiment 
(Figure 4.4B). Instead an 800 bp DNA fragment was amplifies as visualised 
upon agarose gel electrophoresis. Control PCR reactions with single or no 
primer additions identified the DNA fragment as a single primer product of C. 
jejuni genomic DNA. Similarly PCR amplification with the CP853B and 
CP854B primer pair of HPC5CP30PL and HPC5CP8PL genomic DNAs 
produced fragments of 200 and 280 bp (Figure 4.4B), that were consistent with 
the presence of phage DNAs corresponding to the phages used in the treatment 
of the biofilms that created them. Control C. jejuni HPC5 genomic DNA did 
not produce a fragment size corresponding with either of the phage DNA 
amplicons but an 800 bp fragment corresponding with the single primer 
amplification product noted above. The C. jejuni genomic DNA controls 
confirmed that neither the extraction or PCR reagents contained CP30 or CP30 
bacteriophage DNAs. The source of the amplifiable DNA was the genomic 
DNA preparations that gave rise to them, which had been subcultured from 
single colony isolates a minimum of three times. The identities of the phage 
DNA products were confirmed by DNA sequencing (presented in appendix 2). 
It is clear that these bacteriophages retain the genotypes of the parent phage 
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from all host sources, and are not the consequence of prophage excision or 
contamination with alternative bacteriophages. Additionally, PCR 
amplification of total DNAs extracted from CSLC cultures produced PCR 
products and the amplified DNA sequence similar to those of the parental 
phage DNAs (Figure 4.4B). These data provide further evidence that the CSLC 
isolates contain phage DNAs of the same genotype as the phage used to treat 
the biofilms from which they were recovered.  
 
 
 
Figure 4.4- (A) PCR products amplified from CP8 and CP30 DNAs.  CP8 was 
propagated from either Campylobacter jejuni PT14 (2), or C. jejuni HPC5 (3), 
or C. jejuni 11168 (4) and CP30 DNA propagated from either C. jejuni PT14 
(5) or C. jejuni HPC5 (6), DNA marker 1 kb ladder(1) and 100 bp (7) 
(Biolabs); (B) PCR products amplified from C. jejuni PT14 DNA (2), C. jejuni 
PT14CP8PL DNA (3), C. jejuni PT14CP30PL DNA (4), C. jejuni HPC5 DNA 
(5), C. jejuni HPC5CP8PL DNA (6), C. jejuni HPC5CP30PL DNA (7), 100 bp 
(Biolabs) (1). Primers were designed on the genomic DNA of CP8 ( CP853B-
CP854B Section 2.12). Note: the band migrating at 800 bp is the unexpected 
product of single forward primer amplification.  
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The continued presence of bacteriophage appearing as propagatable clear 
plaques in bacterial lawns of single colony subcultures coupled with evidence 
for the presence of bacteriophage DNA in these cultures support the idea that 
the bacteriophage virulent life cycle had been interrupted, and that phage DNA 
is intimately associated with the host bacteria either as internalised DNA or 
pre-absorbed phage particles. The host bacteria are released from nutrient 
limitation upon subculture in rich media but the associated phage persist. Based 
on the definitions outlined by Abedon (2009) these observations are consistent 
with the formation of a carrier state life cycle. Moreover, the treatment with 
specific antiserum raised against bacteriophage CP8 that was able to neutralise 
the bacteriophage CP8 indicated the CSLC bacteriophages to be protected 
either as internalised particles or adsorbed on the bacteria. The antiserum was 
able to inhibit the phage CP8 alone or when mixed with parent bacteria but not 
when associated with the CSLC strains (Table 4.1).    
Table 4.1-Treatment of C. jejuni HPC5 and PT14 parent bacteria, CP8 phage, 
HPC5CP8PL and PT14CP8PL carrier strain bacteria with pre-immune and 
anti-phage sera  
 Pre-immune serum  Anti-phage serum 
Combination Bacteria count  
Log10 CFU/ml 
Phage count 
Log10 PFU/ml 
Bacteria count 
Log10 CFU/ml 
Phage count 
Log10 PFU/ml 
CP8 phage only  0 5.3 0 0 
HPC5 parent 
(bacteria only) 
7.5 0 7.8 0 
HPC5 parent 
bacteria mixed with 
phage 
7.3 4.8 6.9 0 
HPC5CP8PL  7.6 7.5 7.5 7.6 
PT14 parent (bacteria 
only) 
7.5 0 7.6 0 
PT14 parent 
bacteria mixed with 
phage 
6.5 6.6 6.6 0 
PT14CP8PL 7.5 7.4 7.5 6.7 
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4.2.2 Frequency of CSLC isolates from Campylobacter phage treatment 
of biofilms  
 
The frequency of CSLC of bacterial isolates recovered from C. jejuni PT14 
biofilms after treatment with either bacteriophage CP8 or CP30, was 
approximately 10 %. In contrast, 40% and 90% of isolates from CP8 and CP30 
treated C. jejuni HPC5 biofilms were respectively found to be CSLC cultures. 
For planktonic cells, the results showed that 10% of isolates recovered from 
PT14 were CSLC strains. The CSLC isolates obtained from the phage 
treatment of biofilms were designated as C. jejuni PT14CP8PL, PT14CP30PL, 
HPC5CP8PL and HPC5CP30PL.  Interestingly, the CSLC strains were found 
to be non-motile compared to wild types on 0.4% Mueller-Hinton agar (Table 
3.1 and Figure 3.8C-D).   Transmission electron microscopy (TEM) showed 
bacteriophage associated with Campylobacter cells and no flagella attached to 
the cells but were associated with phage particles (Figure 4.5).  
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Figure 4.5-Transmission electron microscopy showing Campylobacter jejuni 
(A), pseudolysogenic Campylobacter jejuni as the carrier state life cycle  
(B,C,D,E). 
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4.2.3 Growth curves of C. jejuni and CSLC strains  
Growth curves were performed to identify if the CSLC cultures differed from 
the parental strain in their ability to replicate under different atmospheric 
conditions. Growth curves were prepared for C. jejuni PT14, PT14CP8PL, 
PT14CP30PL, HPC5, HPC5CP8PL, and HPC5CP30PL that had been grown in 
Mueller-Hinton broth at 42 °C under microaerobic (Figure 4.6), low oxygen 
(<1% O2) (Figure 4.7) and atmospheric (Figure 4.8) conditions, with samples 
taken over 24 h (Section 2.7.1). The mean ratio of free bacteriophage and 
bacterial cells (Log10 PFU/ Log10 CFU) of C. jejuni PT14CP8PL, 
PT14CP30PL, HPC5CP8PL, and HPC5CP30PL were 0.792 ± 0.101 (n=19), 
0.722 ± 0.133 (n=19), 0.780 ± 0.134 (n=16) and 0.939 ± 0.084 (n=18), 
respectively after bacterial cells were sub-cultured on blood agar for all 
experiments. The doubling time or generation times (g) and growth rate 
constants (µ) are shown on Table 4.2. The doubling time and growth rates of 
the Campylobacter controls and all of the CSLC strains showed no significant 
difference (P>0.05, t-test) under microaerobic conditions. The CSLC strains 
were therefore, not affected by the presence of phage and grew as well as the 
non-CSLC bacteria under these conditions (Figure 4.6). These growth curves 
showed typical log exponential phase during 2-12 h followed by a stationary 
phase. There were however, reductions in numbers of viable CSLC cells 
compared to the parental strain between 10 and 14 h for C. jejuni PT14CP30PL 
(Figure 4.6A), while the numbers of viable C. jejuni HPC5CP8PL and 
HPC5CP30PL were decreased slightly between 8 and 12 h (Figure 4.6B) 
compared to the parental strain.  During this period phage titres from CSLC of 
C. jejuni PT14 rose substantially, when the numbers of viable bacterial cells 
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reached to 107 CFU/ml (Figure 4.6A). In contrast, the CSLC of C. jejuni HPC5 
produced very high titres of phages when the numbers of viable bacterial cells 
reached 105 CFU/ml and the phage titres continued to increase rapidly along 
with the growth of bacteria (Figure 4.6B). The numbers of bacteriophages 
reached a maximum 12 h post-incubation for both CSLC of C. jejuni PT14 and 
HPC5.   
 
Table 4.2- The doubling time and growth rate constant of C. jejuni PT14, 
HPC5 and CSLC strains 
Strains The generation time, g (h) The growth rate constant, µ (h
-1) 
Microaerobic  Low oxygen  Microaerobic  Low oxygen 
C. jejuni PT14 0.916 1.254 0.757 0.552 
C. jejuni PT14CP8PL 0.949 1.239 0.730 0.560 
C. jejuni PT14CP30PL 0.976 1.142 0.710 0.607 
C. jejuni HPC5 0.894 1.058 0.775 0.656 
C. jejuni HPC5CP8PL 0.952 1.241 0.728 0.558 
C. jejuni HPC5CP30PL 0.934 1.028 0.742 0.674 
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Figure 4.6- (A) Growth curve of C. jejuni PT14 and CSLC strains, (B) C. jejuni 
HPC5 and CSLC strains. Growth curves were performed at 42 °C under 
microaerobic (5% O2) conditions in Muller-Hinton broth. The curves are 
representatives of two biological replicates where the points are the means and 
SD of triplicate viable count determinations. 
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For growth curves produced under low oxygen conditions (<1% O2), there was 
no significant differences (P> 0.05) in the generation times and growth rate 
constants between the control and CLSC cultures (Table 4.2). However, the 
growth curves revealed a delay in the onset of the exponential phase in the 
CSLC of C. jejuni PT14 cultures by 6 h compared to the parent strain, which 
was followed by a rapid increase in the number of viable cells and a 
corresponding increase in phage titre after this time (Figure 4.7A). The growth 
of C. jejuni HPC5 and its CSLC variants under low oxygen conditions were 
similar.  The generation times under low oxygen conditions were notably 
longer than those observed under microaerobic conditions (Table 4.2, Figure 
4.7B). The numbers of phages remained constant until 4 h and then increased 
substantially after this time. After 12 h the phage titres did not increase any 
further. These data suggest that the controls and CSLC bacteria could grow 
under low oxygen conditions and that the CSLC cultures could produce phage 
but the titres produced were lower than that produced by these cultures under 
microaerobic conditions.       
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Figure 4.7- (A) Growth curve of C. jejuni PT14 and CSLC strains, (B) C. jejuni 
HPC5 and CSLC strains. Growth curves were performed at 42 °C under low 
oxygen (<1% O2) conditions in Muller-Hinton broth. The curves are 
representatives of two biological replicates where the points are the means and 
SD of triplicate viable count determinations. 
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When C. jejuni PT14 and HPC5 cultures were incubated under atmospheric 
conditions the numbers of viable cells remained constant for 4 h but 
dramatically decreased thereafter (Figure 4.8). The decay constant rates of C. 
jejuni PT14, PT14CP8PL and PT14CP30PL strains during 6-9 h were -0.523h-
1
, -0.352h-1, -0.564h-1, respectively.  Additionally, the decay constant rates of 
HPC5, HPC5CP8PL and HPC5CP30PL strains during 5-10 h were -0.341h-1, -
0.297h-1, -0.296h-1, respectively. The phage titres obtained from each sample 
point for both of the CSLC-PT14 strains was approximately 103 PFU/ml and 
these titres persisted throughout the experiment (Figure 4.8A).  In contrast the 
phage titres obtained from both the CSLC-HPC5 strains increased by 1-2 Log10 
PFU/ml after incubation for 2 h and thereafter remained constant up to 11 h 
(Figure 4.8B). These results indicate that phage titres do not increase under 
atmospheric conditions for PT14, probably because the host was unable to 
replicate so neither could the phage. However, for HPC5 increased numbers of 
phage particles were released in the first 2 h of aerobic incubation and 
thereafter the titres remained constant. The increased phage numbers may have 
been a result of the presence of pre-formed phage particles that were then 
released rather than being a direct result of replication. Neither phage showed 
any viability reduction as a result of incubation under atmospheric conditions. 
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Figure 4.8-(A), Viability of C. jejuni PT14 and CSLC strains (B) C. jejuni 
HPC5 and CSLC strains. Growth curves were performed at 42 °C under 
atmospheric conditions in Muller-Hinton broth. The curves are representatives 
of two biological replicates where the points are the means and SD of triplicate 
viable count determinations. 
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4.2.4 Survival of C. jejuni and CSLC strains under nutrition limitation  
Survival studies under nutrition limitation conditions were performed in order 
to determine if the CSLC cultures differed from their parental strains in their 
ability to persist under different atmospheric conditions. Survival of C. jejuni 
and CSLC variants under nutrition limitation (incubated in maximum recovery 
diluent) were assessed at 42 °C under aerobic, low oxygen, and microaerobic 
conditions (Section 2.7.2). The results showed that all of the cultures were able 
to survive (100%) throughout the experiment (6 h) under microaerobic and low 
oxygen conditions (Figure 4.9B-C and 4.10B-C). Moreover, the bacteria were 
able to survive and could be detected at 24 h under these conditions.  The 
number of bacteriophages also tended to remain constant throughout the 
experiment for all conditions. Interestingly however, under atmospheric 
conditions, the percentage survival rate of CSLC of C. jejuni PT14 (~95%) was 
higher than for non-CSLC bacteria (~79%) at 2 h as shown as Figure 4.9A. The 
viable count fell below the limit of detection (>2 Log10 CFU/ml) at 4 h for C. 
jejuni PT14 and the CSLC of C. jejuni PT14CP8PL, and 6 h for PT14CP30PL.  
Similarly, for the CSLC-HPC5 strains, at 2 h the percentage survival rate of 
CSLC of C. jejuni HPC5CP8PL and HPC5CP30PL strains was  approximately 
75% and 92% respectively, compared to the parent strain, which had fallen 
below the detection limit (recorded as 0%). The CSLC of C. jejuni could 
therefore survive longer than the wild type strains under aerobic conditions in 
nutrient deficient medium (Figure 4.10A).  
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Figure 4.9- Survival of Campylobacter jejuni PT14 and CSLC strains under 
nutrient limitation incubated in atmospheric (A), low oxygen (<1% O2) (B), 
and microaerobic (5% O2) (C) conditions. The data are the means and SD of 
three independent experiments (n=3). 
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Figure 4.10- Survival of Campylobacter jejuni HPC5 and CSLC strains under 
nutrient limitation incubated in atmospheric (A), low oxygen (<1% O2) (B), 
and microaerobic (5% O2) (C) conditions. The data are the means and SD of 
three independent experiments (n=3). 
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4.2.5 Effect of temperature on the survival of C. jejuni and CSLC strains 
The survival of CSLC strains and parent bacteria under ambient atmosphere in 
the absence of nutrition  at low temperature (4 °C) and high temperature (50 
°C) were examined to evaluate the effect of cold and heat stresses on the 
viability of the bacteria and bacteriophage (Section 2.7.3).   
 
Figure 4.11- Survival of C. jejuni PT14 and CSLC strains (A), survival of C. 
jejuni HPC5 and CLSC strains (B) at 50 °C under ambient atmospheric 
conditions in the absence of nutrients. The data are the means and SD of three 
independent experiments (n=3).  
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The viability of CSLC and parent bacteria decreased after incubation at 50 °C 
(0.5 h) at ambient atmosphere, whereas the numbers of bacteriophages 
remained constant throughout the experiment (Figure 4.11). The percentage of 
survival of the CSLC strains was approximately 70% (PT14CP8PL and 
PT14CP30PL), 63% (HPC5CP8PL) and 38% (HPC5CP30PL), while the 
parent strains were approximately 56% (PT14) and 0% (HPC5) at 1 h post-
incubation. Interestingly, the percentage of survival of CSLC cultures was 
higher than the parent bacteria after incubation for 1 h.  The decay constant 
rates of C. jejuni PT14, PT14CP8PL and PT14CP30PL strains during 0.5-1 h 
were -7.168h-1, -3.68h-1, -4.348h-1, respectively.  Additionally, the decay 
constant rates of HPC5, HPC5CP8PL and HPC5CP30PL strains during 0.5-1 h 
were -14.158h-1, -4.712h-1, -6.418h-1, respectively. These results suggest that 
the CSLC strains are more likely to persist at the higher temperature than their 
parent strains. 
 
At 4 °C parent and CSLC bacteria survived better than at 42 °C. However, 
there was no significant difference (P> 0.05) between the behaviour of the 
parent and CSLC bacteria throughout the experiment (Figure 4.12). 
Additionally, the bacteriophage titres were largely unaffected over the 9 day 
course of the experiment. These data indicate that the CSLC and parent strains 
survive at refrigeration temperature under atmospheric oxygen conditions. 
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Figure 4.12-Survival of C. jejuni PT14 and CSLC strains (A), survival of C. 
jejuni HPC5 and CSLC strains (B) at 4 °C under ambient atmospheric 
conditions in the absence of nutrients. The data are the means and SD of three 
independent experiments (n=3). 
 
 
 
 
0
20
40
60
80
100
120
140
0 2 4 6 8 10
%
 S
ur
iv
iv
a
l 
Time (days) 
C. jejuni PT14
C. jejuni PT14CP8PL
C. jejuni PT14CP30PL
Phage CP8PL
Phage CP30PL
0
20
40
60
80
100
120
0 2 4 6 8 10
%
 S
ur
iv
iv
a
l 
Time (days) 
C. jejuni HPC5
C. jejuni HPC5CP8PL
C. jejuni HPC5CP30PL
Phage CP8PL
Phage CP30PL
A 
B 
                           Chapter 4 Formation and physiological studies of CSLC 
137 
 
4.2.6 Transduction of chloramphenicol resistance gene via phages and 
CSLC phages  
 
Transduction is the process by which DNA is transferred from one bacterium 
to another mediated by bacteriophages during the lytic cycle of growth (Miller, 
2001). The transfer of antibiotic resistance genes and pathogenic traits are 
undesirable in terms of phage therapy. The transfer of antibiotic resistance 
genes was used to assess if transduction could be occurring in Campylobacter 
via conventional phages or CSLC phages by using C. jejuni PT14 constructed 
with either yfp (encoding yellow fluorescent protein) or gfp (encoding green 
fluorescent protein) adjacent to a chloramphenicol resistance gene (camR). 
Bacteriophages CP8 and CP30 (approximately 109 PFU/ml) that were 
propagated on C. jejuni PT14YFP and PT14GFP, containing either yfp or gfp 
and the chloramphenicol resistance gene (camR), were mixed with wild type C. 
jejuni PT14 and NCTC 11168 at a multiplication of infection (MOI) 
approximately 1, for 1 h at 42 °C under microaerobic conditions (Section 2.6).  
No chloramphenicol resistant Campylobacter were recovered suggesting that if 
transduction had occurred then the  frequency was less than 10-9. The CSLC 
bacteriophages (CP8PL and CP30PL, approximately 1010 PFU/ml) obtained 
from C. jejuni PT14YFPCP8PL and PT14YFPCP30PL were mixed with wild 
type C. jejuni PT14 and NCTC 11168 at an MOI of 1, for 1 h at 42 °C under 
microaerobic conditions. No chloramphenicol resistant Campylobacter isolates 
were obtained after treatment with these CSLC phages.  This suggests that the 
transduction of the chloramphenicol resistance gene via phages or CSLC 
phages either did not occur or was at a frequency less than 10-10. 
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4.2.7 Comparison of the ability of conventional propagated 
bacteriophages and CSLC phages to plaque on different hosts  
 
A comparison of the host profiles of the parent phages and CSLC phages was 
carried out to determine if the CSLC phage were altered in their host range. In 
addition, the effect of the propagation host on the host ranges of the phages 
was compared to detect possible host modification effects. Routine phage titres 
(approximately 106 PFU/ml) were used to examine the ability of parent 
bacteriophages and CSLC phages to form plaques on the different C. jejuni 
strains, including the CSLC strains (Section 2.7.4; Table 4.3). All the parent 
phages and CSLC phages were able to efficiently lyse PT14 irrespective of 
host used to propagate them. A similar result was obtained for 11168 but with a 
reduction in plaque number for CP30PL phage propagated on PT14CP30PL 
host indicating a possible host restriction effect.   
 
Table 4.3- Ability of bacteriophages and CSLC phages to form plaques on 
different Campylobacter strains 
Phages Propagating strains 
Hosts 
PT14 11168 HPC5 
CP8 PT14 CL CL CL 
CP8PL PT14CP8PL CL +++ CL 
CP8 HPC5 CL CL CL 
CP8PL HPC58PL CL +++ CL 
CP30 PT14 CL ++++ CL 
CP30PL PT14CP30PL CL ++ ++++ 
CP30 HPC5 CL ++++ CL 
CP30PL HPC5CP30PL CL CL CL 
    CL, complete lysis; +, < 30 plaques; ++, mean number of plaques = 30-100; +++, mean 
number of plaques = 100-200; ++++, mean number of plaques = 200-500.     
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In contrast, the plaque forming ability of these phages and CSLC phages on 
11168 strains was markedly different, particularly for the CP8 phages, 
depending on whether they originated from lysis of a parental strain or were of 
CSLC origin. Notably CP8PL exhibited a reduction in the number of plaques 
irrespective of the propagation host. The CP30 parent phage propagated on 
PT14 could not affect complete lysis of C. jejuni 11168, whilst the CSLC 
phage, CP30PL, produced less plaque on the same host indicating a reduction 
in potency for the CSLC derived phage. However, the CSLC derived phages, 
CP30PL, propagated on the CSLC host, and HPC5CP30PL in contrast was 
more potent than the parental phage propagated on the parental strain.  These 
results suggest that the ability of CSLC phage CP8PL and CP30PL to form 
plaques are distinctly different from the parent bacteriophages released upon 
completion of the lytic cycle when applied to C. jejuni 11168. In general being 
derived from a CSLC host was associated with a reduction in plaque forming 
ability.         
 
4.2.8  Efficiency of plating of parent phages and CSLC phages 
In order to quantify the changes observed in 4.2.6 the efficiency of plating for 
parent and CSLC strains was determined. Efficiency of plating (EOP) is the 
ratio of the number of plaques formed by phage infected strains (HPC5 and 
11168) cells to the number of plaques assayed on strain C. jejuni PT14 (Table 
4.4) using the routine phage calculation (Section 2.7.5). The strain C. jejuni 
PT14 was used as reference due to its broad susceptibility to bacteriophage 
infection.  
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Table 4.4-Efficiency of plating (EOP) 
Phages Propagating strains EOP(HPC5/PT14) EOP(11168/PT14) 
CP8 PT14 0.761 (SD±0.190) 0.041 (SD±0.018) 
CP8PL PT14CP8PL 0.633 (SD±0.526) 0.022 (SD±0.002) 
CP8 HPC5 0.953 (SD±0.513) 0.934 (SD±0.130) 
CP8PL HPC5CP8PL 0.624 (SD±0.615) 0.113 (SD±0.107) 
CP30 PT14 0.724 (SD±0.050) 0.022 (SD±0.027) 
CP30PL PT14CP30PL 0.318 (SD±0.034) 0.006 (SD±0.008) 
CP30 HPC5 0.760 (SD±0.368) 0.480 (SD±0.355) 
CP30PL HPC5CP30PL 1.544 (SD±0.382) 0.155 (SD±0.017) 
Mean and SD of three independent experiments (n=3). 
In general the EOP of C. jejuni HPC5 over PT14 strains did not reveal any 
marked differences (P> 0.05, t-test) between the parental bacteriophage and 
CSLC phages. The exception to this was CP30PL, which conversely plaqued 
more efficiently on HPC5 than PT14 (1.544).  Comparison of the EOP ratios 
between C. jejuni 11168 and PT14 hosts showed that for the EOP of the 
parental phages, varied more than the HPC5/PT14 comparison, with the most 
efficient phage being CP8, propagated on HPC5 (0.934), whilst the least 
efficient was an order of magnitude lower for CP30 propagated on PT14 
(0.022).   The CSLC phages however, revealed reductions in EOP (0.006-
0.022) compared to the parental phages, the exception being CP30PL phage, 
which propagated on the HPC5CP30PL host (0.155 compared to 0.480 for 
&3SDUHQWDOSKDJHRQWKH+3&KRVW7KHODFNRI³UHGXFHGHIILFLHQF\´IRU 
this CSLC phage compared to the parental phage had already been observed in 
Table 4.3.  
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4.2.9 Binding assay of bacteriophages and CSLC phages on different 
hosts under microaerobic conditions 
 
The ability of phages (CP8, CP30, approximately 105 PFU/ml) and CSLC 
phages (CP8PL and CP30PL, approximately 105 PFU/ml ) to bind to different 
C. jejuni strains (11168, PT14 and HPC5) at 42 °C under microaerobic 
conditions were examined by determination of the percentage of  bacteriophage 
binding (Section 2.7.6; Figure 4.13 and 4.14). Whilst binding was determined 
after 30, 60 and 90 min, there was actually little change after the first 30 min 
for the majority of phage host combinations indicating that most binding 
occurred during this time.   Bacteriophage CP8 and CP8PL propagated on 
PT14 and PT14CP8PL hosts respectively, bound equally well to HPC5 and 
PT14, while these phages bound significantly less well to the 11168 host (P< 
0.05, paired t-test) (Figure 4.13A).  Similarly, the binding ability of CP30 and 
CP30PL replicated on PT14 and PT14CP30PL hosts was not significantly 
different on HPC5 and PT14 (P> 0.05, paired t-test). However, whilst CP30 
was found to bind approximately 20 % of the 11168 cells at each sample point, 
CP30PL was only found to bind to approximately 5% of the C. jejuni 11168 
cells at 30 and 60 min rising to approximately 15% at 90 min (not significantly 
different to CP30), indicating a retardation of binding for this phage host 
combination (Figure 4.13B).  Importantly, the CSLC phages obtained from 
CSLC of C. jejuni HPC5 were able to bind more effectively (30-35%) to PT14 
and HPC5 strains than the parent phages (20%, Figure 4.14A-B). These results 
indicate that the binding ability of CSLC phage CP8PL and CP30PL on distinct 
hosts were significantly different from phage CP8 and CP30 (P< 0.05, 
ANOVA). With the exception of the comparison of CP30 and CP30PL 
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propagated from PT14 which was not significantly different, the binding of 
CSLC phage and parental phage to different hosts show significant differences 
(P< 0.05, ANOVA). A pair wise comparison of CSLC phage and parent phage 
are shown in Figures 4.13 and 4.14 over the time course.  
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Figure 4.13-Binding ability of CP8, CP8PL (A); CP30 and CP30PL (B) on C. 
jejuni PT14, 11168 and HPC5. These phages were propagated on PT14 and 
CSLC isolates. The letters on each bar demonstrate the grouping for the mean 
YDOXHVGHULYHGIURP7XNH\¶VFRQILGHQFHLQWHUYDOVDQGWKHGLIIHUHQWOHWWHU
indicate significant differences (P< 0.05). The * indicate significant differences 
P < 0.05, between pairs of CSLC phage and parent phage using ANOVA. 
These data are the means and SD of triplicate determinations of phage binding 
based on three independent post-binding phage titre determinations, and are a 
single representative of two biological replicates. 
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Figure 4.14- Binding ability of CP8, CP8PL (A); CP30 and CP30PL (B) on C. 
jejuni PT14, 11168 and HPC5. These phages were propagated on HPC5 and 
CSLC isolates. The letters on each bar demonstrate the grouping for the mean 
YDOXHVGHULYHGIURP7XNH\¶VFRQILGHQFHLQWHUYDOVDQGWKHGLIIHUHQWOHWWHU
indicate significant differences (P< 0.05). The * indicate significant differences 
P < 0.05, between pairs of CSLC phage and parent phage using ANOVA. 
These data are the means and SD of triplicate determinations of phage binding 
based on three independent post-binding phage titre determinations, and are a 
single representative of two biological replicates. 
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Table 4.5- Comparison of binding ability of CSLC phage and parent phage on 
different hosts using t-test: unpaired two samples for means. 
Comparison Propagating strains Probability  
CP8 and CP8PL PT14 0.002* 
CP30 and CP30PL PT14 0.1 
CP8 and CP8PL HPC5 <0.001* 
CP30 and CP30PL HPC5 <0.001* 
*Significant difference at P< 0.05 
 
Table 4.6-Summary of phenotypic differences of bacteria and phages from 
CSLC cultures 
CSLC isolates CSLC phages 
  Non-motile  Host Changes 
 Normal growth under microaerobic 
and low oxygen conditions 
  EOP differences 
 Greater decay in rich medium with 
atmospheric oxygen 
 Binding differences 
 Increased survival under nutrition 
limitation at ambient atmosphere 
  
 Normal survival  at 4 °C under 
nutrition limitation and ambient 
atmosphere conditions 
  
 Increased thermo-tolerance (50 °C) 
under nutrition limitation and 
ambient atmosphere conditions 
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4.3 Discussion 
Alternative phage life cycles such as CSLC and pseudolysogeny are a 
phenomenon that impact on the viability of bacteria and their viruses in the 
environment (Ripp and Miller, 1997). This chapter describes the occurrence of 
CSLC in Campylobacter biofilms after phage treatment. Experiments were 
carried out to investigate the characteristics of CSLC bacteria. These included 
an analysis of the genomic DNA by PFGE that showed that the genomic phage 
DNA was established in the bacterial cells. The presence of the phage genome 
(approximately 140 kb) was confirmed by hybridization with phage DNA. This 
evidence indicated that the interaction of bacteriophage and biofilm caused 
some bacteria to be in a carrier state life cycle. An explanation for this may be 
that the full replication cycle of bacteriophage may be suppressed during phage 
treatment on biofilms due to starvation within the biofilm comparable to the 
observations on pseudolysogeny (Ripp and Miller, 1998; Hunt et al., 2004). 
This situation means that the CSLC strains may then infect and release phage 
particles when bacterial cells are subsequently able to grow under suitable 
conditions such as nutrient addition (Ripp and Miller, 1997 and 1998). The 
frequency of occurrence of CSLC in both CP8 and CP30 phage-treated C. 
jejuni PT14 biofilm was approximately 10%. However, 40% and 90% of the 
isolates recovered from C. jejuni HPC5 biofilms treated respectively with CP8 
and CP30 were CSLC isolates. The tendency to form CSLC strains varies 
according to the host bacteria and probably the nutrient associated stress 
environment responsible for their formation. Additionally, CSLC isolates was 
found in planktonic cells in approximately 10% of the PT14 isolates. None of 
the C. jejuni 11168 recovered from phage-treated biofilms proved to be CSLC 
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strains, most probably because almost all of these isolates were resistant to 
both the bacteriophages examined. In contrast, none of the bacterial isolates 
from PT14 treated biofilms were resistant to the phages that they had been 
treated with, and very few isolates recovered from the C. jejuni HPC5 biofilms 
were resistant, again indicating differing host encoded factors, and potentially 
that selection for resistance was not compatible with survival of these two 
strains in biofilms. C. jejuni 11168 in contrast was able to become resistant and 
successfully be retained in biofilm. The mechanisms of phage resistance such 
as restriction-modification systems, the CRISPR-Cas system and phage 
immunity proteins may differ between strains and may prevent the CSLC in C. 
jejuni 11168 derived strains (Labrie et al., 2010). The interaction of 
environmental factors, such as nutrient limitation, and inherent host encoded 
factors are likely to govern the propensity of cultures to form CSLC strains. 
These combinations may elicit variable selective pressures that either drive 
phage lifecycle arrest and possible gene expression or lead to phage resistance 
or simply arrest cell division. 
Transmission electron microscopy allowed visualization of CSLC isolates and 
revealed Campylobacter cells associated with bacteriophage together with 
some infected bacterial cells.    CSLC bacteria were non-motile evidently due 
to loss of their flagella (Figure 4.5), while the wild type controls remained 
motile and retained their flagella. The CSLC clearly impacts on the motility of 
C. jejuni. Cell motility is critically important in colonization of hosts such as 
poultry by C. jejuni (Karlyshev et al., 2002; Jones et al., 2004), and therefore 
its loss must be considered disadvantageous for colonization but advantageous 
to avoid phage infection and lysis.     
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An analysis of growth characteristics showed that the growth of CSLC isolates 
was generally similar to the growth of the parental strains under microaerobic 
conditions with indistinguishable generation times and growth rate constants. 
Phage titres were observed to increase markedly when the viable counts of 
Campylobacter cells reached 107 CFU/ml for the PT14 strain and 
approximately 106 CFU/ml for the HPC5 strain. This observation is consistent 
with the proliferation threshold required to support productive phage 
replication in the lytic lifecycle, i.e. the cell concentration required to increase 
in phage titres (Cairns et al., 2009).   Phage particles were released 
spontaneously from CSLC bacteria without induction, when they were grown 
on normal growth media. These phages could therefore potentially infect the 
progeny cells, resulting in an increase in numbers of phages once the 
permissive host population had achieved the proliferation threshold. A typical 
latent period and burst size were observed, indicating that a process similar to 
the one-step growth of normal phage infection of the host could be achieved 
once nutrient limitation had been lifted (Cairns et al., 2009).  
The growth of C. jejuni and their pseudolysogens under low oxygen (<1%) 
conditions were observed. Generally, C. jejuni has been considered to be an 
obligate aerobe as a microaerophile that is unable to grow in the complete 
absence of oxygen but requiring oxygen at approximately 5% for respiration 
(Weingarten et al., 2008). Nevertheless, C. jejuni was able to grow under 
oxygen environment of less than 1% possibly due to the availability of an 
alternative respiration pathway that can contribute to energy conservation 
(Sellars et al., 2002). However, the generation times under these conditions 
were longer than those observed in a microaerobic environment and featured 
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an extended lag phase. Interestingly, the latent period of CSLC phage under 
low oxygen conditions was also extended compared with that of the 
microaerobic environment.  This may be because the energy for phage 
propagation was not adequate at lag phase and growth was therefore delayed 
until bacterial cells had started the exponential growth phase before an increase 
in phage propagation was possible.   
 No growth of any C. jejuni strain or their CSLC derivatives was observed 
under aerobic conditions. The absence of growth did not enable phage 
propagation under these conditions. The CSLC bacteria remain obligate 
microaerophiles like their parental strains. However, the persistence of the 
CSLC bacteria and the parental strains in atmospheric oxygen was 4-5 h before 
their viability was decreased. The phage numbers were not increased due to the 
fact there was no growth of Campylobacter under these conditions. However, 
phage numbers remained constant under atmospheric oxygen conditions.  
The survival of C. jejuni parental strains and their CSLC derivatives were 
examined under atmospheric, low oxygen and microaerobic conditions 
combined with nutrition limitation. All of the isolates and parental bacteria 
could persist under nutrient limitation throughout the experiments carried out 
under low oxygen and microaerobic conditions. Interestingly, the numbers of 
survivors of the CSLC isolates under aerobic conditions were significantly 
higher than parental strains at 2 h post incubation (P<0.05). The results also 
showed that the survival times for the CSLC strains under nutrition limitation 
conditions were shorter (2 h) than those incubated in Mueller-Hinton broth (4 
h) under atmospheric conditions.  The survival of C. jejuni in the environment 
depends on many factors such as temperature, nutrient availability, oxygen 
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stress, biofilms formation and biotic interactions (Jackson et al., 2009; Sanders 
et al., 2008; Davis and Conner, 2007; Snelling et al., 2005; Buswell et al., 
1998). It is therefore notable that nutrient and CSLC phage affected the 
survival of C. jejuni in an atmospheric environment. Importantly, in terms of 
food safety, CSLC may help C. jejuni to survive for longer periods in 
environments where non-CSLC would be impaired.  
The survival of CSLC derivatives under nutrient limitation and ambient 
atmosphere at 50 °C and 4 °C was investigated. The CSLC were able to 
survive heat shock (50 °C) better than their parent bacteria under nutrient 
limitation and atmospheric conditions. The CSLC derivative strains exhibited 
enhanced thermotolerance and therefore should be examined for the induction 
of their heat shock response (Holmes et al.%ǙNet al., 2011). However, 
the survival of the CSLC strain at 4 °C was not significantly different to that of 
the parent strains over a 9 days incubation period. Similarly, previous studies 
have demonstrated the survival of C. jejuni at refrigeration temperatures (4 °C) 
with 77% viability after a week on cooked chicken meat (Bhaduri and Cottrell, 
2004; Eideh and Al-Qadiri, 2011).  Haddad et al. (2009) reported that the 
survival of C. jejuni in nutrient-rich media at 4 °C ambient atmosphere was 
70% after an incubation period of 7 days. It is noted that the CSLC variants 
reported here were able to survive prolonged exposure to low temperature just 
as well as the parental strains.  
The transduction of the chloramphenicol resistance gene from campylobacters 
carrying the resistance determinant alongside either green or yellow fluorescent 
cell markers was examined. CSLC phages recovered from either the lysis of 
genetically marked bacteria or those recovered from CSLC host bacteria were 
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unable to mediate the transduction of chloramphenicol resistance.  It is 
therefore clear that the CSLC phages and free bacteriophages do not mediate 
generalized transduction and are therefore unlikely to be able to disseminate 
pathogenic traits via this process (Konkel et al., 2001; Kelly et al., 2009).    
The ability of CSLC phages to form plaques on different hosts was notably 
different from the parental phages particularly using C. jejuni 11168 as the 
host. Similarly, the ability of CSLC phage to bind to distinctive hosts was 
significantly different to phage propagated by lysis of the parental bacteria.  
However, comparison of the host binding ability of CSLC phage and 
conventionally propagated phage on C. jejuni 11168 was not significantly 
different. In contrast, the plaque forming ability and EOP of CSLC phage and 
their parent phage on 11168 were very different, in particular CSLC phage 
derived from the C. jejuni PT14 strain.  The production of variant progeny 
phage particles could arise by the interactions between the host and the phage 
that can manifest through modification of the phage particles themselves and/or 
changes in genetic or physiological processes within the host cells (Maio and 
Zahler, 1958). The type strain C. jejuni 11168 has been reported to be able to 
adapt to stressful environments through changes in the expression of cell 
surface antigens either via transcription or unusually as a consequence of 
sequence slippage placing key components in and out of reading frame 
(Parkhill et al., 2000; Gaynor et al., 2004; Dorrell et al., 2001; Wilson et al., 
2010). These variations in surface structure can include capsular 
polysaccharide and flagella, which are candidate structures for the efficient 
recognition and binding of host cells by Campylobacter bacteriophage (Linton 
et al., 2001; Taboada et al., 2004; Hiett et al., 2008). According to Coward et 
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al. (2006), surface structures such as capsular polysaccharide and flagella  are 
required for bacteriophage infection of C. jejuni based on the interaction of 
typing phage with mutated host derivatives. In addition, mutation of genes 
involved in variation of the sugar moiety on capsular polysaccharide showed a 
reduction in plaque formation by Campylobacter bacteriophage (Sørensen et 
al., 2011).  It is notable that bacteriophage infection of CSLC hosts might 
result in phage modification and phage diversity leading to the loss of plaque 
forming ability and ability to adsorb to the host.  This is particularly notable for 
C. jejuni 11168 strains but not using C. jejuni PT14 or HPC5 hosts as 
propagation strains. The diversity among distinctive strains may therefore 
affect the ability of phage infection and host induced modification of the 
bacteriophage because of the variation in surface structure and metabolic 
profiles of each Campylobacter strain (Fouts et al., 2005; Duong and Konkel, 
2009).  The insertion or deletion of restriction/modification systems of 
distinctive species has been observed in comparative genomic hybridization 
surveys, implying that the different hosts have the capacity to encode the 
apparatus to support distinguishable mechanisms for the prevention of 
bacteriophage replication (Furuta et al., 2010).    
 
4.4 Conclusion 
The formation of CSLC in C. jejuni biofilms is likely dependent on several 
factors but these include nutrient limitation and the physiological state of the 
host bacteria.  The CSLC isolates had similar viability under microaerobic and 
low oxygen conditions to their parental strains. However, higher numbers of 
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phage particles were propagated under microaerobic conditions than under low 
oxygen conditions. Of significant note the CSLC strains could survive under 
nutrient limited conditions in an ambient atmosphere longer than their parent 
bacteria, conditions which are likely to occur frequently in the environment. 
The CSLC cultures needed to produce growth to enable phage propagation, 
likely due to the metabolic needs required to support the process. Additionally, 
the CSLC cultures exhibited greater thermotolerance than their parental 
counterparts under atmospheric oxygen but exhibited similar survival rates 
under conditions of atmospheric oxygen, low temperature and nutrient 
limitation. The CSLC phages were found to be different from the parental 
phages in their plaque forming ability, host binding ability and efficiency of 
plating on 11168 strains but not on the propagating strains. The transduction of 
chloramphenicol resistance did not occur by conventionally propagated 
bacteriophage or CSLC phages.  Host encoded factors such as phage resistance 
mechanisms and changes of surface structures warrant further study to 
demonstrate their influence on the characteristics of the CSLC phages and 
formation of CSLC within biofilms.  
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CHAPTER 5 
TRANSCRIPTOMIC STUDY OF THE     
CARRIER STATE LIFE CYCLE OF 
CAMPYLOBACTER JEJUNI 
5.1 Introduction 
DNA microarray technologies have been used to monitor the gene expressions 
during the infection cycle bacteriophage. The transcriptional profiles of 
bacteriophage genes during infection of their respective hosts were able to 
classify the majority of genes into early, delayed early, middle and late, based 
on their expression profiles (Poranen et al., 2006; Su et al., 2010). For instance, 
Frye et al. (2005) reported using a DNA microarray to measure temporal 
changes in phage and host genomic DNA expression during lytic growth of 
temperate bacteriophages of Salmonella enterica serovar Typhimurium LT2.  
Duplessis et al. (2005) studied temporal gene expression of the two groups of 
phages infecting the Gram-positive lactic acid bacterium Streptococcus 
thermophilus.  
 
Chapter 4 described the formation of the carrier state life cycle (CSLC) of 
Campylobacter jejuni isolated post phage treatment of Campylobacter 
biofilms. The growth of the CSLC strains was similar to their parent bacteria 
under microaerobic and oxygen-limited conditions. However, the CSLC strains 
were better able to survive under nutrient limited conditions in atmospheric 
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oxygen compared to their parent strains. Additionally, phages recovered from 
these cultures showed host range changes associated with host dependent 
differences in EOP and binding. The CSLC cultures may therefore have a 
critical influence on the ecology of Campylobacter and the bacteriophages that 
infect it. Phenotypic modification of the host bacteria in CSLC cultures would 
not only confer an increased capacity for the host to survive atmospheric 
oxygen but also play an important role in the protection and evolution of 
bacteriophages in these environments. 
Transcriptomic studies of the CSLC strains may provide a useful insight into 
phage-host interactions of the CSCL strains. Transcriptional changes 
associated with the phage-host interaction during the growth of the CSLC 
strains have not been previously studied in any species. This study therefore 
aims to determine the transcript profiles of the C. jejuni CSLC strains growing 
at 42 °C under microaerobic conditions.  
 
5.2 Results 
Data collected on the differential transcription of the CSLC strains were 
compared to the parent bacteria during early exponential phase of growth under 
microaerobic conditions at 42 °C. The cultures were harvested at a time to 
maximise growth yield for RNA extraction but before reaching the phage 
proliferation threshold of log10 7 CFU/ml, and therefore before the increase in 
the phage titres that are likely to be the result of orthodox infection and lysis 
(Figure 5.1) (Section 2.9). Transcript levels were determined using microarray 
hybridizations under conditions where equal quantities of cDNA were labelled 
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with the same dye and competed against a common labelled cDNA control 
(Section 2.10). Genes exhibiting significant differential expression between the 
parent and CSLC strains (P<0.05 by ANOVA and using the Benjamini 
Hochberg False Discovery Rate correction) were classified into functional 
groupings according to the Sanger Institute database 
(www.sanger.ac.uk/resources/downloads/bacteria/campylobacter-jejuni.html) 
compiled with respect to the re-annotation of the C. jejuni 11168 genome 
(Gundogdu et al., 2007).  The oligonucleotide microarray contains the gene 
repertoires (locus tags) from C. jejuni 11168 (Gundogdu et al., 2007; Parkhill 
et al., 2000), C. jejuni RM1221 (Fouts et al., 2005), C. coli RM2228 (Fouts et 
al., 2005), and all new non-redundant locus tags associated with C. jejuni and 
C. coli genomes available in the GenBank database at the time of construction 
(May 2009). In addition, oligonucleotides representing all the Campylobacter 
bacteriophage genes for representative class II (CP220 Accession No: 
FN667788.1; Timms et al., 2010) and class III (CPX Accession No: 
JN132397.1; Al-kandari et al., unpublished) bacteriophage. 
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Figure 5.1- The growth curve of the CSLC strains and parent bacteria at 42o C 
under microaerobic conditions. This graph shows the time point of RNA 
extraction and represents where the transcriptome of the CSLC strain was 
compared to the parent strains before an increase in phage titre.  
 
5.2.1 Transcriptome analysis of CSLC strains of C. jejuni HPC5 
Transcriptomic analysis of the CSLC strain HPC5CP8PL compared to the 
parent strain showed 2-fold or greater changes in the levels of transcription for 
22 host genes with 7 genes showing up-regulation (Table 5.1) and 15 genes 
down-regulation (Table 5.2). Four bacteriophage genes also showed a 
significant increase in expression over background, which are also recorded in 
Table 5.1. The CSLC strain HPC5CP30PL showed a 2-fold change in host 
gene expression in a total of 24 genes that included 8 genes showing up-
regulation (Table 5.3) and 16 genes showing down-regulation (Table 5.4). 
HPC5CP30PL also showed a significant increase over the background signal of 
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the bacteriophage gene CPT_0011 (P=0.0003), a situation that it shares with 
HPC5CP8PL (Table 5.3). 
Table 5.1± Gene expression at least 2-fold up-regulation of the CSLC of C. 
jejuni (HPC5CP8PL) at exponential phase of growth under microaerobic 
conditions at 42 °C. * The phage genes are measured over background. 
locus_tag 
gene 
name function fold change 
Phage-encoded genes   
CPT_0011  RNaseH 3.4* 
 
 
CPT_0084  
Hypothetical (radical SAM 
domain protein) 3.3* 
CPT_0111  
Hypothetical (possible 
membrane lipoprotein) 3.0* 
CPT_0148  
UvsW RNA-DNA and DNA-
DNA helicase, ATPase 9.2* 
 
  
 
Biosynthesis of cofactors, prosthetic groups and carriers 
 
Cj1347c cdsA phosphatidate  
cytidylyltransferase 
2.0 
 
Cj1044c thiH thiH protein 2.1 
Synthesis and modification of macromolecules 
 
Cj0847 psd Putative phosphatidylserine 
carboxylase 
9.4 
 
Cj0342c uvrA excinuclease ABC subunit A 2.5 
 
Cj0322 perR peroxide stress regulator 4.8 
Conserved hypothetical proteins 
 
CCOA0173  conserved hypothetical protein 3.3 
Unknown 
 
CCOA0077  hypothetical protein 2.8 
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Table 5.2 ± Gene expression at least 2-fold down-regulation of the CSLC of C. 
jejuni (HPC5CP8PL) at exponential phase of growth under microaerobic 
conditions at 42 °C 
locus_tag 
gene  
name function fold change 
 
Amino acid biosynthesis 
 
 
Cj1716c leuD putative 3-isopropylmalate  
dehydratase 
5.3 
Synthesis and modification of macromolecules 
 
 
Cj0018c  small hydrophobic protein 3.3 
 
Cj1035c  possible transferase 4.4 
 
Cj0493 fusA elongation factor G 2.7 
Cell envelope 
 
 
Cj0830  putative integral membrane 
protein 
3.6 
 
Cj0906c  putative periplasmic protein 2.4 
 
Cj1414c kpsC possible polysaccharide  
modification protein 
2.3 
 
 
Chaperones, chaperonins, heat shock 
 
 
Cj1034c  possible dnaJ-like protein 3.5 
 
Cj0518 htpG hsp90 family heat shock protein 2.9 
 
Conserved hypothetical proteins 
 
 
Cj0073c  hypothetical protein 2.2 
 
CCOA0164  conserved hypothetical protein 3.0 
 
Unknown 
 
 
Cj0249  hypothetical protein 3.8 
 
CJE0202  hypothetical protein 4.4 
 
Misc 
 
 
CCO_CctmRNA1 
  6.5 
 
CJE_tRNA-Trp-1  
 2.4 
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Table 5.3- Gene expression at least 2-fold up-regulation of the CSLC of C. 
jejuni (HPC5CP30PL) at exponential phase of growth under microaerobic 
conditions at 42 °C. * The phage genes are measured over background. 
 
    
 
locus tag gene 
nam
e 
function fold 
change 
 
Phage 
 
CPT_0011  RNaseH 2.5* 
 
Biosynthesis of cofactors, prosthetic groups and carriers 
 
Cj1347c cdsA phosphatidate cytidylyltransferase 3.2 
 
Cj1044c thiH thiH protein 2.0 
 
Synthesis and modification of macromolecules 
 
Cj0847 psd phosphatidylserine decarboxylase 4.1 
 
Cj0342c uvrA excinuclease ABC, A subunit 2.0 
 
Protein and peptide secretion 
 
Cj1092c secF protein-export membrane protein SecF 2.7 
 
Cj0322 perR transcriptional regulator, Fur family 3.5 
 
Conserved hypothetical proteins 
 
CCOA0173  conserved hypothetical protein 3.3 
 
Unknown 
 
CCOA0077  hypothetical 9.0 
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Table 5.4- Gene expression at least 2-fold down-regulation of the CSLC of C. 
jejuni (HPC5CP30PL) at exponential phase of growth under microaerobic 
conditions at 42 °C.  
 
    
 
locus tag gene 
name 
function fold 
change 
Amino acid biosynthesis 
 
Cj1716c leuD 3-isopropylmalate dehydratase, 
small subunit 
3.8 
Synthesis and modification of macromolecules 
 
Cj0018c  small hydrophobic protein Cj0018c -
related 
2.1 
 
Cj1035c  probable transferase Cj1035c 4.0 
 
Cj0493 fusA translation elongation factor G 2.0 
Degradation of macromolecules 
 
Cj0980  probable peptidase Cj0980 2.2 
Cell envelope 
 
Cj0830  probable integral membrane protein 
Cj0830 
3.0 
 
Cj0906c  conserved hypothetical secreted 
protein 
2.0 
 
Cj1414c kps
C 
capsule polysaccharide biosynthesis 
protein 
2.2 
 
Cj0060c fliM flagellar motor switch protein FliM 2.4 
Chaperones, chaperonins, heat shock 
 
Cj1034c  DnaJ domain protein 3.7 
 
Cj0518 htpG hsp90 family heat shock protein 
Cj0518 
2.4 
Conserved hypothetical proteins 
 
Cj0073c  conserved hypothetical protein 2.5 
 
Cj0249  conserved hypothetical protein 3.7 
Unknown 
 
CJE0202  hypothetical 3.8 
 
CCOA0164  hypothetical 3.3 
Misc 
 
CCO_CctmRNA1 
  6.2 
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5.2.2 Transcriptome analysis of CSCL strains of C. jejuni PT14 
Gene transcription of the CSLC C. jejuni PT14CP8PL showed a large number 
of transcriptional differences in genes representing all functional categories 
with 21 genes exhibiting more than 2-fold significant (P < 0.05) differences in 
transcript levels between the CSLC strains and parent strains. Of these, 13 
genes exhibited a two-fold or more increase in the host CSLC strains compared 
to the parent bacteria (Table 5.5) with 8 showing the opposite trend (Table 5.6). 
Two bacteriophage genes exhibited a significant increase in expression against 
the background hybridization levels and these are recorded in Table 5.5. The 
microarray data indicate the transcript levels of CSLC C. jejuni PT14CP30PL 
show at least a 2-fold change in 65 host genes  with 26 host genes showing a 
relative increase in transcription (Table 5.7) and 37 genes a decrease in 
expression in the CSLC strains (Table 5.8). The phage gene CPT_0172 in 
common with PT14CP8PL shows a significant increase in expression against 
the background hybridization (P=0.0005). 
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Table 5.5- Gene expression at least 2-fold up-regulation of the CSLC of C. 
jejuni (PT14CP8PL) at exponential phase of growth under microaerobic 
conditions at 42 °C. * The phage genes are measured over background. 
locus_tag gene name function Fold change 
 
   
Phage 
 CPT_0144                 hypothetical 13.8* 
 CPT_0172                 hypothetical 7.7* 
 
Central intermediary metabolism 
 Cj1366c glmS Glucosamine-fructose-6-
phosphate 
2.2 
 
Purines, pyrimidines, nucleosides and nucleotides 
 Cj0233c pyrE putative orotate 
phosphoribosyltransferase 
5.1 
 
Synthesis and modification of macromolecules 
 Cj0207 infC translation initiation factor IF-
3 
73.3 
 Cj1673c recA recA protein 3.8 
 
Cell envelope 
 Cj0818 ----- putative lipoprotein 93.8 
 CCO1443 flaB flagellin Cj1338c 4.4 
 
Conserved hypothetical proteins 
 CCO0807 ----- conserved hypothetical protein 16.1 
 
Unknown 
 Cj1232 ----- hypothetical protein 119.5 
 Cj1242 ----- hypothetical protein 7.5 
 Cj0550 ----- hypothetical protein 6.4 
 Cj0794 ----- hypothetical protein 10.3 
 Cj1216c ----- hypothetical protein 4.7 
 CCOA0165              ----- hypothetical protein 32.2 
 CJE1462 ----- hypothetical protein 118.8 
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Table 5.6- Gene expression at least 2-fold down-regulation of the CSLC of C. 
jejuni (PT14CP8PL) at exponential phase of growth under microaerobic 
conditions at 42 °C. 
locus_tag gene name function Fold change 
 
Biosynthesis of cofactors, prosthetic groups and carriers 
 
Cj0443 accA acetyl-coenzyme A 
carboxylase 
2.9 
Cell envelope 
 
Cj1424c gmhA2 phosphoheptose 
isomerase 
3.5 
 
CCO1330  probable periplasmic protein 
Cj1240c 
6.2 
 
Conserved hypothetical proteins 
 
Cj0761  hypothetical protein 3.3 
 
CCOA0201 conserved hypothetical protein 5.8 
 
Unknown 
 
Cj1309c  hypothetical protein 3.4 
 
Cj0873c  hypothetical protein 2.1 
 
Cj0738  hypothetical protein 13.9 
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Table 5.7- Gene expression at least 2-fold up-regulation of the CSLC of C. 
jejuni (PT14CP30PL) at exponential phase of growth under microaerobic 
conditions at 42 °C. * The phage genes are measured over background. 
locus_tag gene name function Fold change 
 
Phage 
 
CPT_0172  Hypothetical 62.5* 
 
Prophage 
   
 
CJE1458  major capsid protein, HK97 
family 
2.2 
Degradation 
 
Cj1624c sdaA L-serine dehydratase 4.6 
 
Energy 
metabolism 
   
 
Cj0465c  truncated haemoglobin 4.5 
 
Cj1586  putative bacterial haemoglobin 25.3 
 
Central intermediary metabolism 
 
Cj1366c glmS glucosamine--fructose-6-
phosphate  
11.5 
Biosynthesis of cofactors, prosthetic groups and carriers 
 
Cj1183c cfa putative cyclopropane-fatty-
acyl-phospholipid 
3.7 
Synthesis and modification of macromolecules 
 
Cj0207 infC translation initiation factor IF-3 409.2 
 
Cj1673c recA recA protein 3.6 
 
    
 
    
Cell envelope 
 
Cj0672  putative periplasmic protein 2.2 
 
Cj1456c  putative periplasmic protein 2.1 
 
Cj0818  putative lipoprotein 450.0 
 
Cj0672  putative periplasmic protein 2.7 
 
Cj0320 fliH putative flagellar assembly 
protein 
3.2 
Transport/binding proteins 
 
Cj0238  putative integral membrane 
protein 
2.2 
Protein and peptide secretion 
 
Cj1470c  pseudogene 3.4 
Conserved hypothetical proteins 
 
Cj0761  hypothetical protein 3.5 
 
CCO0807  conserved hypothetical protein 174.0 
Unknown 
 
Cj1232  hypothetical protein 572.3 
 
Cj1242  hypothetical protein 40.7 
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Table 5.7 continued 
locus_tag gene name function Fold change 
 
    
 
Cj0550  hypothetical protein 37.0 
 
Cj1216c  hypothetical protein 14.6 
 
CCOA0032  hypothetical protein 8.2 
 
CCOA0165  hypothetical protein 249.7 
 
CJE0139  hypothetical protein 3.4 
 
CJE1462  hypothetical protein 831.9 
 
CJE_tRNA-Arg-3  tRNA-Arg 3.3 
 
CJE_tRNA-Asn-1  tRNA-Asn 3.9 
 
CJE_tRNA-Cys-1  tRNA-Cys 2.4 
 
 
Table 5.8- Gene expression at least 2-fold down-regulation of the CSLC of C. 
jejuni (PT14CP30PL) at exponential phase of growth under microaerobic 
conditions at 42 °C  
locus_tag gene name function Fold change 
Amino acid biosynthesis 
 
Cj0346 trpD anthranilate synthase component 
II 
2.4 
 
Cj0345 trpE putative anthranilate synthase 
component I 
2.2 
 
Cj0348 trpB tryptophan synthase beta chain 3.7 
 
Cj0347 trpF N-(5'-phosphoribosyl) 
anthranilate isomerase 
3.8 
 
Synthesis and modification of macromolecules 
 
Cj1705c rplW 50S ribosomal protein L23 3.9 
 
Cj1690c rpsE 30S ribosomal protein S5 2.2 
 
Cj1700c rplP 50S ribosomal protein L16 2.5 
 
Cj1697c rplN 50S ribosomal protein L14 2.4 
 
Cj1699c rpmC 50S ribosomal protein L29 3.2 
 
Cj1702c rplV 50S ribosomal protein L22 2.5 
 
Cj1701c rpsC 30S ribosomal protein S3 2.5 
 
Cj0473 nusG putative transcription  
antitermination protein 
2.2 
 
Cj0765c hisS histidyl-tRNA synthetase 2.0 
 
Cj1704c rplB 50S ribosomal protein L2 2.7 
 
Cj1706c rplD 50S ribosomal protein L4 3.0 
 
Cj1691c rplR 50S ribosomal protein L18 2.5 
 
Cj0476 rplJ 50S ribosomal protein L10 2.4 
 
Cell envelope 
 
Cj1316c  hypothetical protein 3.0 
 
Cj1424c gmhA2 putative phosphoheptose 
isomerase 
2.8 
 
Cj1339c flaA flagellin 5.1 
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Table 5.8 continued 
locus_tag gene name function Fold change 
 
Cj0549 fliS flagellar protein 3.0 
 
Cj0547 flaG possible flagellar protein 2.5 
 
Cj1316c  hypothetical protein 2.7 
 
Cj1338c flaB flagellin 4.6 
 
Cj1211  putative integral membrane 
protein 
2.3 
 
Cj0548 fliD putative flagellar hook-
associated protein 
2.6 
 
Cj1127c wlaE putative glycosyltransferase 2.0 
 
CCO1443 flaB flagellin Cj1338c 5.0 
 
CCO1444 flaA flagellin Cj1339c 4.9 
 
Transport/binding proteins 
 
Cj0679  truncated KdpD protein 2.2 
 
Conserved hypothetical proteins 
 
Cj1465  hypothetical protein 2.4 
 
Cj1463  hypothetical protein 2.1 
 
Unknown 
 
Cj0873c  hypothetical protein 7.7 
 
Cj1656c  hypothetical protein  4.3 
 
Cj0738  hypothetical protein 9.3 
 
Misc 
 
CCO_tRNA-Gly-2 
 tRNA-Gly 2.3 
 
CJE_tRNA-Gly-1 
 tRNA-Gly 2.5 
 
CJE_tRNA-Trp-1 
 tRNA-Trp 2.5 
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5.3 Discussion 
Transcriptome analyses of the CSLC strains obtained after phage treatment of 
Campylobacter jejuni biofilms were performed. The transcript analysis 
identified differential host gene expression between parent and CSLC 
derivative strains. Phage gene expression was examined over background 
because the parent cultures did not have phage present. Using this criterion at 
the specific point in the growth period before the rise in phage titre resulted in 
a limited set of phage genes that were observed to produce significant 
expression.  It is possible that early stage CSLC cultures may not contain phage 
DNA inside the host cells and that the gene expression recorded represents the 
start of phage replication or non-synchronous replication before achieving the 
bacterial density of susceptible cells required for mass infection.  However, the 
expression of phage genes is evident from C. jejuni HPC5CP8PL, with the 
genes CPT_0011, CPT_0084, CPT_0111 and CPT_0148 all show significant 
levels over background. The hypothetical functions of CPT_0084 and 
CPT_0111 are not specifically phage related, encoding respectively a putative 
radical S-adenosyl-l-methionine (SAM) domain protein (paralogous genes for 
which are prevalent in Campylobacter bacteriophage), and a membrane 
lipoprotein. It is notable that the database contains an analogue of CPT_0084 
located in the chromosome of C. fetus subspecies fetus and annotated as a 
haem biosynthesis protein (Timms et al., 2010), an observation that is 
consistent with the contention that these genes are not strictly required for 
bacteriophage replication.  In contrast the putative function ascribed for 
CPT_0148 is that of the phage DNA repair helicase UvsW. The product of 
uvsW gene in T4 phage acts in DNA replication to reactivate stalled DNA 
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replication forks leading to the formation of double-stranded DNA ends 
(Nelson and Benkovic, 2010), which could relate to the stalled replication of 
the phage genomes in HPC5CP8PL CSLC cultures. Expression of phage gene 
CPT_011 that encodes ribonuclease H (RNase H) was up-regulated in both 
HPC5CP8PL and HPC5CP30PL. RNase H functions in the T4 multienzyme 
replication system to remove ribopentamer primers from nascent DNA chains 
during synthesis by specific hydrolysis of the phophodiester bond of RNA-
DNA and DNA-DNA dulplexes. Evidence suggests RNaseH has an important 
role in T4 phage replication since a T4 null mutation of this gene reduced the 
burst size two fold (Hollingsworth and Nossal, 1991; Hobbs and Nossal, 1996; 
Bebenek et al., 1999). This gene may contribute to the control of phage 
replication in the CSLC isolates. The CSLC of C. jejuni PT14CP8PL and 
PT14CP30PL exhibited an increase in phage gene expression of CPT_0172 
that shows a significant BLAST match with a hypothetical protein of C. jejuni 
RM1221. The hypothetical gene CPT_0144 also showed expression in 
PT14CP8PL (Timms et al., 2010).      
 
Chapter 4 demonstrated that CSLC cultures were able to grow at similar 
growth rates to their parent bacteria under microaerobic conditions but notably 
showed discontinuities in their growth that were contemporary with the 
observed increases in phage titres. Under the experimental conditions adopted 
(microaerobic) for the transcriptional studies, perhaps the most notable 
phenotypic change common to all CSLC cultures was their loss in motility. 
TEMs presented in chapter 4 indicate the flagella are not just paralysed but 
absent. Consistent with this observation is the 5-fold down regulation of the 
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flagellin genes flaA and flaB together with genes encoding several flagellar 
structural proteins (flaG, fliD and fliS) in PT14CP30PL. Although it should be 
noted the putative flagellar assembly protein fliH is 3-fold up-regulated. In 
PT14CP8PL the alternative minor flagellin component encoded by flaB is also 
up-regulated. These differences could reflect the active growth and cell 
division if the culture in early exponential phase with the daughter cells of the 
CSLC strains reverting to phage sensitivity, which could account for the sharp 
rise in the phage titre, observed in the PT14 derived CSLC cultures. Deficiency 
in flagellar synthesis can lead to phage resistance (Coward et al., 2006; Scott et 
al., 2007b), and reinstating flagellar synthesis could be one of the triggers to 
enable orthodox bacteriophage infection of daughter cells. 
 
The CSLC cultures derived from C. jejuni HPC5 (HPC5CP8PL and 
HPC5CP30PL) show up-regulation of cdsA and psd. CdsA encodes 
phosphatidate cytidylyltransferase that catalyses the synthesis of CDP-
diacylglycerol from cytidine triphophate and phosphatidate, which act as an 
intermediate in the biosynthesis of lipids and complex carbohydrates. In E. coli 
and Bacillus subtilis these are essential for phospholipid biosynthesis, and 
likely many other organisms (Weber et al., 1999; Sparrow and Raetz, 1985). 
Significantly, phosphatidylserine decarboxylase encoded by psd catalyses the 
synthesis of phosphatidylethanolamine (PE), which plays an important role in 
the motility and chemotaxis functions of E. coli. Mutant strains of E. coli 
deficient in psd are reported to be non-motile and to lack flagella, and thereby 
link the functional expression of the flagellar apparatus with the availability of 
PE (Shi et al., 1993).   
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The peroxide stress regulator of C. jejuni encoded by perR plays a vital role in 
maintenance the redox balance within cell, and specifically at reduced oxygen 
tensions where 104 genes have been reported to show associated regulatory 
changes (Palyada, et al., 2009). Campylobacters lack the global oxyR regulator 
present in many other Gram-negative bacteria, and therefore rely upon the 
metalloregulator perR. Notably mutation in perR also results in significantly 
reduced motility (Palyada et al., 2009). The perR gene is up-regulated in the 
CSLC strains HPC5CP8PL and HPC5CP30PL, however, reasons behind this 
are unclear because PerR is not only a repressor of the genes involved in 
oxidative stress but is also autoregulatory (Kim et al., 2011). Increased 
production of PerR could result in the tight regulation of the oxidative stress 
response genes but the increased transcription could also be indicative of the 
absence of PerR leading to derepression of the perR gene.  PerR uses iron as a 
co-repressor, which could also have role in the induction of perR if iron was 
limited. The genes encoding catalase (katA) and superoxide dismutase (sodB) 
also show modest up-regulation but not sufficiently so to conform to the 
selection criteria imposed on the data. Consistent with this observation it has 
been noted that under circumstances of iron depletion the classic oxidative 
stress genes are already transcribed and therefore do not often show additional 
transcriptional changes in microarray data (Palyada et al., 2009). This 
interpretation would favour the hypothesis that PerR is indeed absent or not 
fulfilling its role as a repressor of oxidative stress related genes.   Presumably, 
the greater aerotolerance and non-motility of the CSLC isolates may be related 
with the function of PerR and associated regulatory network.  
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Independent of perR regulation but also indicative of an oxidative stress 
response is the up-regulation of uvrA in the CSLC strains HPC5CP8PL and 
HPC5CP30PL.  The role of UvrA as subunit A of excinuclease ABC is to 
control excision repair of DNA in E. coli, suggesting a response to DNA 
damage may occur in the CSLC HPC5 isolates (Orren and Sancar, 1989). The 
genes Cj1586 and Cj0465c encode bacterial haemoglobin (cgb) and a truncated 
form (ctb) in Campylobacter, which are reported to be co-regulated by NssR in 
response to nitrosative stress, and that are up-regulated at higher oxygen levels 
(Monk et al., 2008; Smith et al., 2011). The CSLC strain PT14CP30PL shows 
25-fold and 4.5-fold up-regulation of the cgb (P=0.00002) and ctb (P=0.02) 
genes respectively that likely contribute to the oxygen tolerance observed.  
 
The ThiH protein encoded by thiH is a member of the radical S-
adenosylmethionine protein superfamily involved in biosynthesis of thiamine 
pyrophosphate, which is an essential cofactor for all organisms (Martinez-
Gomez et al., 2004). The thiH gene was up-regulated in the CSLC strains 
HPC5CP8PL and HPC5CP30PL in contrast to the lysogenic lifestyle of Shiga 
toxin-converting bacteriophage of E. coli for example, which down-regulate 
the thiH gene (Su et al., 2010).  It is also noteworthy that Campylobacter 
bacteriophage genomes contain multiple copies of S-adenosylmethionine 
domain encoding proteins but their significance remains obscure at this time 
(Timms et al., 2010).  
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Genes showing differential reductions in their transcript levels of the CSLC-
HPC5 isolates included: leuD, cj0018c, cj1035c, cj0493, cj0830, cj0906c, 
cj1414c, cj1034c, cj0518, cj0073c, CCOA0164, and CCO-CctmRNA1. The 
leuD gene putatively encodes 3-isopropylmalate dehydratase, a gene in the 
leuABCD operon involved in leucine synthesis (Vartak et al., 1991).  The DnaJ 
protein is a requirement for motility in E. coli as result of the fact that cells 
deleted for dnaJ affect a reduction in the transcription of flhD and fli4 leading 
to non-motility and no flagella (Shi et al., 1992). Remarkably, the suppressed 
dnaJ-like protein encoded by cj1034c may reflect the lack of motility evident in 
the CSLC cultures. HtpG (cj0518), a member of the heat shock protein 90 
family, is a molecular chaperone for folding and regulation, suggesting that 
repression of htpG may have an effect on the house-keeping functions (Picard, 
2002). FusA (cj0493), elongation factor G (EF-G), has a function involved in 
the regulation of mRNA translocation through the ribosome following peptide 
bond formation (Hou et al., 1994). Suppression of fusA may effect protein 
synthesis, suggesting that protein synthesis may be interrupted by phage in 
preparation for making its own proteins.  The repression of kpsC (cj1414c), 
involved in capsular polysaccharide biosyntheis is of interest as capsular 
polysaccharide has been implicated as a phage receptor or co-receptor (Coward 
et al., 2006; Sørensen et al., 2011).  A change in capsular polysaccharide in the 
CSLC isolates could alter the cellular surface of the CLSC cultures leading to 
resistance to bacteriophage infection or the retention of bacteriophage particles 
without infection. The genes gmhA2 and wlaC were down-regulated in, and 
encode components responsible for the synthesis of the cell surface 
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carbohydrates lipooligosaccharide and capsular polysaccharide (Karlyshev et 
al., 2005). 
 
 The differential transcription of host genes recorded for the CSLC strains 
PT14CP8PL and PT14CP30PL showed some marked changes compared to the 
CSLC cultures derived from HPC5 despite growth under similar conditions. 
An increase in the expression of glmS (glucosamine-frutose-6-phophate 
aminotransferase) that has an essential function involved in the production of 
UDP-N-acetylglucosamine was observed in both CSLC cultures of PT14. Up-
regulation of this essential component for cell metabolism could be indicative 
of robust growth of the CSLC cultures.  Similarly, an increase in the 
transcription of sdaA (L-serine dehydratase) involved in gluconeogenesis by 
deamination L-serine to gain pyruvate is a vital component of the metabolism 
of Campylobacter to yield the energy for growth. These findings suggest that 
the CSLC strains may be able to exploit the prevalent cell metabolism to 
maintain the growth of cells and energy for phage production. Translation 
initiation factor IF3 encoded by infC is one of three factors for initiation of 
protein synthesis in bacteria by interaction with 30S ribosomal subunit (Petrelli 
et al., 2001), importantly showing that bacteriophage may take in advance to 
initiate the phage protein synthesis. Transcription studies of the development of 
bacteriophage infection demonstrate that phage require host promoters at early 
stages of infection, thus an increase in the transcription of IF3 may be related 
with the early host-gene subversion by the phage associated with CSLC 
isolates in preparation for the efficient translation of phage transcripts 
(Berdygulova et al., 2011). However, the host 50S and 30S ribosomal proteins 
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were repressed in the PT14CP30PL. The recA gene of PT14CP30PL shows a 
3.6-fold increase over the parent strain. A similar increase in the expression of 
the RecA protein has been reported when bacteriophage infect Salmomella 
enterica, a finding that has been related to the degradation of bacterial 
chromosome and/or the production of a significant amount of ssDNA within 
the cell (Campoy et al., 2006). Finally the tryptophan operon (TrpB, TrpD, 
TrpE and TrpF) in was down-regulated in its entirety in PT14CP30PL.  
 
5.4 Conclusion 
A differential transcription analysis of the CSLC strains growing under 
microaerobic conditions at exponential phase of growth was conducted by 
comparison with parent bacteria. These studies demonstrate that a number of 
genes show 2-fold or greater up-regulation and down-regulation in the CSLC 
cultures. Interestingly, there were significant changes in host gene expression 
between distinctive strains, whereas there were fewer differences between 
CSLC strains arising from the association of different bacteriophage. The 
different physiology of the CSLC strains may lead to alterations of 
transcription in the CSLC cultures and subsequently modification of phage 
progeny. In this study, the transcription of the CSLC isolates showed a few 
phage gene expressions at early exponential growth before the number of 
Campylobacter achieved the proliferation threshold. It is notable that capsular 
polysaccharide, lipooligosaccharide, protein may be modified or adapted by the 
CSLC phage associated with the CSLC strains. Notably, the suppression of a 
set of flagellar associated genes including flagellin (flaA and flaB) with other 
                                         Chapter 5 Transcriptomic study of the CSLC 
176 
 
structural and regulatory components (flaG, fliD and fliS) correlated with 
flagellar modulation that may have an effect on the motility of the CSLC 
cultures leading to the flagella deficient phenotype and non-motility.  Many of 
the genes identified in this study have also been implicated in the ability of 
Campylobacter to colonise chickens. It would therefore be of interest to 
examine the colonisation competence of CSLC strains. However, validation of 
microarray results using quantitative real-time PCR (qRT-PCR) needs to be 
undertaken to confirm the transcriptional changes observed for the CSLC 
strains.  
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CHAPTER 6 
FINAL DISCUSSION AND FUTURE WORK 
6.1 Final discussion 
Campylobacter is an important pathogen causing gastroenteritis worldwide. 
Campylobacter jejuni is typically able to form biofilms on various surfaces 
under microaerobic and aerobic conditions. Biofilms are a common mechanism 
employed by bacteria to protect them from harsh environments. Generally, 
natural biofilms are comprised of single or multiple bacterial species embedded 
in a surface extracellular polymeric matrix. In the case of C. jejuni these 
structures are likely to play an important role in the spread and transmission of 
the bacterium into the food chain and thereby cause human disease. 
Importantly, bacteria within biofilms often exhibit an increase in resistance to 
antibiotics and other chemical antimicrobials. Thus, methods that avoid the use 
of antibiotics need to be developed to eradicate biofilms without giving rise to 
antimicrobial resistance. Bacteriophages are a natural predator of bacteria that 
are potential biological agents with the prospect to control and disperse 
bacteria in biofilms. The application of Campylobacter-specific bacteriophage 
in the form of phage therapy has been reported as an effective biological 
control of Campylobacter colonising the intestinal tracts of chickens (Loc 
Carillo et al., 2005). The findings presented in chapter 3 showed that 
reductions in the viability of C. jejuni were observed in biofilms after treatment 
with group III bacteriophage (CP8 and CP30). Additional evidence showed 
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that the quantity of extracellular polysaccharide was reduced after phage 
treatment compared to mock treatment following measurements of absorbance 
change of ethanol-solubilised biofilms stained with crystal violet. These data 
suggest that bacteriophage can disperse Campylobacter biofilms. The 
mechanisms by which bacteriophage can disperse surface biofilms have still to 
be studied in Campylobacter but are associated with the action of 
polysaccharide depolymerases in bacteriophage infecting other species 
(Hughes et al., 1998a and b; Lu and Collins, 2007).  However, the genome 
sequences of Campylobacter bacteriophage did not identify any candidate gene 
encoding a polysaccharide depolymerase (Timms et al., 2010; Hammerl et al., 
2011; Kropinski et al., 2011). However more recently a putative 
polysaccharide depolymerase was identified in the genome sequence of the 
group II phage VB_CcoM-IBB_35 that infects Campylobacter coli (Carvalho 
et al., 2012). Polysaccharide depolymerase enzymes encoded within 
bacteriophage would have to be translated during infection and therefore assist 
in the release of bacteriophage upon lysis. Alternatively bacteriophage also 
feature enzymes fused in frame with their structural proteins. For example, the 
tailspike protein of bacteriophage P22 infecting Salmonella contains a 
rhamnogalacturonase (Steinbacher et al., 1996), and the tailspike proteins of 
the Vi-like phage feature beta-parallel coil structures that resemble the pectin 
lyase protein family (Hooton et al., 2011).  The primary action of a 
bacteriophage polysaccharide depolymerase would be to degrade extracellular 
polysaccharide that constitutes a major component of biofilms. Subsequently, 
the post action of bacteriophage would occur after phage infection of the 
bacteria where upon the lysis process may destroy the structure of biofilms due 
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to the production of lysins or lysozyme that degrade bacterial cell membranes 
and subsequently release the cell contents, which will either degrade biofilm 
components and/or kill bacteria within biofilms leading to the loss of biofilm 
structure and bacterial viability. However, these mechanisms require further 
study to understand the processes involved in phage-biofilm interactions.   
 
Phage resistance is a potential limitation to phage applications. However, the 
resistance is often reversible to bacteriophage sensitivity because the resistant 
types are at a selective disadvantage. The bacteriophage resistant types 
recovered from the phage treatment of Campylobacter biofilms largely 
depended on the physiological characteristics of the initial Campylobacter 
strains under treatment.  The type strain C. jejuni NCTC 11168 exhibited a 
higher frequency of phage resistance than either C. jejuni PT14 or HPC5. 
Mechanisms of bacterial defence to infection by bacteriophage may involve 
modification of cell surface components that have been demonstrated to have 
phase variable expression in C. jejuni, which could accordingly mediate against 
the adsorption of bacteriophage (Coward et al., 2006). In addition, 
restriction/modification mechanisms and the CRISPR/Cas system of each 
strain may affect variation in the acquisition of phage resistance (Abedon, 
2011).  
 
Interestingly, the formation of carrier state life cycle (CSLC) of C. jejuni 
occurred during phage treatment of biofilms (described in Chapter 4). The 
CSLC cultures are mixtures of bacteriophage and bacteria that contain 
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uninfected bacteria, uninfected but phage associated bacteria, infected bacteria 
and free phage (Abedon, 2009). The evidence presented in chapter 4 indicated 
that phage DNA did not integrate into bacterial chromosomal DNA based on 
southern hybridisation of total extracted DNAs separated by PFGE using phage 
DNA as a control to identify the bacteriophage DNA associated with the CSLC 
cultures. It is clear that phage DNA present in CSLC cultures is similar to the 
phage used to treat the biofilms and is not prophage DNA excised from the 
genome. Bacteriophages are preserved and maintained within biofilms, and 
thereby possibly promote the occurrence of the carrier state life cycle alongside 
the normal lytic cycle. CSLC formation may involve many factors such as 
nutrition limitation and the physiological state of growth.     
 
The physiological characteristics of the CSLC isolates were generally similar 
to their parent bacteria. Interestingly, the growth of CSLC strains under 
microaerobic and oxygen limited conditions (<1% O2) were accompanied by 
an increase in the phage titres.  Importantly, the increase in number of phage 
was related to the phage proliferation threshold, which relates to the minimal 
density of bacteria required to give rise to an increase in the number of phage 
particles (Cairns et al., 2009). This would suggest in this phase of growth that 
phage infection of sensitive bacteria is occurring as it might in any orthodox 
culture. As observed for C. jejuni generally the CSLC isolates did not grow 
under atmospheric conditions leading to a constant phage titre throughout the 
incubation time. The growth of CSLC cultures therefore plays an important 
role in phage production and propagation, without which the bacteria would 
lack an adequate energy supply for phage production. Transcriptome analysis 
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of the CSLC cultures at early exponential phase of growth (described in 
chapter 5) showed a differential increase in host gene expression involved in 
the energy metabolism, in particular energy metabolism related to amino acid 
utilisation. C. jejuni is a non-saccharolytic species and typically utilises the 
amino acid L-serine and TCA cycle intermediates for energy requirements by 
using oxygen as a terminal electron acceptor.  In this context transcription 
analysis of the CSLC growth under microaerobic conditions in this study 
showed up-regulation of sdaA, glmS which would benefit the cell to gain 
energy for cell growth and phage production.  
 
Notably, the survival of the CSLC isolates under nutrient limitation in 
atmospheric conditions was longer than the parent bacteria.  Several genes 
involved in oxidative defence mechanisms of Campylobacter were up-
regulated in CSLC strains. For example, the up-regulation of perR in CSLC 
cultures is consistent with changes in oxygen tolerance as it is responsible for 
maintaining redox potential within the cell (Palyada et al., 2009). In addition, 
the oxygen binding bacterial globin genes ctb and cgb were up-regulated 
(Monk et al., 2008; Smith et al., 2011). These genes could play an important 
role in oxygen tolerance of CSLC strains. The priming of CSLC cultures ready 
for oxidative stress may also extend to DNA damage since uvrA is notably up-
regulated in these cultures. Transcriptome analysis of the CSLC cultures 
should therefore be additionally performed under either low oxygen or 
atmospheric conditions with controlled nutrition to understand how they 
respond to oxygen and how this may be related to the interaction of phage and 
host.  
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Interestingly, the CSLC strains were non-motile and no flagella were observed 
by TEM, while the parent bacteria have normal flagella and are motile. Flagella 
have been implicated as structures necessary for phage replication and required 
for chicken colonisation and virulence (Coward et al., 2006; Scott et al., 
2007b; Wessenaar et al., 1993). Transcription analysis of CSLC cultures 
demonstrated changes in flagellin expression and flagella biosynthesis. 
 
Factors affecting the formation of CSLC may involve nutrition limitation of the 
bacterial host, a condition that occurs within mature biofilms. CSLC phages 
were released when the CSLC cultures were grown under suitable conditions. 
Physiological characteristics of CSLC phages derived from CSLC cultures 
were distinguishable from the parental phage. Different plaque forming and 
binding abilities of bacteriophages were observed on distinct hosts that may be 
dependent on genotypic modification of the host strains producing them. The 
data confirmed that CSLC phages recovered from the CSLC cultures were 
genetically related to the initial phage used to treat the biofilms and are not 
prophage or a result of contamination with another bacteriophage. However, 
changes in host modification of CSLC phages could affect a change in 
physiology of these phages.    
 
 In conclusion, in this thesis it has been demonstrated that bacteriophage are a 
potential biological agent for use in the biocontrol of biofilms. Bacterial 
viability and biofilm matrix content were reduced after treatment with 
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bacteriophage. Perhaps surprisingly the bacteriophage treatment of biofilms 
gave rise to the formation of CSLC cultures. This study is the first to show 
phage-host interactions leading to the formation CSLC within phage treated 
biofilms.  The physiological characteristics of CSLC cultures were typically 
similar to their parent bacteria cultures in terms of growth rate under 
microaerobic and low oxygen conditions. Interestingly, however, differences in 
the physiologies observed between CSLC cultures and parent bacteria included 
non-motility, greater aerotolerance and thermotolerance when subject to 
nutrient limitation under atmospheric conditions. Indeed, transcriptome 
analysis of CSLC cultures under microaerobic conditions provided further 
support for changes in gene expression related to these phenotypes. CSLC 
cultures in early exponential phase of microaerobic growth featured up-
regulated genes involved in respiration, oxidative stress response, and were 
down-regulated in specific flagellar biosynthesis functions. CSLC phages 
could be modified by CSLC cultures, reflecting distinguishable plaque forming 
and binding abilities on distinctive host strains as well as the efficiency of 
plating.  
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6.2 Future work 
Further work after this thesis study should be carried out to gain a greater 
understanding of phage and biofilm interactions and in particular the 
circumstances under which the phage may be applied. These conditions could 
include the examination of non-static biofilms and a range of surfaces as 
substrates for biofilm formation. Bacteriophage treatment of biofilms could be 
used to further investigate the kinetics of phage infection and how this may 
effect populations of biofilm bound bacteria and planktonic cells. The 
influence of the host genotype and phenotype should be investigated with 
respect to the above processes and the development of phage resistance. The 
action of bacteriophage to disperse biofilms could also be investigated, and in 
particular the potential for the bacteriophage to either produce or elicit from the 
host biofilm matrix depolymerising enzymes.   The transcriptome of CSLC 
cultures under atmospheric conditions in the absence of nutrients to support the 
growth of Campylobacter should be performed to yield a greater understanding 
of why the CSLC cultures exhibit increased aerotolerance and thermotolerance 
over their parental bacteria. Additionally, the transcriptional profiles and 
proteome analysis during the growth of CSLC cultures and development of 
CSLC phages could provide an understanding of the status of the phages 
associated with CSLC strains.  
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Appendix 1 
The DNA sequenced of PT14CP30PL DNA identical to CP30 (Contig 8) 
tcaatgcggtttgataaaaagcgaatatctttacctatatttaataattc 
 
acacaatttattataattataattttgtaaaagtattctaccagctaatt 
 
ctatattaccatcatacatacaaaacgagtatttcacattattattactt 
 
tccaatatacctataaaacatctatttgtcatcttaatcctctgtgtagt 
 
taataaaacttagttttattaactacaaaatatcatcataaattgagtaa 
 
cctacctatatttacatcattttgttattcccaaaatatttcacacaaat 
 
aattcattttagtttccttctttattaaatacagctaatgaaacattatc 
 
tgggcaacctttttgtagtttttcctttaaaaaaattataattgagtata 
 
aattaataacattttcaaaataatcatcattatatgaatatcttccattt 
 
gcaccataatacacaaccttatatccaatgctatagacatctccgatata 
 
atgaagaagataacaccaagaaactgttccataagttttgtcttcattaa 
 
gagtttctatttctttagaaatttttaatacttcctcaacttctttaata 
 
ttctttttagttgttatttcaggaaattttagttcaatacattttaacat 
 
taaatcatatatttgtagttttttgttatcatcgcttttttgtagttcca 
 
ta 
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Appendix 2  
 
The distinct DNA sequence of bacteriophage CP8 and CP30  
 
AAATTCCTTTAATATATTGTTTGTTTTTTGAATACCCTCATTTACAATAG CP8 
AAATTCCTTTAATATATT~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ CP30 
ATTCAACATATTCTCTTTCTTTTCTTATTTCTTCTAATTTTTCATCAGTA CP8   
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~              CP30  
TATTCTTTTTCTTTTTCTTTTAAAACTTTTTCA     CP8 
~~~~~~~~~~~~CTTTTTCTTTTAAAACTTTTTCA     CP30 
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Appendix 3 
Validation of 10 µl spot lawn technique compared to addition of 
100 µl to soft top agar technique 
A) 100 µl of 10-5 dilution of CP30 phage added to whole plate 1 
Replicate Count Times dilution log10 Ave SD 
1 364 364000000 8.56 8.57 0.04 
2 429 429000000 8.63 
  3 352 352000000 8.55 
  4 380 380000000 8.58 
  5 408 408000000 8.61 
  6 321 321000000 8.51 
  7 354 354000000 8.55 
  8 360 360000000 8.56 
  9 358 358000000 8.55 
  10 363 363000000 8.56 
  
 
1Aliquots of 100 µl of the 10-5 dilution of CP30 phage were added to each of 
10 eppendorf tubes containing  0.5 ml of 10 9  CFU/ ml C. jejuni HPC5. These 
were mixed and then added to each of 10 vials of 5 ml molten NZCYM top 
agar, mixed and dispensed onto each of 10 NZCYM plates and allowed to set. 
The plates were incubated for 24 h at 42o C under microaerobic conditions 
before all the plaques for each plate were counted. 
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B) Spot technique using 10 µl of 10-6 dilution of CP30 phage dispensed 
onto lawn2 
Rep. 
Count 
1 
Count 
2 
Count 
3 
Count 
4 
Count 
5 Sum 
Times 
dilution log 10 Ave SD 
1 4 7 3 5 5 24 4.8 x 108 8.68 8.69 0.04 
2 8 4 2 4 6 24 4.8 x 108 8.68 
 
 3 3 6 5 6 5 25 5.0 x 108 8.70 
 
 4 4 8 3 4 2 21 4.2 x 108 8.62 
 
 5 4 4 7 4 8 27 5.4 x 108 8.76 
 
 6 5 6 4 4 3 22 4.4 x 108 8.62 
 
 7 3 1 9 6 7 26 5.2 x 108 8.72 
 
 8 6 3 6 6 6 27 5.4 x108 8.78 
 
 9 4 4 5 4 5 22 4.4 x 108 8.64 
 
 10 4 7 5 5 5 26 5.2 x 108 8.76 
 
 
           
2Lawns (10 in total) were prepared using 0.5 ml of 10 9  CFU/ ml C. jejuni  
HPC5 which was added to 5 ml of molten NZCYM top agar, mixed and 
dispensed onto NZCYM plates.  The plates were allowed to set then dried for 
20 min at 42o C.  Each plate was inoculated with 5 droplets of 10 µl and left 
until the droplets were absorbed into the agar. The plates were incubated for 24 
h at 42o C under microaerobic conditions. Plaques were counted from each 
individual spot then combined. 
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C) ANOVA: Single Factor Analysis 
ANOVA: Single Factor 
      
         SUMMARY 
       Groups Count Sum Average Variance 
    Spotting 10 86.972 8.6972 0.0033 
    Top agar 10 85.656 8.5656 0.0012 
    
         
         ANOVA 
        Source of 
Variation SS df MS F P-value F crit 
  Between 
Groups 0.08662 1 0.08662 37.9150 8.18E-06 4.41387 
  Within 
Groups 0.04112 18 0.00228 
     
         Total 0.12775 19         
  
         
 
The bacteriophage CP30 was selected because it is not notably impaired in 
plaque formation when placed in top agar. This is not true of all 
Campylobacter bacteriophage, which can aggregate upon mixing with the 
high concentrations of host bacteria encountered in the top agar overlay 
method.   The methods have similar standard deviations suggesting they 
are of similar precision, and that the pipetting operations are reproducible 
and accurate. However, the means determined by the methods differ by 
log10 0.12  pfu/ml, and are significantly different due to their high 
precision.  Nano particle counts estimated from Nanoparticle Tracking 
Analysis (NanosightTM) of the clarified phage preparation suggests there 
are log10  8.9 particles of 200 nm radius. 
Reference: Anonymous in www.nanosight.com. 2009. Review: Applications of 
Nanoparticle Tracking Analysis (NTA) in Nanoparticle Research. 
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Appendix 4  
Removal attached cells of C. jejuni NCTC 11168 on the glass coverslip were 
re-determined the viable count to make sure removal all the attached bacterial 
cells on a glass slide. 
#1 to detach the attached bacterial cells using 20 times pipette up and down 
#2 to detach again with the same method after washed the glass coverslip with 
MRD 2 times 
 
Rep. Bacterial Count after 
detached # 1 
(log10CFU/cm2) 
Bacterial Count after 
detached # 2 
(log10CFU/cm2) 
 5.176  ND 
 5.204 ND 
 5.116 ND 
 5.322 ND 
 5.415 ND 
 5.462 ND 
 5.255 ND 
 5.845 ND 
 5.778 ND 
 5.342 ND 
ND: not detection at dilution 10 and 10-1 
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Appendix 5 
To pipette 10 µl of water  
Replicate Weight of  water (mg) Average SD 
1 0.0098 0.0099 0.000229 
2 0.0099   
3 0.0097   
4 0.0100   
5 0.0098   
6 0.0099   
7 0.0101   
8 0.0095   
9 0.0096   
10 0.0099   
11 0.0099   
12 0.0103   
13 0.0100   
14 0.0099   
15 0.0098   
16 0.0097   
17 0.0096   
18 0.0105   
19 0.0101   
20 0.0098   
21 0.0104   
22 0.0102   
23 0.0097   
24 0.0099   
25 0.0100   
26 0.0100   
27 0.0101   
28 0.0100   
29 0.0099   
30 0.0098   
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Appendix 6 
Reproducible of enumeration of viable biofilm cells of C. jejuni NCTC 11168 
under microaerobic condition at 37 °C for 5 days was analysed using ANOVA. 
Enumeration of viable count  
Experiment (Log10 CFU/cm2) 
1 2 3 4 
5.267 5.831 4.665 4.744 
5.267 5.831 4.693 4.603 
5.334 5.768 4.665 4.665 
5.489 5.719 4.811 4.635 
5.530 5.665 4.904 4.885 
5.489 5.635 4.951 4.603 
5.665 6.188 4.744 4.392 
5.530 6.091 4.744 4.603 
5.634 6.392 4.744 4.188 
 
 
Anova: Single 
Factor 
      
       SUMMARY 
      Groups Count Sum Average Variance 
  Experiment 1 9 49.209 5.468 0.022 
  Experiment 2 9 53.124 5.903 0.068 
  Experiment 3 9 42.925 4.769 0.010 
  Experiment 4 9 41.322 4.591 0.040 
  
       
       ANOVA 
      Source of 
Variation SS df MS F P-value F crit 
Between Groups 10.080 3 3.360 95.801 4.53E-16 2.901 
Within Groups 1.122 32 0.035 
   
       Total 11.203 35         
 
  
 
Conclusion ± low variance within batches but significant batch-to-batch 
differences <0.05. 
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Reproducible of enumeration of viable biofilm cells of C. jejuni HPC5 under 
microaerobic condition at 37 °C for 5 days was analysed using ANOVA. 
Enumeration of viable count 
 
Experiment (Log10 CFU/cm2) 
1 2 3 
4.694 5.079 5.443 
4.720 4.954 5.392 
4.832 5.060 5.392 
4.666 5.000 5.334 
4.444 4.845 5.392 
4.531 4.845 5.568 
4.699 5.204 5.267 
4.903 5.176 5.603 
4.845 5.114 5.489 
 
Anova: Single Factor 
     
       SUMMARY 
      Groups Count Sum Average Variance 
  Column 1 9 42.334 4.704 0.022 
  Column 2 9 45.277 5.031 0.017 
  Column 3 9 48.884 5.432 0.012 
  
       
       ANOVA 
      Source of 
Variation SS df MS F P-value F crit 
Between Groups 2.392 2 1.196 70.862 8.51E-11 3.403 
Within Groups 0.405 24 0.017 
   
       Total 2.796 26         
 
 
 
Conclusion ± low variance within batches but significant batch-to-batch 
differences <0.05. 
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Reproducible of enumeration of viable biofilm cells of C. jejuni PT14 under 
microaerobic condition at 37 °C for 5 days was analysed using ANOVA. 
 
Experiment (Log10 CFU/cm2) 
1 2 3 4 
6.268 6.694 6.335 6.954 
6.092 6.489 6.531 6.954 
6.335 6.694 6.603 6.845 
6.118 6.444 6.981 7.204 
6.092 6.444 6.967 7.000 
6.092 6.335 6.981 7.204 
 
Anova: Single 
Factor 
      
       SUMMARY 
      Groups Count Sum Average Variance 
  Column 1 6 36.997 6.166 0.012 
  Column 2 6 39.100 6.517 0.021 
  Column 3 6 40.398 6.733 0.079 
  Column 4 6 42.161 7.027 0.021 
  
       
       ANOVA 
      Source of 
Variation SS df MS F P-value F crit 
Between Groups 2.367 3 0.789 23.70 8.61E-07 3.098 
Within Groups 0.666 20 0.033 
   
       Total 3.033 23         
 
 
Conclusion ± low variance within batches but significant batch-to-batch 
differences <0.05. 
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Appendix 7 
Reproducibility of  crystal violet staining measurement of 3 independent C. 
jejuni HPC5 biofilms formed on 6 replicate coverslips under microaerobic 
conditions at 37 ºC for 5 days analysed using ANOVA. 
Crystal violet staining A570 nm 
1 2 3 
0.097 0.110 0.113 
0.109 0.073 0.104 
0.113 0.076 0.080 
0.070 0.093 0.100 
0.084 0.062 0.137 
0.090 0.105 0.075 
 
Anova: Single Factor 
     
       SUMMARY 
      Groups Count Sum Average Variance 
  Column 1 6 0.563 0.093833 0.000257 
  Column 2 6 0.519 0.0865 0.000366 
  Column 3 6 0.609 0.1015 0.000513 
  
       
       ANOVA 
      Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.000675 2 0.000338 0.891 0.43082 3.682 
Within Groups 0.005682 15 0.000379 
   
       Total 0.006357 17         
 
Conclusion ± not low variance within batches and no significant batch-to-batch 
differences 
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Reproducibility of crystal violet staining measurement of 3 independent C. 
jejuni NCTC 11168 biofilms formed on 6 replicate coverslips under 
microaerobic conditions at 37 ºC for 5 days analysed using ANOVA. 
 
Crystal violet staining A570 nm 
1 2 3 
0.513 0.642 0.739 
0.508 0.618 0.672 
0.670 0.836 0.636 
0.737 0.914 0.536 
0.656 0.884 0.655 
0.686 0.720 0.659 
 
Anova: Single Factor 
     
       SUMMARY 
      Groups Count Sum Average Variance 
  Column 1 6 3.770 0.628 0.009 
  Column 2 6 4.614 0.769 0.016 
  Column 3 6 3.897 0.650 0.004 
  
       
       ANOVA 
      Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.069 2 0.03451 3.51746 0.055892 3.68232 
Within Groups 0.147 15 0.00981 
   
       Total 0.216 17         
 
 
 
 
Conclusion ± low variance within batches but batch-to-batch variation evident 
but not significant >0.05. 
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Reproducibility of crystal violet staining measurement of 3 independent C. 
jejuni PT14 biofilms formed on 6 replicate coverslips under microaerobic 
conditions at 37 ºC for 5 days analysed using ANOVA. 
 
Crystal violet staining A570 nm 
1 2 3 
1.227 1.438 1.878 
1.614 1.396 1.552 
1.569 1.374 1.544 
1.488 1.846 1.926 
1.340 1.662 1.204 
1.227 1.628 1.370 
 
Anova: Single Factor 
     
       SUMMARY 
      Groups Count Sum Average Variance 
  Column 1 6 8.465 1.411 0.029 
  Column 2 6 9.344 1.557 0.035 
  Column 3 6 9.474 1.579 0.079 
  
       
       ANOVA 
      Source of 
Variation SS df MS F P-value F crit 
Between 
Groups 0.100423 2 0.050212 1.054747 0.37274 3.682 
Within Groups 0.714082 15 0.047605 
   
       Total 0.814506 17         
 
 
Conclusion ± not low variance within batches and no significant batch-to-batch 
differences 
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Appendix 8 
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F
requ
en
cy
 of ph
ag
e
 resistance
 (sectio
n
 3.2.4)
 
                
A: C. jejuni NCTC11168, B: C. jejuni HPC5, C: C. jejuni PT14, D: Isolate no. 12 of C. jejuni HPC5 biofilm treated with 
CP30 that referred a sensitive isolate, E: Isolate no. 32 of C. jejuni HPC5 biofilm treated with CP30 referred a resistant 
isolate,  F:  Isolate no. 6 of C. jejuni HPC5 biofilm treated with CP30 that referred a carrier state life cycle isolate (note 
the background appearance of phage plaques).  Phage CP8 and CP30 are recovered from different replicating strains as 
indicated were applied at concentration 105-106 PFU/ml. 
A 
D 
B 
E 
C 
F 
